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Abstract 
Title: Use of Poly Vinyl Alcohol (PVA) Cryogelation for Tissue Engineering: 
Composites, Scaffold Formation and Cell Encapsulation 
PVA cryogelation is a physical hydrogel formation method, which yields cryogels 
with comparable mechanical properties to vascular tissue. However PVA cryogels 
are not suitable for cell attachment and proliferation alone. This can be overcome 
by the development of composite cryogels. Moreover, cryogelation provides a 
unique opportunity for encapsulation and storage of cells in one-step; if the correct 
composite structure and gelation conditions can be attained. In this study, 
PVA/Biomacromolecule composite cryogels were produced with a two step physical 
crosslinking (cryogelation and coagulation bath treatment) in the presence of 
different additives and a novel procedure to produce cell encapsulated PVA 
cryogels was developed for vascular tissue engineering. Also it was postulated that 
the disturbed shear stress could be used to facilitate endothelialisation of the PVA 
cryogel surface. 
The results demonstrated that, the two step gel formation method was beneficial 
for degradation resistance and mechanical properties. All composites used 
supported cell attachment and proliferation, however PVA/Gelatin composites 
were superior compared to the others. Endothelialisation of PVA/Gelatin cryogels 
was achieved both under static and shear stress conditions with low levels of 
apoptosis and steady secretion of Nitric Oxide. It was shown that application of 
disturbed shear stress dramatically facilitated endothelialisation of the cryogel 
surface. 
A general method of encapsulation via cryogelation was developed and robust cell-
laden cryogels which promoted cell proliferation were obtained. Storage in frozen 
conditions did not affect the viability of the encapsulated cells, which suggests the 
prospect of safe long-term storage. Smooth muscle cell-laden cryogels were also 
able to support co-culture with endothelial cells. The results suggest that the novel 
encapsulation system developed is suitable for vascular and possibly other tissue 
engineering applications. 
XXVII 
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CHAPTER 1 
1 Introduction 
Tissue engineering is a promising technology that may provide solutions to a wide 
range of pervasive medical conditions. The tissue engineering research field 
represents an interdisciplinary effort to design, develop and manufacture artificial 
tissues and, in the long run, organs by combining engineering methodologies with 
knowledge stemming from the biological sciences (Mikos et al. 2006). Development 
of such artificial tissues would be a giant step forward in implant and 
transplantation technologies which are currently hampered by the long-term 
unreliability of synthetic implants and by donor scarcity, respectively. These 
products also promise to be useful experimental tools for researchers in both cell 
biology and pharmaceutical development by providing tissue-like structures that 
would enable in vitro testing of scientific or clinical hypotheses, involving therapies 
or drugs, on controlled 3D biological environments.  
The need and urgency for development of tissue engineered products vary with 
respect to target organ or tissue. In some of the target tissues, such as cartilage and 
skin, tissue engineered products are mainly required for facilitation of the healing 
process and improving life quality. However, such as in the case of vascular tissue, 
tissue engineering products are desperately needed as a remedy for highly fatal 
conditions. It has been reported that each year cardiovascular diseases are 
responsible for 22% of premature deaths in Ireland (Irish Heart Foundation, 2009). 
Although the percentage of the cardiovascular disease related deaths has been 
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decreasing for the last 30 years, still 4 out of every 10 death are related to a 
cardiovascular condition. In a year, nearly 500,000 operations related to small 
diameter vessel replacement are conducted in the U.S.A. alone (Isenberg, Williams 
& Tranquillo 2006b). If tissue engineering can overcome the limitations of the 
current surgical procedures, cardiovascular disease related deaths can be further 
decreased. 
As a way to imitate natural tissues, one philosophy of tissue engineering involves 
the presence of a biodegradable scaffold onto which cells from appropriate sources 
are seeded. After a suitable incubation time, tissue-like structures are formed 
(Freed et al. 2006). The scaling-up of this procedure would involve mass production 
of scaffolds followed by storage, with cell seeding and culture conducted 
immediately prior to implantation. Another option would be to develop storage 
methods for pre-manufactured engineered tissue, although this has not proven to 
be very feasible in practice. In this context, a system, where scaffold production, 
seeding and storage can be synchronized, with the possibility of a single batch of 
product being able to produce scaffolds with tunable functional properties, would 
be desirable.  
Hydrogels have been among the most versatile tools in the arsenal of biomedical 
engineers (Brandl, Sommer & Goepferich 2007). They have been used as contact 
lenses, in drug delivery systems (Peppas et al. 2000), and for immunoisolation 
applications, and are now also the focus of much tissue engineering research 
(Hoffman 2002).  Successful application of hydrogels in tissue engineering is due in 
part to the possibility of encapsulating cells without adversely affecting their 
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viability to a significant degree. Most of the connective tissue in the body is 
composed of tissue-specific cells encapsulated within a specific extracellular matrix 
(ECM) composition of their own secretion which has a complex function-oriented 
structure (Goh et al. 2007). The robustness of this structure is one of the signals 
that keep the cells in a certain phenotype and a change in structure, such as injury, 
triggers a wide range of cellular responses. Since connective tissue applications are 
an important part of the wider tissue engineering efforts, special attention should 
be given to this property. Entrapment of cells in a swollen hydrogel structure is a 
good imitation of cell-matrix interaction under in-vivo conditions. Therefore, as long 
as cell viability, function and the mechanical properties of the final hydrogel can be 
ensured, this is prospectively a viable approach for the production of tissue 
engineering constructs for connective tissues. 
Tissue engineering investigators have long sought to incorporate the effects of 
physical strains and stresses on cell behaviour into their protocols (Barron et al. 
2003). These stimuli might be used either to imitate the physiological environment 
or to replicate injury situations. The in vitro conditions under which an engineered 
tissue is produced and the physiological environment with which it will interact 
after implantation are different. Although this fact generates some technical 
problems, it can also be utilized to produce scaffolds which are more adaptable. 
One of the advantages of in-vitro scaffold culture is the ability to impose a wide 
range of possible stimuli. These stimuli can be at physiological levels, or, 
alternatively, sub- or supra-physiological stimuli levels can be selected when cellular 
response to such extreme conditions might have short term benefits. 
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Tissue engineering scaffolds have to be biocompatible, non-cytotoxic, and 
preferably biodegradable and should have the necessary mechanical properties to 
withstand the physiological stress and strain conditions of its target tissue 
(Suuronen et al. 2005). For thick tissues (above 500 µm in thickness) it is important 
to populate the whole scaffold structure with the cells (Malda, Klein & Upton 2007). 
To achieve this, two approaches are possible; either seeding cells evenly on to a 
porous scaffold which would enable  cells to migrate and inhabit all available 
surfaces on and within the scaffold, or encapsulation of cells which are evenly 
distributed in a polymer solution which upon a certain treatment (such as 
photocrosslinking, physical crosslinking or non-cytotoxic chemical crosslinking) 
would turn into a hydrogel which contains cells within its 3 dimensional structure. 
The advantages of encapsulation include lesser dependence on cell migration and 
the immediate presentation of an extracellular matrix like environment to the cells 
from the start of the culture. In porous scaffolds, pores needs to be filled by the 
cells own secretion for the generation of a tissue like structure. 
1.1Objectives of the Research Project 
This study focuses on characterisation and utilization of PVA-based cryogels for 
vascular tissue engineering. The basis for this research is the proposition that 
combined hydrogels of PVA with appropriate macromolecules which would provide 
bio-functionality can act as scaffolds which exhibit surfaces conducive to 
endothelial cell attachment, display appropriate functional mechanical properties 
and degradation profiles for blood vessel applications, and successfully transmit 
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mechanical and biological cues which promote viability and functionality of 
encapsulated vascular smooth muscle cells. 
It is anticipated that the preparation of such hydrogels by cryogelation of cell laden 
poly vinyl alcohol solutions, which involves freezing them to the sub-zero 
temperatures also necessary for cell storage, would ultimately allow the final 
functional properties of any given scaffold to be fine-tuned by control of the 
thawing process immediately prior to use.  
Since a physical crosslinking method is proposed for a composite system, an 
additional physical crosslinking might be necessary to ensure the retention of the 
additives within the cryogels. For this end, coagulation bath treatment, another 
physical crosslinking method that works through precipitation of polymers via 
solvent/non-solvent interactions can be utilized. This method has not previously 
been considered as a reinforcement technique; thus it needs to be evaluated for 
this approach. 
 
To test this proposition, the following key steps were taken: 
1. The effect of the number of freeze-thaw cycles on specific PVA/Chitosan 
cryogel properties with respect to cellular behaviour was determined, to 
extend the previous body of work in this area (Mathews et al. 2008). In 
light of these results, the question of whether other biomacromolecular 
additives could also be used was answered via assessment of a set of 
three candidate natural macromolecular additives (Chitosan, Starch and 
Gelatin) for use in combined hydrogels with PVA. Moreover, coagulation 
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bath treatment as a reinforcement method was quantified, and its effect 
on composite cryogel properties such as mechanical, degradation, 
protein adsorption, and cell attachment was measured. On the basis of 
this experimental body of work, one PVA/biomacromolecule hydrogel 
composition was selected for further investigation. 
2. A detailed investigation of the health of the endothelial lining and its 
behaviour under static and turbulent shear stress conditions, typical of 
flow conditions at anastomosis areas, on the selected 
PVA/biomacromolecule composite was performed. The possible positive 
effects of disturbed shear stress induced by oscillatory flow were 
assessed. 
3. A novel cell encapsulation technique was developed, utilizing the 
cryogelation capability of PVA, to enable the storage and subsequent 
formation of cryogels with mechanical properties open to fine-tuning by 
adjusting the thawing rate and the gel components. The mechanical and 
biological performance of cell-laden hydrogel scaffolds was 
experimentally evaluated under cyclic strain conditions.  
4. Finally, co-culture of encapsulated smooth muscle cells and endothelial 
cells was performed and the optimal conditions for commencing 
endothelialisation of the cell laden cryogels were determined.  
The first step started with PVA/Chitosan cryogels and initially the effect of 
utilization of the coagulation bath on these properties was examined. Then the 
effect of increasing the number of freeze-thaw cycles on physical properties of the 
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cryogels was evaluated. The next step involved production of PVA-based cryogels 
using 3 different biomacromolecular additives (Chitosan, Starch and Gelatin), and 
then characterizing the mechanical properties, degradation, water content, surface 
hydrophilicity, protein adsorption capability and surface morphology (by phase 
contrast microscopy and scanning electron microscopy). These cryogels were then 
compared with respect to their ability to support endothelial cell culture on their 
surface and also their ability to encapsulate smooth muscle cells.  One of the 
candidates was selected due to its overwhelming superiority in several items listed 
above. 
The second step involved the formation of an endothelial lining on the selected 
hydrogel under both static and dynamic conditions. For this purpose, the 
characterisation focused on metabolic activity, proliferative capacity, apoptosis and 
expression of cell-cell contact proteins which are important either for activation or 
support of the endothelial lining (Resnick et al. 2003). The shear stresses created 
under oscillatory flow conditions are known to induce a higher endothelial cell 
proliferation rate (Chien 2008a); in the current study this effect was investigated as 
a possible route to facilitate endothelial lining formation.  The analyses used were 
(i) Alamar Blue proliferation assay, (ii) Flow assisted cell sorting (FACS) system for 
proliferation and apoptosis analysis, (ii) Real-time RT-PCR  for determination of the 
selected target protein expression, (iv) Griess method for determination of the 
Nitric Oxide release by the endothelial cells and Fluorescence microscopy and SEM. 
The use of cryogelation for smooth muscle cell encapsulation is new, and 
necessitates other additives to ensure long term cell viability. The encapsulation 
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system was optimized for a wide range of parameters such as thawing rate, PVA 
viscosity and concentration of serum and cryoprotectants by utilization of factorial 
and Box-Behnken experimental designs which make it possible to see the 
interactions between different parameters. These allow the development of 
response models. Also, the effect of cyclic strain and long-term storage on 
encapsulated cells were evaluated. Cell viability was assessed by Live/Dead cell 
viability assay and Alamar Blue. Cell morphology and hydrogel structure were 
observed with SEM, phase-contrast microscopy and histology. The mechanical 
properties of the gels in the presence and absence of the smooth muscle cells were 
determined by uniaxial tensile tests. Finally, to ensure that the cryogels with 
encapsulated cells would support endothelial lining formation, co-culture 
experiments are undertaken. 
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Figure 1.1 The scheme of experimental procedure followed in this study 
PVA based hydrogel preparation and 
characterization
Selection of the optimal composite based on 
physical properties and cell behaviour
Characterization of endothelial cell behaviour 
under static and dynamic conditions on the 
selected hydrogel
Development of an encapsulation and storage 
method for smooth muscle cells with the 
selected materials
Evaluation of effect of strain and 
Endothelial/Smooth Muscle Cell Co-culture
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CHAPTER 2 
2 Literature Review 
The following literature review deals with the reasons behind the necessity for and 
widespread use of vascular grafts, their shortcomings and the challenges these pose 
to scientists, engineers and clinicians. The structure of vascular tissue is briefly 
explained to understand the structures that need to be imitated with the artificial 
tissue constructs. Then, tissue engineering and specifically vascular tissue 
engineering is defined and the achievements and methods in the field are briefly 
discussed. After reviewing the available vascular tissue engineering scaffold 
structures, hydrogels are taken into focus and their physical properties, their 
capability to encapsulate cells and their feasibility as vascular tissue engineering 
scaffolds is introduced. Finally, mechanotransduction and its specific importance to 
vascular tissue (pulsatile blood flow induced shear stress and cyclic strain) and its 
possible uses for vascular tissue engineering are reviewed. This sets the background 
for why smooth muscle cell encapsulation and endothelialisation of the hydrogels 
are important, what kind of physical advantages are inherent to the hydrogels and 
how these can be exploited for vascular tissue engineering.    
2.1 Cardiovascular Diseases and Current Remedies 
Cardiovascular diseases are the leading cause of death in the world, especially in 
Western countries. Worldwide deaths related to cardiovascular diseases were 
estimated by World Health Organisation (WHO) as 17.5 million in 2005, which 
comprises nearly 30% of all recorded deaths (Figure 2.1). Specifically when Ireland 
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is considered, WHO statistics showed that 123,000 out of 312,000 deaths (nearly 
40%) in 2002 occurred from cardiovascular diseases. For 2007, the Irish Heart 
Foundation reported similar percentages (36%). Aside from fatal conditions, 
cardiovascular system related surgeries are one of the most frequent type 
conducted. Because of this, together with the frequency of secondary surgeries, 
vascular health has become one of the most investigated areas in medical and 
biomedical sciences (Birla et al. 2004). Occlusion of the vessel lumen due to the 
accumulation of fat deposits (atherosclerosis) or multi-vessel dysfunctions, such as 
intimal hyperplasia, render the vasculature dysfunctional. Surgical intervention then 
becomes essential, especially in conditions such as myocardial infarction or critical 
limb ischemia (Brewster et al. 2007).  
 
Figure 2.1. Cause of death statistics in 2005. 30% of all deaths worldwide 
were due to cardiovascular diseases. The graph was obtained from World 
Health Organization website. 
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The number of by-pass surgeries is already in the several millions around the world 
and the need is constantly increasing. For a significant group of patients, no 
autologous arteries or veins are available (Campbell, Campbell 2007). This 
incredible level of demand hinders, in some cases, the capabilities of surgeons in 
procedures such as coronary artery by-pass, since the availability of donor tissues is 
scarce (Figure 2.2). Normally, autografts are used as the golden therapy method, 
and with considerable success. There are some available donor sites in the human 
body (mainly saphenous vein, radial and internal mammary arteries), but in elderly 
patients these vessels might be unsuitable due to trauma, previous surgeries or 
vascular diseases such as varicose. Moreover, even after successful surgery, a graft 
may not function properly, due to compliancy problems, in which the mismatch in 
the extensibility of the natural vasculature and the synthetic graft material causes 
severe flow disturbance which in turn can lead to significant cellular response 
(Sarkar et al. 2007), such as intimal hyperplasia formation or thrombosis. In fact, 
vein grafts have only 50% patency within 10 years of implantation (Kannan et al. 
2005). Allografts (vessels retrieved from other humans for implantation) and 
xenografts (vessel obtained from other species such as pig) face similar problems, 
and complications related to them are compounded by the risk of disease 
transmission and chronic inflammatory response, which might necessitate further 
surgeries. An attractive option is the development of artificial vascular grafts that 
would replace current grafts and more importantly would provide surgeons with 
readily available implants, which can be tailor-made and would be without the 
problem of scarcity. 
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Artificial vessels without any biological components (such as Dacron, ePTFE 
(Expanded polytetrafluoroethylene), Polypropylene or Polyurethane based vessels) 
have been used as vascular grafts with limited success. Although they can be 
rendered relatively compliant, the biggest problem with these artificial vessels is 
thrombogenicity and neointimal hyperplasia formation, both of which can, in the 
long run, cause occlusion of the vessels due to thrombus formation and may 
Figure 2.2 Arterial by-pass procedure a) Blockage of coronary artery causes nutrient and 
oxygen deprivation of the heart muscle, which causes necrosis and dysfunction. b) By-
pass procedure to solve coronary artery blockage. An autologous graft (Saphenous vein in 
this case) is used to literally by-pass the blockage and re-direct the blood flow and re-
establish the nutrient and oxygen flow to the heart muscle. Although highly successful, 
this procedure mostly depends on the availability of the autologous graft, which is not 
available in a big portion of cases. Images obtained from USA National Institute of Health 
Website, Medical encyclopedia (www.nih.com). 
14 
 
necessitate further surgical interventions (Clarke et al. 2001). Thrombogenicity, 
which can be defined as the proclivity of a material to induce blood clot (thrombus) 
formation when coming into contact with blood can be decreased for synthetic 
materials by surface coatings or use of smoother surfaces, but only to a certain 
extent. The surface would be still thrombogenic and this imposes a risk on long 
term viability of the graft, especially for small diameter grafts where occlusion is 
much easier. The main reasons behind surface thrombogenicity are serum protein 
adsorption, surface affinity to cells (such as platelets) and surface roughness. 
Attachment of thrombogenic proteins and subsequent platelet attachment has a 
positive feedback loop and subsequently the accumulation grows exponentially. 
When the graft surface is big enough (for wider arteries) this accumulation may not 
reach to a degree where the blood flow can be hindered. Thus this may be the 
reason why even though these artificial vessels are successful as large diameter 
substitutes, their utilization for small diameter vessel replacement (≤6mm) has low 
patency (Sarkar et al. 2007). These facts, together with  parameters such as flow 
rate , the flow regime of the target artery environment compounded with the 
patient’s own blood individual specific tendency to form clots, make it really hard to 
assess the feasibility of the artificial grafts for a given implant condition (Lopez-
Soler et al. 2007). These problems were the driving force behind development of 
less thrombogenic vascular graft surfaces to obtain long term patency. Recently, it 
was shown that biologically derived graft materials, such as umbilical cords,  suffer 
from similar thrombogenicity issues and neointimal hyperplasia formation, even 
though they are better for cell recruitment and integration, i.e. formation of a neo-
endothelial lining on these grafts has a higher probability (Scharn et al. 2006). To 
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improve integration ability, synthetic grafts are implemented with several features 
such as a double velour knitted surface design to provide the necessary area for cell 
migration, hence improving integration with the surrounding vascular tissue 
(Figure2.3). 
One way to circumvent the thrombogenicity problem is the development of graft 
surfaces that are less thrombogenic and more conducive to endothelial cell 
migration and proliferation (Birchall, Lee & Ketharanathan 2001). In this way, the 
interaction of the graft surface with the blood can be kept minimal (Cuy et al. 
2003). It has been suggested that this problem can be overcome by covering of the 
lumen surface of the artificial vessels with autologous endothelial cells. There was a 
significant increase in short-term and long term patency of the grafts via this route 
(Meinhart et al. 2001, Deutsch et al. 2008). However, problems such as the degree 
Figure 2.3 Arterial graft design. Hemashield Platinum Dacron based double velour graft for 
arterial surgeries produced by Boston Scientific Inc. A) Graphical representation of the 
grafts after implantation b) SEM micrograph of Surface structure (Double velour woven) 
for improved integration of the graft with the target vessel (Obtained from Boston 
Scientific Inc website www.bostonscientific.com). 
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of coverage and the strength of adhesion of the endothelial cells onto the artificial 
lumen surface still remain unsolved.  In-vitro experiments showed that physiological 
level shear stress can cause detachment of endothelial cells from the polymer 
surfaces, thus exposing the graft surface to the blood flow. This can potentially be 
prevented by coating the lumen surface with cell adhesive proteins but no 
conclusive results have been obtained via this route (Chen, Barron & Ringeisen 
2006). This lack of success is mainly due to the limited proliferative and migratory 
capacities of the endothelial cells and their mode of migration being two 
dimensional, which makes it nearly impossible to cover the whole area presented 
by an artificial graft. This can be overcome by the body by recruitment of circulating 
endothelial progenitor cells, which have high proliferation rates and can achieve 
fast lumen coverage (Melero-Martin et al. 2007), but the rate of this process versus 
the rate of platelet and fat deposition or intimal hyperplasia is difficult to control, 
unless with the inclusion of growth factor delivery systems (such as FGF) or gene 
delivery systems within the implant (Frerich, Kurtz-Hoffmann & Lindemann 2005). 
Moreover, these polymers are not very permissive to tissue in-growth and 
remodelling, and thus a total healing of the vasculature is impossible in their 
presence.  
In short, what is expected of a functional synthetic vascular prosthesis could be 
impossible to achieve with a mere synthetic solution. They need to be non-
thrombogenic, haemocompatible, fatigue and creep resistant yet compliant enough 
not to disturb the blood flow at the integration sites. It seems that the ideal 
solution for future generation of vascular prosthesis is to integrate cellular 
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components to better imitate the functionality. For this end, it is crucial to have an 
understanding of the structure and behaviour of the vascular tissue. 
2.2 Structure and Composition of Vascular Tissue 
Vascular tissue is composed of two main vessel types, arteries and veins which have 
different morphologies due to their different functions. Arteries are responsible 
from distribution of the oxygenated blood, whereas the veins function is the 
collection of the deoxygenated blood back from organs. These functional 
differences result in physiological differences too, such as higher burst strength for 
arteries and the presence of valves within veins for prevention of back-flow of the 
blood. The vascular health related problems are nearly always related to arterial 
dysfunction. There are two categories of arteries, elastic and muscular. Elastic 
arteries are the large diameter ones such as the aorta in which smooth muscle cells 
are accompanied by several elastic laminae. They are located proximal to the heart. 
Muscular arteries are smaller in diameter and their tunica media is mainly 
composed of smooth muscle cells and ECM. Their location in the vasculature is 
more peripheral. Arteries close to the heart are thick and more compliant whereas 
further along the circulatory system, they become stiffer and thinner. Arteries are 
composed of three layers, intima, tunica media and tunica adventitia (Figure 2.4). 
The thickness and the composition of each of these layers changes throughout the 
arterial tree due to the different pressure conditions present in the respective 
areas. 
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The intima starts with a single layer of squamous endothelial cells which are 
elongated in the direction parallel to that of blood flow. They sit on a basal lamina 
which in turn lies on a sub-endothelial layer (this layer is more evident in highly 
elastic arteries). The tunica media is populated by smooth muscle cells. In the 
elastic arteries, it is formed of alternating elastic laminae and smooth muscle cells 
in a circular arrangement. The main components of its extracellular matrix (ECM) 
are collagen and elastin. The concentric arrangement of the fenestrated elastic 
laminae which are connected to each other with elastic fibrils is the reason behind 
the resilience and strength of elastic arteries. Smooth muscle cells within the 
framework are elongated cells with several extensions with a defined orientation. 
Figure 2.4 General structure of Arteries, arterioles and capillaries. The three layer 
structure of arteries, endothelium oriented in the direction of blood flow residing on a 
basement membrane and circumferentially oriented Smooth Muscle cells with 
interdispersed elastic tissue and the outer fibroblastic coating. For arterioles both elastic 
tissue and the outer coating(tunica adventitia) is less prominent due to less demanding 
loading conditions and for capillaries they are non-existent (Sherwood 2001). 
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The structure is held together by a fibrillar collagen network and 
mucopolysaccharides. This network structure provides the means to resist both 
longitudinal and lateral forces by the tunica media. The tunica adventitia is a 
collagen rich fibroelastic tissue. The nutrition of the vascular wall is supplied by 
vessels coming through the adventitia and it also contains innervations. The main 
function of adventitia is the stability and connection of the vessel to the 
surrounding tissue (Rhodin, 1980). 
The media layer is rich in collagen type I and III, elastin and several proteoglycans. 
In this structure, the presence of the collagen fibrils contributes to the strength of 
the vessel and the elastin molecules render it elastic (Heydarkhan-Hagvall et al. 
2006). This structure is important for the laminar flow of blood within the lumen 
and the control of blood vessel diameter as a response to hormonal or neural 
stimulations. Another role of the ECM is the sequestering of soluble biochemical 
signals (Noh et al. 2006, Heydarkhan-Hagvall et al. 2006). The load due to the 
pulsatile blood flow is mainly borne by the media layer. Vascular tissue is composed 
of nearly 70% water, and hence resists volumetric compression (Peattie, Fisher 
2007).  
2.2.1 Endothelial Cells 
The endothelial lining is a single layer of cells covering the interior surface of the 
vessels, and is responsible for the antithrombogenicity of the inner surface, the 
response of blood vessels to injuries and the blood vessel activity control through 
secretions. The endothelial cells control blood homeostasis, regulate the transport 
of materials from and to blood, smooth muscle cell proliferation and fibrinolysis 
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(Table 2.1). Thus coverage of the inner vessel wall with a healthy, confluent 
endothelium is very important. The absence of an intact endothelium was shown to 
induce conversion to the synthetic phenotype for SMCs, which means that smooth 
muscle cells will proliferate more and secrete more ECM proteins due to lack of 
controlling signals by endothelium, and to play an important role in occlusion of the 
artificial grafts due to intimal hyperplasia (Deutsch et al. 2008). A healthy 
endothelium prevents initiation of the coagulation cascade. Their most 
distinguishing structure is their cobblestone like shape and their wide range of cell 
to cell adhesions. Under normal conditions endothelial cells secrete the 
anticoagulant thrombomodulin, but in case of an injury they start to express pro-
platelet adhesive proteins such as selectins. They react to shear stress by increasing 
their surface area through spreading. Aside from shear stress it has been shown 
that the surface topography of the basement membrane plays an important role in 
the behaviour of the endothelial cells. The nanometre scale roughness of the inner 
surface of the vessels is said to be an essential aspect of the endothelial lining. This 
roughness is provided by the basement membrane secreted by the endothelial 
cells. 
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Table 2.1 Functions of Vascular Endothelial Cells(Davies 2009, She, McGuigan & Sefton 
2007, McGuigan, Sefton 2007) 
Function Mode of Action Agents 
Vascular tone Change in SMC morphology 
Nitric Oxide, Endothelin, 
Angiotensin 
Blood clotting, fibrinolysis Platelet activation 
Von Willebrand factor, 
Thrombin, Plasmin 
Inflammation 
Leukocyte and platelet 
activation 
Complement system, 
Selectins 
SMC activity 
Proliferative, anti-
proliferative 
NO, prostoglandin 
Transportation Barrier function Surface proteins 
ECM secretion Basement membrane 
Collagen type IV, laminin, 
heparin sulphate 
 
Endothelial cells are the first surface to be in contact with blood and they sit on a 
very thin basement membrane (40-120 nm). The basement membrane is composed 
mainly of collagen type IV, type V, laminin and heparin sulphate which are arranged 
as fibres. The lining also acts as a secretory tissue in the whole body with abilities to 
direct smooth muscle cell and blood cell responses and the onset of coagulation 
and inflammation. Some of the secretions that are important anti-thrombogenic or 
fibrinolytic factors include Nitric Oxide, prostocyclin and tissue plasminogen 
activator (Bachetti, Morbidelli 2000). 
 Endothelial cells act as a first line of response to the changes in shear stress due to 
the blood flow, which affect endothelial cells’ gene expression profile which in turn 
causes changes in smooth muscle cell behaviour. Modulation of thrombosis is 
achieved through expression of several surface positive or negative feedback 
molecules (McGuigan, Sefton 2008). Endothelial cells express PECAM 
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(Platelet/Endothelial Cell Attachment Molecule) when they are in contact and are 
forming tight junctions. Thus PECAM expression is a good indicator of integrity of 
endothelial lining. Some other surface proteins such as ICAM (Intercellular 
Adhesion Molecule) and VCAM (Vascular Cell adhesion Molecule) which are mainly 
related to endothelium-leukocyte interactions can also be  used to assess the 
health of endothelium, since they are expressed at a constant level under normal 
physiological conditions.  Another protein that can be used to evaluate the 
endothelial lining is von Willebrand factor which is a protein that has an important 
role in coagulation cascade but is also expressed constitutively. Another important 
role of endothelial lining is the secretion of Nitric Oxide (NO) which has several 
functions such as vasodilatation, inhibition of vasoconstrictor signals and 
prevention of platelet adhesion and also anti-inflammatory and anti-proliferative 
functions. Antiproliferative functions are important for the prevention of intimal 
hyperplasia due to the overgrowth of smooth muscle cells. It was shown that 
endothelial cells respond to the underlying basement membrane or the coating of a 
tissue culture surface with cell attachment promoting molecules with a decrease in 
apoptosis and the maintenance of anti-thrombogenic phenotype. This is an 
important parameter that defines that the culture conditions have a strong effect 
on the behaviour of the endothelial cells (Prasad Chennazhy, Krishnan 2005).  
Pro or anti-thrombogenic effects can be affected by the presence of shear stress 
but also by the substrate on which endothelial cells are grown; i.e. the strength of 
adhesion of endothelial cells and their ability to spread on the substrate surface. 
For a tissue engineered blood vessel, the endothelial lining should be in a 
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phenotypic state in which it prevents blood coagulation, so it is important to check 
signals and effects that trigger coagulation, complement activation and blood cell 
activation. 
Endothelial cells have a cobblestone shape upon confluence in a tissue culture plate 
and their rate of division is much higher compared to that of in-vivo rates. Their 
presence is important for preventing platelet adhesion since platelets can easily 
attach to a denuded area of endothelium where they can interact with the 
underlying basal lamina. One of the active bio-signal that has an important role in 
homeostasis of the vasculature is Nitric Oxide (NO). It is a free radical with a wide 
range of functions in multicellular organisms; specifically in vasculature, 
upregulation of NO synthesis results in vasodilatation by directly affecting vascular 
smooth muscle cells. In the vasculature, NO synthesised by endothelial cells from 
arginine via the enzyme called e-NOS (endothelial nitric oxide synthase). NO can 
also act as an anti-proliferative signal for vascular smooth muscle cells during the 
remodelling process. NO also prevents platelet adhesion (Ibrahim, Ramamurthi 
2008). NO synthesis can be affected by the presence of shear stress. Shear stress 
and cyclic strain are known to increase the expression of NO by upregulating eNOS. 
2.2.2 Smooth Muscle Cells 
The tunica media, populated by smooth muscle cells, is responsible for vascular 
tone/diameter and, in this sense; highly differentiated smooth muscle cells are 
responsible for the dilatation and constriction of vessels.  This is how they regulate 
blood pressure and the distribution of blood flow. Smooth muscle cells appear in a 
helical pattern mainly in the circumferential direction. This orientation is important 
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for the vasoconstriction/dilation cycles and also for the mechanical strength of the 
vessels. They are also very sensitive to strain and dynamic culture experiments have 
shown that smooth muscle cells become more oriented under such conditions. Cell 
proliferation is also affected by the application of strain.  They have fibroblast like 
highly orientated shapes which are closely related to their function (Figure 2.5). The 
vascular tissue is a stable tissue, which means that it can heal. This is possible due 
to the phenotypic plasticity of smooth muscle cells; which enables them to switch 
between a wide range of phenotypes with distinct characteristics; defined as 
contractile and synthetic phenotypes for the two extreme conditions (Owens, 
Kumar & Wamhoff 2004). 
2.2.2.1 Contractile versus Synthetic Phenotype of Smooth Muscle Cells 
Smooth muscle cells are mostly in the quiescent, contractile stage under in vivo 
conditions. However upon injury, they convert to a more synthetic phenotype 
resulting in cell proliferation, enzymatic degradation of ECM and remodelling via 
newly secreted extracellular matrix. When grown under in vitro conditions, SMC 
generally exhibit this conversion and proliferate. This is mainly related to the static 
culture conditions which are very different from the native vessel environment 
where there is constant stretching and radial distension due to the blood flow. 
These effects are sensed by SMCs through the interaction of their integrin mediated 
connections with the extracellular matrix (Owens 2007).  
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There are very notable differences between contractile and synthetic SMC 
phenotypes, such as increased smooth muscle actin expression in contractile cells 
and a pronounced increase in the ECM molecule synthesis in the synthetic 
phenotype. However, this phenotype conversion is not like a Boolean switch. It is 
more similar to a continuum of several phenotypes with differing degrees of 
contractile or synthetic properties. Mostly, maintenance of the contractile 
phenotype is dependent on the shear stress and pulsatile flow conditions and 
Figure 2.5 General smooth muscle cell. Spindle-like appearance of Smooth muscle 
cells with elongated cytoplasm in the direction of strain and also elongated nuclei. 
ECM secretion, collagen, follows the same pattern too (Obtained from 
www.uscf.edu, Histology Lecture Series, bladder). Left Inset) Appearance of 
vascular smooth muscle cells during explants culture (Obtained from 
www.strath.ac.uk) Right Inset) Single GFP transfected smooth muscle cell (Obtained 
from Nature Cell Biology, www.nature.com). 
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biochemical signals, such as growth factors and/or the presence of ECM 
components (like GAGs). It has been shown that cyclic strain and shear stress are 
crucial for the well being of both endothelial and SMCs (Owens 2007).  SMCs align 
themselves in the circumferential direction, in order to bear the stretching 
(Standley et al. 2002). This obviously has an effect on their phenotype and 
subsequent behaviour.  
Another aspect of the SMC phenotype is the relation between the phenotype 
conversion and the ECM molecules.  Several studies have been carried out in order 
to determine their effect. It has been shown that presence of collagen type I and 
fibronectin tend to trigger the synthetic phenotype, whereas components of the 
basement membrane, such as collagen type IV, laminin or elastin, suppressed the 
synthetic phenotype. However, such effects also show variation between 2D and 3D 
cultures. For example, even though collagen coatings increase the synthetic 
phenotype expressions, it was shown that cell proliferation was slower for cells 
encapsulated in a 3D collagen gel. Phenotype change from contractile to synthetic 
is important in atherosclerosis and restenosis. The main markers of the contractile 
smooth muscle phenotype are smooth muscle α actin, calponin, myosin heavy 
chain isoforms (Halka et al. 2006). 
The modulation of smooth muscle cell phenotype is directly related to the tone of 
the underlying ECM. The mechanosensing capability of smooth muscle cells dictates 
the phenotype through sensing strains due to the pulsatile blood flow (Jeong et al. 
2005). 
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The wide range of functions of both endothelial and smooth muscle cells indicates 
the reasons behind the shortcomings of purely synthetic grafts and a need to 
incorporate these cellular components in the future implant. Tissue engineering 
offers a method for achieving this goal. 
2.3 Vascular Tissue Engineering 
As a sub-field of tissue engineering, vascular tissue engineering deals with the 
production of bio-artificial implants that can replace arteries functionally and in the 
long run integrate with the host artery totally. This is planned to be achieved by 
successful culturing of arterial cells on biodegradable natural or synthetic scaffold 
materials which would endow the system with its mechanical properties and 
provide the arterial cells with a template to reproduce the 3 dimensional structure 
of arteries (Wang et al. 2007) . For this end porous matrices either produced via 
decellularisation of tissues or manufactured from synthetic  polymers such as Poly 
Glycolic acid (PGA), Poly lactic acid (PLA) or from natural polymers such as collagen 
and fibrin have been used to promote smooth muscle growth and tunica media 
production (Cetrulo 2006, Thomas, Campbell & Campbell 2003). After maturation 
of the medial part, the inner surface is seeded with endothelial cells. 
2.3.1 Aims and Requirements of Vascular Tissue Engineering 
Vascular tissue engineering has three main aims. The first is the provision of a 
biological alternative to autografts and allografts used in current surgical 
procedures which is functional both structurally and biochemically, and is readily 
available or can be produced in a short time interval. The second goal is to develop 
in vitro systems that imitate the natural blood vessels with high fidelity, so some of 
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the research on cardiovascular diseases can be conducted on these systems and the 
final aim is to manufacture small diameter artificial vessels as complementary 
structures within the tissue engineering scaffolds for other target tissues in order to 
facilitate and improve revascularization. Although great achievements have been 
attained in the past, none of the stated goals have been fully realized yet. 
The reasons behind the relatively low level of success, or rather low level of 
successful clinical outcomes, are the onerous requirements for a functional vascular 
tissue engineering product. Aside from the general prerequisites of biocompatibility 
and infection-resistance; as blood contacting materials, artificial arteries should be 
thromboresistant, with long term mechanical reliability (kink resistance, burst 
strength, compliance, suturability) and on top of that they should also act as a 
secretory tissues via the endothelial lining and be able to respond to mechanical 
and neural stimuli by being able to change its diameter (Thomas, Campbell & 
Campbell 2003). 
There are some additional problems related to the engineering of the vascular 
tissue which are not encountered in other tissue engineering applications. The 
biggest issue is the necessity of the immediate functionality. Unlike other tissues 
such as bone, cornea or cartilage, the tissue engineered vessel does not have an 
opportunity to remodel prior to assuming full functionality following implantation. 
Since it is linked to the circulation, it is required to function as a circulatory element 
immediately. Moreover, integration of the artificial tissue with the host body 
happens under very dynamic conditions in the case of vascular tissue engineering, 
making design of such prostheses quite difficult. Moreover an unsuccessful attempt 
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can lead to several complications, such as formation of thrombus on the implant 
that may compromise the well-being of circulatory system. Thus, the design and 
production of an artificial vessel is a very sophisticated procedure. The mechanical 
demand on the scaffold is perpetual, and this demand might not be met by the 
secreted ECM especially if the application will utilise autologous cells from elderly 
patients, which are limited in capacity to grow and secrete. 
2.3.2 Methods and Achievements of Vascular Tissue Engineering 
There are three main approaches to vascular tissue engineering. The first is 
utilization of scaffolds which are populated with arterial smooth muscle cells. 
Population is achieved mainly through two routes; cell seeding at the beginning of 
the cell culture or encapsulation of the cells within the scaffold structure.  As for 
scaffold material, the main choices are decellularised natural tissues (xenogenic 
arteries or small intestine submucosa) or manufactured synthetic or natural 
polymer based structures (Kakisis et al. 2005). As for scaffold forms the main 
choices are porous foams or hydrogels, mainly for encapsulation purposes. 
Generally, seeded scaffolds are conditioned in bioreactor systems under pulsatile 
flow to imitate the effect of blood flow (Isenberg, Williams & Tranquillo 2006, 
Buttafoco et al. 2006). The second approach is to use the patient’s own body as a 
bioreactor for production of the artificial vessels and a third option is the 
scaffoldless systems which rely on the triggering of ECM secretion capabilities of 
the smooth muscle cells and fibroblasts (Baguneid et al. 2006). Below, the most 
prominent examples of these methods are discussed. 
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The first successful example of vascular tissue engineering has been demonstrated 
by Weinberg et al in 1986 (Weinberg, Bell 1986). They used bovine originated cells 
in collagen based hydrogels and after a long-term culture vessel like structures 
were obtained, albeit with low strength (Figure 2.6). Their model was quite strong, 
since it had all three cellular components (endothelium, SMC layer and the 
fibroblast layer). However a Dacron mesh was needed as a mechanical stabilizer. 
Other natural polymers, especially fibrin since it can be obtained from patient’s 
own blood so would be less immunogenic, have also been successfully used in 
similar schemes (Helm, Zisch & Swartz 2007, Mol et al. 2005). 
 
An option to overcome the physical limitations of the natural scaffolds yet having 
natural components is to utilize decellularised vessels, which have been used with 
Figure 2.6 Step by step production of Weinberg Bell arterial model. Even though, it is 
quite beneficial for smooth muscle cell circumferential alignment, it suffers from lack of 
physical strength due to the weakness of the starting collagen gels (Isenberg 2006b) 
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limited success (Kerdjoudj et al. 2006, Martin et al. 2005). Decellularised scaffolds 
are advantageous in the sense that the orientation and distribution of the ECM 
molecules are very close to those of native structures. Also, decellularised scaffolds 
may retain entangled or fixed growth factors that can be further released after 
culture and remodelling. However, the generally harsh nature of the 
decellularisation process can result in batch to batch differences between different 
decellularised scaffolds. Moreover, decellularised systems, especially from other 
donors or species, also pose disease transmission problems.  
For improving the mechanical properties of the conduits, several synthetic 
materials have been utilized as vascular tissue engineering scaffolds (Figure 2.7). 
Utilized polymers include PCL, PLGA, PGA. Although synthetic materials offer better 
mechanical properties and long term stability, their degradation rate and the effect 
of degradation products on the behaviour of the cells is of major concern. Niklason 
and co-workers used PGA based scaffolds and have successfully covered the surface 
of these scaffolds with endothelial cells (Niklason, Langer 1997, Gong, Niklason 
2006). Polyurethane scaffolds were also used as a scaffold for SMCs under a laminar 
flow regime. They were populated by cells and cells synthesized ECM. Following 
endothelialisation, scaffolds were grafted to dog coronary artery and remained 
active for 1 month. 
A very novel approach was carried out by Campbell et al, in which silicone tubes 
were inserted into rabbit peritoneal cavity and a vessel-like structure was obtained 
through the inflammatory response of the host body (Campbell et al. 2004, Chue et 
al. 2004). After silicone tubes were covered with cells they were removed and 
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grafted to the same animal, to serve as autologous grafts, with moderate success. 
Another quite innovative experiment conducted by L’Heureux et al, suggests 
production of a functional artificial vessel without any scaffold (L'Heureux et al. 
2006). In this system, confluent layers of SMCs and fibroblast were wrapped around 
each other and after maturation of these layers; the inner lumen was seeded with 
endothelial cells. This structure stayed patent for at least one month, with a burst 
strength comparable to that of native blood vessels (Figure 2.8). However, the total 
manufacturing period is more than three months for each vessel and there was a 
high degree of interference with the culture system, which is very risky when the 
probability of contamination is considered. 
 
 
 
 
Figure 2.7. Cell seeded synthetic scaffold vs. carotid artery. Comparison 
of smooth muscle cell seeded synthetic composite graft (made of PVDF 
and fibrin) and natural carotid artery cross-sections after 2 weeks of cell 
culture. Similar cell numbers were obtained in the composite graft; the 
original polymer scaffold is still visible in places (Marked with arrows) 
(Tschoeke et al. 2008). 
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2.3.3Endothelialisation 
One of the most important aspects of vascular tissue engineering is the 
endothelialisation of the construct and the retention of the endothelial layer after 
exposure to laminar flow. Unfortunately, most of the current designs are not 
successful in this respect. Several approaches have been developed to overcome 
this problem, such as different seeding techniques, magnetic orientation of the 
cells, or coating of the lumen with cell adhesion promoting molecules and the 
preconditioning of the cells at lower shear stresses (Alobaid et al. 2006, Feugier et 
al. 2005, Turner et al. 2004). Even though there are problems with the 
endothelialisation, tissue engineering constructs are easier to endothelialise 
Figure 2.8 Scaffoldless vessel production.  L’Heureux Model of 
scaffold-less artificial vessel after 9 weeks of maturation, a 
self-sustaining vessel like structure without using any scaffold 
material (L'Heureux et al. 1998) 
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compared to the standard vascular graft, due to the generally more suitable nature 
of the substrate for cell attachment (Ibrahim, Ramamurthi 2008, He et al. 2005) 
especially for the case of decellularised tissues and natural polymer based scaffolds. 
In addition to this, in-vitro shear conditioning of the endothelial layer is hugely 
beneficial (Inoguchi et al. 2007). 
As can be seen from the examples, the main short term aim is the development of 
the first two layers of the vasculature; the intima and the tunica media. This 
composite structure actually is composed of two different tissue types, namely 
epithelium and smooth muscle tissue. Thus what is necessary is to successfully 
develop the basement membrane for the endothelium, so that there would be a 
strong attachment of the endothelial cells and the connection between the 
endothelium and the tunica media would be possible. The second challenge would 
be the development of the media with smooth muscle cells in a contractile 
phenotype so that upon implantation they could react to the nerve impulses and be 
able to change the diameter of the vessel.  The main purpose of using smooth 
muscle cells is to achieve ECM secretion during the degradation of the scaffold, so 
that it  can be replaced with the native ECM which is the product of smooth muscle 
cells. The removal process can be passive if the scaffold is mainly made of synthetic 
polymers or active if it contains natural polymers which can be degraded by the 
smooth muscle cells by enzymes, such as metalloproteinases. The level and rate of 
ECM secretion, composition of the final ECM structure and modulation of smooth 
muscle cell phenotype between contractile and synthetic phenotypes are the main 
parameters that need to be controlled during the process of artificial vessel 
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manufacture. Therefore, one of the most important parameters in vascular tissue 
engineering is the control over this conversion, since proliferation of smooth 
muscle cells is necessary in the beginning of the culture. However, after a certain 
density is reached, this proliferation must stop. Otherwise, overpopulation of the 
structure with SMC may occur, and this would result in something similar to intimal 
hyperplasia.  
Another important aspect of vascular tissue engineering is the determination of the 
effects of stresses or strains present under in vivo conditions on different cell types 
and possible methods of exploiting these relationships. Physical properties of the 
scaffolds, such as porosity, surface roughness and stiffness can also have marked 
effects on smooth muscle cells. Also another important parameter is the 
organization and orientation of the smooth muscle cells which are oriented in a 
spiral-like structure in native vessels with respect to the direction of the load and 
this orientation has an effect on ECM secretion too (DeLong, Moon & West 2005/6). 
The stiffness and the density of the encapsulating scaffold are also important for 
cell behaviour, because the density of the scaffold would have an effect on the 
migration rate of the cells and the stiffness of the 3D structure will influence the 
attachment profile.  
Mechanical properties have a high priority in vascular tissue engineering 
applications. Compliancy of the grafts is especially crucial. Thus, any material that is 
to be used as a vascular tissue engineering scaffold should exhibit viscoelastic 
properties similar to those of soft tissues and they should be resistant to fatigue 
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and creep due to cyclic stretching. For these purposes, hydrogels in general are 
viable candidates. 
2.4 Hydrogels 
Hydrogels are one of the most prominent forms of scaffold in tissue engineering 
owing to the similarity of their mechanical properties to soft tissues, their ease of 
fabrication, their comparable water content to that of tissue and their suitability for 
cell encapsulation processes either as pre-made structures or as injectable scaffolds 
(Kopecek 2007). Injectability is especially important for tissues where a complex 
architecture is necessary. There are a wide range of natural and synthetic polymers 
which can be used in the manufacture of hydrogels, such as alginate, collagen, 
fibrin, polyethylene glycol (PEG), polyvinyl alcohol (PVA), poly ethylene oxide (PEO), 
Polyacrylic acid (PAA), Polypromyl fumarate (PPF) (Hong et al. 2007, Drury, Mooney 
2003). Hydrogels are hydrated networks of one or more polymers which are held 
together either by entanglements of the polymer chains or crosslinks between 
them (Figure 2.9). Several different methods can be used to trigger gelation such as 
temperature change, physical crosslinking, chemical crosslinking, photocrosslinking, 
or the utilization of radiation (Razzak et al. 1999). 
Hydrogels have high water content and generally show viscoelastic behaviour. They 
have been used as contact lenses, artificial corneas and artificial cartilage scaffolds. 
They have been shown to be beneficial for three dimensional cell network 
formation, which facilitates the formation of a tissue-like structure. One of the most 
important properties of the hydrogels is their hydrophilicity which decreases the 
rate of protein adhesion onto hydrogels and thus increases their biocompatibility 
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(Nicodemus, Bryant 2008a). However their highly hydrophilic nature can sometimes 
be detrimental for some applications, since cells generally tend to adhere to 
surfaces with intermediate hydrophilicity. The reason behind this is that the cells 
adhere to a surface through the adhesion proteins absorbed onto that surface and 
the protein adsorption is quite low for highly hydrophilic or hydrophobic surfaces. 
This situation can be improved by addition of cationic building blocks, which are 
known to promote cell adhesion. Another plausible route would be the 
development of composite hydrogels (Lozinsky, Savina 2002). The hydration level of 
hydrogels is generally higher than 30% (Drury, Mooney 2003).  
Synthetic hydrogels are advantageous since their chemical properties can be easily 
altered which in turn provides more control over essential hydrogel properties such 
as the degree of crosslinking, degradation, the dynamics of gel formation and 
mechanical properties. Another advantage is their high level of reproducibility. 
However, synthetic hydrogel structures have an inherent problem with cell 
attachment. Unlike collagen, most hydrogel forming molecules do not have cell 
attachment promoting domains. Thus cellular attachment depends on the 
absorption of adhesion proteins.  On the other hand, natural polymers have 
properties quite similar to ECM which improve their biocompatibility and 
performance as tissue engineering scaffolds. Collagen, fibrin, and hyaluronic acid 
are all natural components of the ECM and thus they are favourable for cell 
attachment and spreading. The mesh size of the hydrogels has an effect on both 
degradation and biochemical signalling. The mesh size of the hydrogel can affect 
the diffusion of biomacromolecules which in turn may change the enzymatic 
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cleavage of the natural constituents of the hydrogel, but can also hinder growth 
factor penetration (Dikovsky, Bianco-Peled & Seliktar 2006). 
It can be said that the ideal hydrogels for tissue engineering would be composites 
of natural and synthetic polymers which can then demonstrate the beneficial 
attributes of both groups.  For soft tissue engineering applications one of the 
available synthetic polymers is Polyvinyl Alcohol. 
2.4.1 PVA Hydrogels 
PVA is a synthetic polymer with pendant –OH groups. It is formed through 
hydrolysis of acetate groups of poly vinyl acetate which itself, is polymerized from 
vinyl acetate monomers. The main properties that define PVA behaviour are the 
degree of hydrolysis and the degree of polymerization. It can be used to form films, 
foams and hydrogels in the tissue engineering area, but it also has several other 
functions, such as surfactant, sealant or cement filler. It is water soluble and its 
solubility depends on its molecular weight (Guo, Xu 2005). 
  
Figure 2.9 Typical structure of cryogels a)Polyvinyl alcohol (Lozinsky et al. 
2007) which shows cryostructuring as can be observed by the presence of  
aligned PVA chains b) Polyacrylamide (Plieva et al. 2004) which shows a 
mesoporous structure 
 
(b) 
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2.4.2 Network Formation 
PVA can form hydrogels of high water content with several different methods such 
as chemical crosslinking (such as glutaraldehyde, succinyl chloride), freeze/thawing, 
gamma irradiation and photopolymerisation. PVA hydrogels have desirable 
mechanical, swelling and optical properties which make them suitable for tissue 
engineering (Mangiapia et al. 2007). The freeze/thaw or cryogelation method has 
an important advantage over chemical methods. Due to its purely physical nature 
there is no risk of remnant chemicals that might compromise the biocompatibility 
of the final hydrogel. Also, gels formed with this method are highly elastic and 
durable, which is quite important for soft tissue engineering. However, PVA based 
cryogels have some disadvantages such as the need for sterilization, which is not 
necessary in the case of the gamma-irradiation crosslinked hydrogels which are 
inherently sterile (Chowdhury et al. 2006). Moreover, in the presence of the natural 
macromolecular additives, such as chitosan, dextran and bacterial cellulose, the 
gelation process is different because generally these additives are not as prone to 
gelation as PVA chains. This causes heterogeneity in the structure and also faster 
loss of the additives than the PVA backbone (Mathews et al. 2008). PVA has been 
shown to be biocompatible, eliciting a minimal inflammatory response upon 
implantation (Stammen et al. 2001). One of the most promising properties of PVA is 
its ability to form physical hydrogels, described as cryogels, via repetitive freezing 
and thawing cycles. 
2.4.3 Cryogels 
Cryogelation is one of the methods of physical hydrogel formation. These gels are 
formed through processes which force formation of non-covalent bonds such as 
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hydrogen bonds, ionic bonds or by basic entanglement of the polymeric chains and 
crystallites after freezing and thawing cycles (Figure 2.10). Most of these gels are 
reversible gels due to these factors. The gels are very beneficial in the sense that 
there is no need for addition of any chemical crosslinker or application of UV light, 
which in some cases cause cytotoxicity and problems due to the remnant 
chemicals. Cryogels form under moderate freezing conditions in which frozen 
solvent causes phase separation and acts as a porogen, leading to a gel with high 
water content. Gelation can occur in each of the three steps of the freeze-thawing 
process; freezing, storage in frozen state or during thawing. For PVA the most 
important step is thawing, since this is where most of the gel formation occurs 
(Komarova et al. 2008). One of the main aspects of cryogelation is that not all of the 
solvent freezes under these conditions and there is always a portion of the solvent 
in the liquid phase (Lozinsky 2002). The surface tension between the thawed 
solvent and the gel phase causes round pores. The conversion between spongy and 
non-spongy cryogels depends on the freezing regime and the concentration and 
composition of solute. The physical gelation occurs through formation of a three 
dimensional non-covalent bond structure, either hydrogen bonds or hydrophobic 
interactions depending on the nature of the solutes. The degree of hydrolysis is 
important for PVA, since a high level of presence of acetyl groups on the chain 
causes inhibition of bond formation. 
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2.4.3 Additives and Coagulation Bath 
PVA by itself is a very poor surface for cell attachment, basically due to its inability 
to adsorb proteins because of its hydrophilicity. This is a limiting property for its 
utilization in tissue engineering applications and this has been overcome mainly by 
two methods; tethering of cell adhesive molecules to the PVA backbone covalently 
(Nuttelman et al. 2001) or development of composite hydrogels. For this end a wide 
range of biomacromolecules, such as hyaluronic acid, egg albumin, chitosan and 
gelatine has been utilized for different applications (Sbarbati Del Guerra et al. 1994, 
Koyano et al. 1998, Koyano et al. 2007, Moscato et al. 2007, Bajpai, Saini 2006). 
Each of these additives has a different effect on the cryogelation and on the 
subsequent final physical properties of the resultant cryogel. Thus, utilization of 
several different additives to determine the optimum additive for a given 
application merits investigation. 
Figure 2.10. Cryogelation process, Gel formation via entanglement, hydrogen bonding and 
formation of crystallites. Reproduced from (Bajpai and Saini 2005) adapted (Peppas and 
Stauffer 1991) for Gelatin. 
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Chitosan is a linear polysaccharide composed of (1–4)-linked d-glucosamine and N-
acetyl-d-glucosamine which is obtained by deacetylation of chitin, which is 
extracted from the exoskeleton of arthropods. Deacetylation degree and molecular 
weight affect several characteristics of chitosan, such as its crystallinity. Chitosan is 
generally soluble in dilute acids due to its pendant amine group, which gets 
protonated in low pH, but it can be made water soluble. Chitosan breaks down in-
vivo enzymatically, through the action of lysozymes. Chitosan can be used for 
various scaffold forms (Chen et al. 2007, Inanc et al. 2007) and it has anti-microbial 
properties (Shi et al. 2006). 
Starch is a plant based storage polysaccharide with good biocompatibility. In plants, 
the end product of photosynthesis, glucose, is stored in the form of starch. There 
are two basic structures in starch: amylase which is a linear chain of glucose, and 
amylopectin which has a branched structure. The ratio of amylase to amylopectin 
differs from species to species. As a water soluble polysaccharide, starch has been 
used in several tissue engineering applications (Tudorachi et al. 2000). 
Gelatin is formed by hydrolysis and denaturation of collagen which is an irreversible 
process. So gelatin lacks the fibrillar structure of collagen, but still contains cell 
attachment sequences and still demonstrates the properties of a protein. The ease 
of extraction and storage and being cost-friendly makes gelatin a widely used 
biomacromolecule in the biomedical field.  The main source of collagen for gelatine 
production is either animal skin or tendons or bone (bovine skin is one of the most 
widely used sources). It is used in several different biomedical and food applications 
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(Fan et al. 2006, Young et al. 2005, Zhu et al. 2004). Gelatin can form physical 
hydrogels by hydrogen bond formation. 
Utilization of these biomacromolecules provides the necessary surface or bulk 
properties for cell attachment, but in the meantime they also interfere with the 
cryogelation process and compromise the mechanical properties of the final 
hydrogel. Moreover, since these polymers do not gelate as strongly as PVA during 
freeze-thaw cycles, their loss during culture period through leeching is likely to be 
quite significant. To prevent this, additional crosslinking procedures might be 
necessary. As PVA cryogels are physical hydrogels, another physical crosslinking 
method would be beneficial to keep the positive attributes of physical crosslinking. 
Polymer coagulation, which is a fast and cost-efficient physical way to crosslink 
polymers, can be used in this manner. PVA hydrogels are known to have the ability 
to change volume and density when contacted by solutions containing solutes 
basically by eliminating water within the hydrogel network (Termonia 1995). This 
can be used for further crosslinking of the hydrogel when highly concentrated 
solutions are used. The so-called coagulation bath treatment results in co-
precipitation of the two components of the composite hydrogel system together 
and produces a stronger hydrogel without modifying the chemical characteristics of 
the hydrogel structure. However, this might also change other physical 
characteristics of the hydrogel, and these need to be quantified. 
In tissue engineering studies, cryogels have been mainly used as substrates for 
cellular growth, which is a suitable scenerio for endothelial cell culture. However 
smooth muscle cells would need a 3 dimensional environment to grow and 
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utilization of cryogelation for cell encapsulation is a less explored territory (Lozinsky 
et al. 2007). The next section discusses the advantages of the cell encapsulation 
route for 3 dimensional cell-laden tissue engineering constructs. 
2.5 Cell Encapsulation and Storage 
In most of the current scaffold schemes, and also in standard tissue culture 
substrates, cells have an empty space around them. This is quite unlike in-vivo 
conditions, where cells are surrounded by an ECM even during wound formation. 
The empty area for cell migration in the ECM in-vivo is not comparable to the area 
presented by pores or inter-fibrillar space in meshes which are produced as tissue 
engineering scaffolds. These open interconnected pores are necessary for cell 
repopulation, but the effect of this discrepancy on overall cell behaviour is not fully 
known. The need for a solid scaffold is a logical prerequisite due to the need (i) to 
keep a specific shape pertaining to the target organ, (ii) to be able to exert some 
sort of control over anchorage-dependent cell attachment and proliferation and (iii) 
to obtain the ability to load these constructs with factors that can direct cell 
behaviour. This is one of the main advantages of tissue engineering over cell 
therapy, as with a scaffold approach the spatial and temporal distribution of the 
cells can be controlled better. However there are some inherent problems too, such 
as vascularisation of the scaffold structure, especially beyond a certain thickness. 
Utilization of different cell types in the given orientation in a scaffold may be 
necessary, since they are generally isotropic and not cell selective. Achieving 
homogenous cell densities within the scaffold is also required, because population 
of the scaffold is inherently dependent on cell migration (Mironov et al. 2009). 
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Moreover, the porous nature of these scaffolds actually provides a 2-dimensional 
environment for the cells, since cells face an empty liquid filled area in their upper 
region, unless they are encapsulated. It is hypothesized that this might lead to a 
slow down on the rate of ECM deposition, since secreted ECM is prone to be 
washed out due to a lack of three dimensional restraining environment like in the 
tissues (Zimmermann et al. 2007).  
An alternative to overcome this problem is encapsulating cells within the scaffolds, 
by which the physiological structure can be somewhat imitated. Cell encapsulation 
first started as a method to immunoisolate cells, such as pancreatic and hepatic 
cells (mainly xenogenic or allogenic cells) from the host without compromising their 
functionality (Canaple, Rehor & Hunkeler 2002). This treatment scheme can be used 
for a wide range of endocrine secretion related diseases and also some 
neurodegenerative syndromes (Uludag, De Vos & Tresco 2000). Another reason for 
encapsulating cells is to protect them from the detrimental effects of in-situ 
crosslinking of a complex, load bearing system, where cells also are desired to be 
functional (Payne et al. 2002). Where accurate control of cell differentiation is 
needed, encapsulation can be used as a diffusion barrier, acting as a rate controlling 
element for the diffusion of growth and differentiation factors and moreover as an 
easier method to distinguish and separate sub-cell populations (Maguire et al. 
2006) (Figure 2.11). For vascular tissue engineering specifically, it will enable the 
separation of the smooth muscle cells within the hydrogel body and the endothelial 
cells on the surface, since SMCs will be encapsulated but ECs would be seeded 
afterwards. 
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Storage of tissues and tissue engineering products is an important obstacle for the 
commercialization of tissue engineering research outcomes. As a patient-specific 
technology, tissue engineering promises to deliver patient-specific products in a 
timely manner. However, the variation in physical properties of each tissue, even 
within the same patient’s system, makes this promise unfeasible and storage 
Figure 2.11 Micrographs of encapsulated cells, phase-contrast and live-dead assay 
results. Phase contrast microscopy (Left hand side images) can be used to locate 
the cell distribution, as cells can be seen within the hydrogel structure at different 
depths, individually or in groups. However to ensure viability, additional tests are 
necessary. Live/Dead assays (Right hand side images) are developed for these 
situations, where green areas denote viable cells, whereas red areas are dead cells 
(Maguire et al. 2006, Khademhosseini and Langer 2007).  
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systems crucial. There is evidence that shows that cryopreserved tissues and tissue 
engineering products have markedly different characteristics, such as different 
mechanical properties and cellular response with respect to fresh samples (Liu et al. 
2002). Encapsulated cells are also a good alternative for storage of the tissue 
engineered constructs or other cell based systems such as biosensors, since it has 
been shown that cell viability under cryopreservation conditions is higher when 
cells are encapsulated within a hydrogel structure (Itle, Pishko 2005).  
This approach would also be beneficial in the sense that the tissue engineering 
constructs can be stored as a ready-made product which contains cells instead of 
needing a long culturing period prior to implantation. Encapsulation of cells has 
been tried for a long period of time for various applications (Jen, Wake & Mikos 
1996). Gelation of the solution containing the cells can be achieved by several 
methods like photopolymerisation, ion addition (e.g. preparation of cell 
encapsulated alginate microspheres by divalent cation crosslinking) and physical 
gelation initiated by changes in pH or temperature. Gelation properties can be 
controlled by pH, temperature and ionic strength but the essential problem 
concerning cell encapsulation is the narrow range of durability of cells for all these 
parameters. Thus, optimization of the final structure is severely hindered by the 
limitations imposed by the presence of the cells. Such limitations were the case for 
silk fibroin hydrogel which under physiological conditions take hours up to days to 
set. This can be prevented by utilization of low pH high temperature conditions 
which are obviously not suitable for cell encapsulation (Wang et al. 2008). In the 
same study, after optimization of gelation, it was observed that cells survived much 
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better in low concentration hydrogels (4%) than in high concentration hydrogels (8 
and 12%). Similar effects of concentration and density of the final gel on cell 
behaviour have been seen with other encapsulation systems too (Burdick, Anseth 
2002). However, generally, the concentration of the gelation solution is dictated by 
mechanical requirements. Cell proliferation is highly restricted in an encapsulation 
system due to the absence of the necessary surface area and volume for the 
dividing cells. Thus the final cell number is reached relatively early during culturing. 
Then further growth is dependent on the degradation rate and it is further 
restricted by cells’ own ECM secretion. Different encapsulation techniques impose 
different sets of threats to cell viability. For example encapsulation via freeze-
thawing is impeded by the ice crystal formation and rupture of the cells which can 
be partly solved by addition of cryoprotectants such as DMSO (Qi et al. 2004). A 
secondary limitation is the size of the hydrogels, since encapsulated cells require a 
steady diffusion gradient for oxygen and nutrients and also for the removal of the 
waste products, which obviously becomes untenable for thicker hydrogels. 
Diffusion of the nutrients will also be affected by their propensity to be absorbed 
on the hydrogel network, which would cause sequestering of certain elements in 
the outer parts of the hydrogel while depriving the inner core. However, hydrogels 
are still better options for thick products; as evidenced by the promising results 
obtained by the 8 mm thick PEO hydrogels with photoencapsulated chondrocytes 
(Bryant, Anseth 2001). This is mainly due to the high water content of hydrogel 
structures in general, which improves permeability properties of hydrogel structure 
and enables better diffusion of the nutrients. Such studies have not established the 
possible differences between different areas within the hydrogel, due to the 
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uneven exposure to light (Baroli 2006). Moreover, the encapsulation process itself 
would impose abrupt changes to the cellular microenvironment which could result 
in phenotypic responses by the cells.  
Encapsulation based therapies can also be utilized to form bottom-up tissue 
engineering scaffolds which would contain different cell types to produce complex 
tissues in a tailor-made manner from small micro-moulded units (Yeh et al. 2006). 
Utilization of photolithography, micromoulding and microfluidics techniques has 
resulted in precise control over cell-laden hydrogel properties (Khademhosseini, 
Langer 2007). This would create the opportunity to be able to separate different 
cell types present in a given tissue while keeping the biochemical communication 
between them intact through the hydrogel network. Cryogelation is a promising 
candidate to be used in this manner too.  
The relationship of the scaffold with cells can be divided into three categories for 
tissue engineering applications. Namely, these are migration of the cells of the host 
in-vivo (recruitment), movements of the seeded cells and their subsequent 
distribution in-vitro and encapsulation of the cells within the scaffold structure in-
vitro. All these three conditions have different effects on the cells and the decision 
of which one would be best suited for a given application is very crucial. 
Interactions of the cells with the scaffold material are very different for all these 
situations. For example, the mode of differentiation of mesenchymal stem cells was 
very different under 2D culture in a differentiation induction medium and in 
encapsulated form in hydroxyapatite containing microspheres, mainly due to the 
interaction and the morphology of the cells within such a structure (Inanc et al. 
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2007). Another aspect of encapsulation is the control over the stiffness of the 
environment faced by the cells in a 3D manner; this way, cellular activities such as 
ECM secretion might be altered as a response to the surroundings. Also, control 
over how cells would attach within the hydrogel is of great import. One of the 
possible methods to control this is chemical addition of cell adhesive protein 
sequences to polymer chains to improve the adhesiveness of the inner space of the 
hydrogels.  
Cell encapsulation has been predominantly achieved by using natural polymers, due 
to their superior conduciveness to cell attachment. Unlike the attachment and 
migration mode of events in cell-seeded on to the scaffolds, in cell entrapment 
there is not enough time between interaction of the medium and the polymer for 
adsorption of proteins for cell attachment and the following initial cell migration. 
Following the gelation, cells are trapped in a restricted area and if this area is not 
permissive for attachment, the result would be apoptosis or necrosis. The most 
widely used encapsulation materials are collagen, gelatine, alginate, chitosan and 
fibrin (Elisseeff et al. 2006, Guaccio et al. 2008), which are known to be highly 
permissive to cell attachment. Another possible advantage of using natural 
polymers is the possible effect of degradation products on cell behaviour, since 
most of them are recyclable within the hydrogel system as base materials by the 
cells. However, some synthetic polymers are very suitable for encapsulation due to 
their physical properties and ease of polymerization, even though they generally 
need to be modified for improving cell behaviour within them. Some options are 
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polyethylene glycol (PEG), polyvinyl alcohol (PVA), polypropylene fumarate (PPF), 
poly ethylene oxide (PEO) (Elisseeff et al. 2006, Wu et al. 2008).  
Additional delivery systems to control the inner biochemical composition of the 
structure is a viable option, but encapsulation of cells in a polymeric system is a 
highly closed system in which all the parameters are greatly dependent on each 
other, which makes the optimization of the process much harder than normal 
tissue engineering methodologies. Restrictions on the system are quite different in 
semi-permeable membrane encapsulation, which is mainly used for metabolic 
product engineering, and the case of connective tissue engineering where 
mechanical properties and ECM secretion also needed to be considered. This 
necessitates utilization of complex statistical models for multiple-variable 
optimization of these parameters for both the start and end point of the construct 
maturation (Villani et al. 2008). For example, for photopolymerisation reactions it is 
essential to determine an optimum photoinitiator concentration that would result 
in enough polymerization while compromising the cell viability minimally 
(Nuttelman et al. 2008). However, this is not a very clear-cut procedure, because 
the cytotoxicity is highly dependent on cell type and it was found that proliferative 
capacity decreases the tolerance of a cell line to photoinitiators (Williams et al. 
2005). This would hint that the condition of the cells in culture just before 
encapsulation is an important determinant of their behaviour. Thus, the confluency 
level of the cells before trypsinisation and seeding becomes an important 
parameter. Also the degree of polymerization would have an effect on the mesh 
size of the hydrogel network, which in turn will define the rate of diffusion to and 
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from entrapped cells. The initial density of the cells, final desired cell density and 
attainable cell density are in this sense very important factors during the design of 
the scaffold. The viscosity of the initial polymer solution imposes an essential 
limitation on several aspects of encapsulation, such as distribution of the cells 
within the final structure, porosity or water content of the structure, mechanical 
properties, roughness, permeability and the amount of area available to cells for 
ECM deposition (Zimmermann et al. 2007).  
In this study, one of the main aims is to develop an encapsulation system for 
vascular smooth muscle cells by utilizing freeze/thaw based physical crosslinking of 
PVA chains. The advantage of this system is that it also acts as a storage medium for 
the cells and the scaffold. An important aspect is the protective capabilities of the 
polymer chains on the cells by mainly keeping the cell membrane intact. However, 
cryopreservation of encapsulated cells by using other encapsulation procedures can 
be problematic and may need high levels of cryoprotectants (Chin Heng, Yu & Chye 
Ng 2004). An encapsulation system utilizing freeze/thawing may need to 
incorporate several items to minimize the damage incurred due to freezing, such as 
addition of cryoprotectants and sugar solutions. Another important parameter is 
the cooling rate, which directly effects the ice crystal formation. To prevent ice 
crystal formation vitrification can be utilized; but it has mainly been successfully 
utilized for encapsulation of single cells (Demirci, Montesano 2007). Our aim is to 
employ cryogelation first for encapsulation of the cells and then develop a 
procedure from the data obtained from the short and long term response of the 
cells to the encapsulation conditions. 
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Encapsulation and the nature of the encapsulating material may have other indirect 
effects on tissue properties, such as the mechanosensing ability of the cells and 
their subsequent response. This is one of the main reasons that necessitate 
(Nicodemus, Bryant 2008b) the modelling of cell behaviour in 3D encapsulation 
schemes under different physical conditions and determination of the underlying 
material-independent mechanisms. Currently, characterisation of a wide range of 
encapsulation systems has given widely scattered and occasionally contradictory 
results. This is mainly due to the early stage effects of loading and resulting ECM 
secretion, changing the interaction of the cells with their surroundings (Nicodemus, 
Bryant 2008b). Moreover, the main method to prepare hydrogels with different 
mechanical properties is to change the initial solution’s concentration, which also 
has a direct effect on the degradation properties of the hydrogels (Bryant et al. 
2004). Hence analysis of the interaction of these two effects on mechanosensing 
capabilities of the hydrogels overlaps. Moreover, the aforementioned reverse 
gelation event causes a very abrupt change in the microenvironment of the cells 
and even though it does not cause a failure, it might have more subtle effects on 
cell behaviour. For example, as the secretion of the collagen and GAGs takes place, 
their diffusion within the hydrogel system is dependent on the mesh size. Thus at 
lower mesh sizes there would be an accumulation of collagen around the cells due 
to this diffusion restriction. This might change the behaviour of the cells by itself, 
since the nearby microenvironment of the cells would become distinctly different 
from that of the whole hydrogel structure. Thus, a mesh size that would permit the 
movement of molecules as big as collagen fibrils should be attained. Encapsulation 
systems are also need to mimic the mechanical properties of their target tissue, 
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which is predominantly a soft tissue. The next section discusses the mechanical 
properties of soft tissues and the similarities of hydrogel mechanical behaviour to 
that of soft tissues.  
2.6 Mechanical Properties of Soft tissues and Hydrogels 
Soft tissues, such as ligaments, cartilage and blood vessels, are highly elastic tissue 
which might need to go through huge deformations as a part of their function. Soft 
tissues are highly complex fibre reinforced composites with interdispersed cells, 
which is the reason for their non-linear viscoelastic behaviour. Mechanical 
behaviour of the soft tissue is directly related to the arrangement and relative 
abundance of these components. The main constituents present in the ECM of soft 
tissues are several types of collagen, elastin and proteoglycans. Collagen is the main 
load carrying element. In blood vessels the most abundant collagen types are 
collagen type I and type III. Collagen is generally found in the form of  fibrils in a 
certain orientation which renders soft tissues anisotropic. Elastin is another protein 
and as its name implies it is highly elastic. Three dimensional networks of elastin 
endows the vessels their elasticity.  The main mechanism behind the elasticity of 
this network is its ability to get oriented with the increasing stress and thus store 
potential energy.  
The main characteristics of the mechanical properties of the soft tissues are their 
anisotropic response to stress and strain, non-linear stiffening and dependence of 
the final strength on strain rate. They can go through large deformations and 
exhibit viscoelastic properties, which are mainly related to the activities of the gel-
like proteoglycans. The response of the soft tissues can be divided into three 
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phases. The first is a nearly isotropic, linear response mainly due to the stretching 
of elastin fibre. The second phase is a nonlinear phase as the collagen fibres 
straighten and start to resist the stress. In the third phase the collagen fibres are 
fully elongated and the material becomes stiffer as the stress increases (Holzapfel, 
2001). In arteries, the arrangement of the smooth muscle cells also contributes to 
the mechanical properties. Arteries contract about 40% when isolated, proving that 
they are under tension under physiological conditions and stress induced by the 
blood flow corresponds to 10-20% strain (Silver, 2003) 
For arteries the most important mechanical parameter is the burst strength; which 
varies with respect to thickness and diameter. An artificial vessel should at least 
match the burst strength of the target area. Another important parameter is 
compliancy. Any compliancy mismatch will result in neointimal hyperplasia 
formation. The elastic vessel wall is highly extensible and has a great capacity to 
recoil; which is crucial for the dilation and constriction of the vessels by smooth 
muscle cells; in the absence of this elasticity artificial vessels can dilate irreversibly 
and can be weakened by creep (Lillie, Gosline 2007).  
Hydrogels are viable options to imitate these behaviours, since they demonstrate 
similar general viscoelastic characteristics. The only difference is the determining 
factors behind the behaviour, such as the density of the crosslinks, degree of 
swelling of the hydrogel (Anseth, Bowman & Brannon-Peppas 1996) or the 
concentration of the initial solution (Anseth 1996). Moreover, the mode of gelation, 
crosslinking, polymerization or physical gel formation, also has an effect on the final 
properties. Hydrogels owe their deformability to the ability of the polymer chains to 
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rearrange themselves under stress conditions; just like the reorientation of elastin 
and collagen chains in native tissues. Depending on the density of the crosslinks and 
the degree of entanglements of the polymer chains, this reorientation will have 
different time-dependency which gives rise to the different viscoelastic properties 
of different hydrogels. Specifically for PVA cryogels, the similarity in the mode of 
non-linear viscoelastic behaviour with the vascular tissue is quite good. Generally 
the results of mechanical tests fit quite well with that of animal tissue sample tests 
(Wan et al. 2002). The response hierarchy of the natural tissues, the low stiffness 
region response by elastin and high stiffness region response by collagen, is 
replaced in the case of PVA cryogels by the amorphous and crystalline parts 
respectively (Millon, Mohammadi & Wan 2006).  Due to these properties, PVA 
cryogels have been used as MR phantoms for more than a decade (Chu, Rutt 1997) 
and this similar response of  PVA cryogels to arterial tissue under stress and strain 
conditions is beneficial for their ability to convey mechanical signals to the 
encapsulated or seeded cells for tissue engineering applications, since the cellular 
response will be affected by the response of the substrate to the mechanical forces. 
2.7 Mechanotransduction 
2.7.1 Bioreactor systems 
Requirements for an animal cell culture bioreactor are based on the properties of 
animal cells. Bioreactors are systems that are designed to amplify cells rapidly while 
providing them with necessary conditions for their viability, without the labour 
intensive manual fed-batch methodologies. Since most of the animal cells are 
anchorage dependent, bioreactor designs for animal cells generally include a solid 
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support matrix. Problems faced in an animal cell based bioreactor system are, 
sensitivity of the cells to high mechanical stimulations, a stringent oxygen and 
nutrient requirement and high risk of contamination. The need for bioreactors for 
animal cells is due to two main needs; production of some important biochemical 
molecules such as antibodies or growth factors and simulation of physiological flow 
and stress/strain conditions (Scragg 1991). In the area of vascular tissue engineering 
the second need is crucial and there have been lots of efforts in developing custom- 
made vascular tissue engineering bioreactors that would provide pulsatile flow 
conditions similar to that of blood flow. These pulsatile flow bioreactors, which are 
designed to imitate the pulsatile nature of blood flow due to the beating of the 
heart, are actually derivatives of more general fluidized bed bioreactor designs. The 
effects obtained range from better nutrient transport, improved extracellular 
matrix formation, enhanced mechanical stability and phenotypic changes 
depending on the target tissue (Flanagan et al. 2007, Jeong et al. 2007, Abilez et al. 
2006). There are also commercialized bioreactors for vascular cells such as CellMax 
Capillary System (Figure 2.12) which is used for endothelial/smooth muscle cell co-
culture systems under pulsatile flow conditions. The stress/strain environment for 
tissue engineering bioreactors is dependent on the target tissue and the 
responsiveness of the cell type used. Whether it is compression, tension or shear; 
all these dynamic loading conditions trigger a wide spectrum of cellular responses 
depending on the cells in question, which can be defined as mechanotransduction 
in general. 
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Mechanotransduction is the general term used for the biochemical or physical 
responses of cells to a mechanical stimulus. In different parts of the body the 
intensity and the mode of response change and also different parts of the body are 
under different mechanical environments. For cartilage and bone, compressive 
forces due to movement and the structural support of the organism are important; 
whereas for the tendons the dominant stimuli are tensile strains. In the case of 
blood vessels, two dominant stress/strains are very important. These are the shear 
strain that endothelial cells are exposed to due to blood flow, and cyclic strain (due 
Figure 2.12 CellMax Hollow Fibre Bioreactor for co-culture of Smooth Muscle cells 
and endothelial cells on hollow fibres, which provide the physical segregation of the 
cell types. Pulsatile flow is obtained by a pump system and 4 bioreactors can be run 
simultaneously (Image is obtained from Spectrum Labs Inc. website, 
www.spectrumlabs.com). 
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to the circumferential stress created by the blood pulses) stemming from the 
pulsatile nature of the blood flow that mainly affects smooth muscle cells (Figure 
2.13). 
 
 
 
2.7.2.1 Shear Stress 
The wall shear stress component, due to the lateral frictional force, of the effect of 
blood flow on vascular cells is mainly felt by endothelial cells, unless the lumen 
surface is denuded. Under normal conditions, the laminar fluid flow related shear 
stress is the main signal for the endothelial cells to maintain quiescence and release 
the signals that would ensure quiescence by the smooth muscle cells also (Kudo et 
al. 2005). In this sense laminar flow induced shear stress limits cell proliferation and 
Figure 2.13 Blood flow induced mechanical stimuli. Mechanical stimuli 
which affect endothelial cells and smooth muscle cells respectively, shear 
stress and cyclic strain (Hahn 2009) 
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prolongs the turnover rate, i.e. decreases apoptosis. Moreover, it promotes NO 
secretion and also inhibits smooth muscle cell activation and proliferation 
(Ballermann et al. 1998). For these reasons, laminar flow is defined as 
atheroprotective. On the other hand, disturbed shear stress, where the shear stress 
direction and distribution is not even or the blood flow is turbulent, is defined as 
atherogenic since it triggers high EC cell turnover, increased proliferation, poor 
alignment, expression of inflammation related genes and high permeability (Chien 
2008b). For example, disturbed shear (oscillatory) increases expression of ICAM 
(Dardik et al. 2005). But this is also evident under physiological conditions in 
disturbed flow areas such as carotid bifurcation. Under laminar shear, in-vitro 
activation of several genes occur in the beginning, like prostacyclin and eNOS but 
then they return back to their baseline levels and cell proliferation is inhibited 
(Chatzizisis et al. 2007). Also the Akt pathway was suggested as one of the reasons 
behind the difference between laminar and turbulent flow, since it gets 
phosphorylated under laminar flow and thus inhibits apoptosis under laminar flow 
condition, but not under turbulent flow (Dardik et al. 2005). This is the general 
atheroprotective effect of physiological level of laminar shear. Even a low level of 
laminar flow has an atherogenic effect. The atherogenic effect depends on the 
disturbed flow, and resulting turbulent flow which increases proliferation. 
There is a proven correlation between the mode of flow and arterial thickening. In 
arterial branch where the flow is unidirectional and laminar there is no intimal 
thickening; however when the flow slows down and becomes turbulent arterial 
thickening can be observed (Davies 2009).The effect of the shear stress exerted by 
61 
 
the flow starts with its effect on endothelial cell proliferation and morphology 
(Johnson, Barabino & Nerem 2006). Moreover, attachment of the cells should be 
strong enough so that the endothelial layer would not be removed under shear 
stress due to the blood flow (Feugier et al. 2005). This is especially crucial in the 
anastomosis sites, since turbulence also contributes to the stress sensed by 
endothelial cells and the removal of them is easier. Thus, in general, a strong 
endothelial lining which will act as a non-thrombogenic surface and at the same 
time biochemical activities that would direct smooth muscle cells is a necessity 
either for synthetic grafts or tissue engineered products (Inoguchi et al. 2007). 
2.7.2.2 Effects of Cyclic strain on Smooth Muscle Cell Activity 
The second component of the mechanical effect of blood flow is mainly effective on 
tunica media and the cells within this layer, smooth muscle cells.  Cyclic strain of a 
an average of 8-10%  acts on the smooth muscle cells and it has been shown that 
cyclic strain can trigger a variety of responses from smooth muscle cells, especially 
under in-vitro conditions whereas the response of endothelial cells was 
comparatively insignificant. Under in-vivo conditions normal levels of cyclic strain 
keep smooth muscle cells in contractile phenotype and regulate the expression of 
ECM molecules such as elastin and collagen and also ECM degrading enzymes, 
metalloproteinases (MMPs)(Moore et al. 2001) . An elevation or depression in 
blood pressure triggers vascular remodeling by smooth muscle cells, which is called 
the myogenic effect, and can cause elevation in proliferation, secretion of ECM and 
also degradation (Stegemann, Nerem 2003b). This response can be either due to 
pathological causes or as a result of injury. For example, atherosclerosis evolution 
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causes “out of phase” cyclic strain and shear stress and it is known to have a further 
atherogenic effect on the induced area (Hahn, Schwartz 2009). Although there is a 
consensus on the general importance of the cyclic strain on smooth muscle cell 
phenotype; the literature available on the subject is largely contradictory, with 
regard to cell proliferation, apoptosis and secretion and the effects are not as clear-
cut as in the case of endothelial cells and shear stress (Kim et al. 1999, Standley et 
al. 2002, Stegemann, Nerem 2003a). The effects are highly dependent on amplitude 
and the frequency of the strain as well as the initial phenotype and origin of the 
smooth muscle cells used (Nerem 2003). However, from a tissue engineering point 
of view, cyclic strain is a valuable asset to modulate smooth muscle cell phenotype 
(Butcher, Barrett & Nerem 2006, Stegemann, Hong & Nerem 2005) and there are 
several attempts to utilize this property, either by custom-made systems or by 
commercial units, such as the Flexercell System (Figure 2.14). Either systems such 
as these or pulsatile flow bioreactors can be used to modulate cell behaviour in 
vascular tissue engineering (Jeong et al. 2005, Engelmayr et al. 2006, Kurpinski et al. 
2006).  
For vascular tissue engineering one of the most suitable scaffold form is hydrogels, 
due to their similarities to the soft tissue mechanical properties. However, the most 
readily available hydrogel options such as collagen and fibrin based hydrogels are 
substantially weak mechanically. As a model, such as a vessel phantom, PVA 
cryogels has shown great promise to mimic mechanical properties of the vessels. So 
if this mechanical superiority can be matched by good cell behaviour PVA cryogels 
can be viable options for vascular tissue engineering. The current study focuses on 
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applying the cryogelation property of PVA as a fast and cost-friendly scaffold 
producing method.  
 
 
 
 
 
 
 
 
 
 
2.8 Summary 
Cardiovascular diseases will continue to be a major health care problem in the near 
future and, as the population grows, the need for artificial blood vessels will 
become more urgent. Despite the presence of some well established procedures, 
especially in the area of small diameter vessels (≤6mm) there is a need for new 
methods, as the standard grafts have major patency problems. It is hoped that 
tissue engineered blood vessels will provide the answer to this need as the 
successful attempts outlined in this review demonstrate their potential. However, 
Figure 2.14 Different modes of applying strain to cells in-vitro. 
Flexible membranes can be displaced by several means such as 
platens or vacuum. Flexercell system used in this study uses the 
third mode of action. Different modalities result in different strain 
distribution on the circular elastomeric tissue culture plate 
surfaces (Brown 2000) 
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the methods have not been perfected yet and novel systems are required for 
improvement of the currently available scaffolds and models. PVA cryogels with 
their viscoelastic properties similar to vessel structures and their ability to support 
cell encapsulation could be promising candidates in this respect. 
Arteries are complex structures which are composed of several different cell types. 
The extremely dynamic environment of the arteries due to the blood flow has a 
huge effect on the cell behaviour. Moreover, the constant stress and strain 
conditions present necessitate mechanical robustness, which has been achieved 
through evolution with fibril and cell alignment and with the special composition of 
the ECM of the blood vessels. So any vascular tissue engineering procedure should 
implement these stress-strain conditions for conditioning of the scaffold and the 
cells within.  
The premises of the current study were drawn with respect to these parameters 
together with the physical characterisation of PVA based cryogels as scaffolds.
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CHAPTER 3 
3 Materials, Methods and Research Equipment 
3.1 Materials 
All materials were of the highest purity commercially available and included:  two 
types of PVA, Molecular Weight (MW) = 78400, Vassar Brothers, USA and Sigma-
Aldrich, MW= 89000-98000. The following items were purchased from Sigma-
Aldrich Inc.;  Starch from potato, Gelatin Type B from bovine skin, Collagen, 
Potassium Hydroxide (KOH), Sodium Sulfate (NA2SO4), FITC Labelled Phalloidin, PBS 
(Phosphate buffered saline), RPMI 1640 cell culture medium, DMSO (Dimethyl 
Sulfoxide), FBS (Foetal Bovine Serum),Triton-X, BSA (Bovine Serum Albumin), α-
smooth muscle actin antibody, 99.6% Ethanol, quartz cuvette, Trypsin, 
Penicillin/Streptomycin, SYBR Green, Trizma base, elastin staining kit, trypan Blue. 
The list of the other agents used and the supplier companies are given below: 
Chitosan (85% deacetylation, Jinan Haidebi Ltd, China), Alamar blue (ABDSerotec), 
CFDA cell proliferation assay, Live/Dead cell viability assay, Vybrant apoptosis assay, 
AlexiFluor 546 labelled Anti Mouse IgG antibody (Invitrogen, CA, USA), Anti-eNOS 
type III (endothelial Nitric Oxide Synthase) antibody, FACS flow, FACS clean, FACS 
rinse (BD Biosciences, USA), 0.2 µm filters, sterile pipettes, 6 and 24 well cell culture 
plates, 96 well Elisa reader plates, rings, 25, 75, 175 cm2 cell culture flasks, 
autoclave tapes, centrifuge tubes, frosted slides (Sarstedt, Germany), iscript cDNA 
synthesis kit (Promega, Germany), BCA protein determination assay, BSA standards 
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(BioSciences, UK) DNase, RNeasy RNA isolation kit , (Qiagen, USA), Real-time RT-PCR 
plates and tubes (Applied Biosystems, USA).  
3.2 Methods 
This study was conducted in 3 main parts.  In the first part; three parameters were 
dealt with to elucidate the cryogel formation and the properties of the final cryogel 
structure. As a secondary physical crosslinking method, coagulation bath treatment, 
was evaluated as a reinforcement and additive retaining system. Then, the effect of 
the number of freeze-thawing cycles on cryogel properties and cell attachment to 
cryogels was examined using PVA/Chitosan cryogels. Furthermore, 3 different 
additives (Chitosan, Gelatin and Starch) were used to assess cryogel properties and 
to determine whether any of them were better for endothelial cell attachment 
when compared to the pure PVA cryogel surface. Moreover, secondly, after 
establishment of the most promising gel type, endothelial cell behaviour on this gel 
under static and shear stress conditions was evaluated and the functionality of the 
endothelial lining was demonstrated. The utilization of shear stress induced by 
turbulent flow was also assessed for facilitation of endothelial cell adherence and 
growth. 
Finally, an encapsulation technique with the selected composite was developed and 
the final cell laden gel was assessed for cell attachment and incorporation under 
static and cyclic stress conditions (Figure 3.1). 
 The experimental procedure for the first part is presented below in a scheme 
where experiments pertaining to a given property are listed in columns as there are 
overlapping parts in these experiments (Figure 3.2) and the methods description is 
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organized accordingly by stating the relevant experiments to each individual part of 
the first experimental group. The lists of materials and the equipment used are also 
listed in the corresponding subsections. 
 
 
 
 
Figure 3.1 The general scheme of the experimental route. The results of first section of 
experiments provided the most suitable candidate for sections 2 and 3, whereas results of 
sections 2 and 3 provided the necessary information to develop the co-culture system. 
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Figure 3.2 Experimental procedures for 1st step of the study. The effects of increasing 
freeze-thaw cycle number on cryogel properties and smooth muscle cell attachment and 
proliferation was studied using PVA/Chitosan cryogels, while the apparent physical effects 
of coagulation bath treatment was carried out simultaneously.  These experiments were 
repeated for the case of different additives and the propensity of the surfaces to cell 
attachment was determined with endothelial cells  
 
3.2.1 Determination of Additive, Freeze/Thaw Cycles and Coagulation 
Bath Effects 
3.2.1.1 Cryogel Preparation: 
10% (w: w) PVA (Molecular Weight (MW) = 78400, Vassar Brothers, USA) and water 
soluble chitosan, solutions were prepared in distilled water and mixed at a w: w 
ratio of 9:1. For even distribution of the additives within PVA solution, the mixture 
was stirred at 60 ºC for 2h.  The mixture was then poured into custom-made 
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persplex templates (Appendix A) with a thickness of 500 µm and frozen at -20 ºC 
overnight. Hydrogels were obtained by thawing the frozen solutions at room 
temperature for an additional 12 hours (1st cycle). 
After the 1st freeze-thaw cycle, two routes were investigated: (i) the effect of cycle 
number on gel properties and cell behaviour with PVA/Chitosan hydrogels and (ii) 
the possible improvement of gel properties by using different additives; namely 
starch and gelatin. PVA/Starch and PVA/Gelatin cryogels were prepared with the 
same procedure described above (Figure 3.3). 
 To determine the effect of number of freeze/thaw cycles, the procedure was 
repeated 2 or 4 more times (3rd cycle, 5th cycle). Hydrogels were further 
crosslinked by immersion into a coagulation bath composed of 1M KOH and 1 M 
Na2SO4 for 1 hour under constant agitation at room temperature.  After the 
coagulation bath treatment the hydrogels were washed with dH2O several times 
and stored at 4 ºC until use. 
 
 
Figure  3.3  Cryogel Formation procedure. First either pure PVA or 9:1 w:w PVA/Additive 
solutions were prepared, then gel formation was induced by successive freeze-thawing 
cycles and the resultant gels were further crosslinked with the coagulation bath treatment. 
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Properties Affected by Coagulation Bath Treatment 
The initial experiments prove the validity of the claim that coagulation bath can 
help retaining the additives within the cryogel structure while improving 
mechanical properties. However, as it was noticed that coagulation bath treatment 
also causing significant physical changes in cryogels, tests 3.2.1.2- 3.2.1.6 were 
carried out to quantify these effects. Then tests 3.2.1.7-3.2.1.9 was done to 
evaluate the effect of coagulation bath with different additives. These experiments 
provided the basis for comparison of different additives and different freeze-thaw 
cycle number with PVA/Chitosan specifically prior to cell culture experiments. 
3.2.1.2 Determination of Water content 
To assess the effect of the coagulation bath treatment on water content of the 
hydrogels, hydrogels were cut into 1x1 cm2 pieces weighed after blotted dry and 
air-dried for 24 hours. The water content was determined by the measurement of 
the difference between wet and dry weight of the hydrogel samples before and 
after coagulation bath treatment (n≥6). Results were given as % Water content. 
3.2.1.3 Surface Hydrophilicity 
Surface hydrophilicity is an important determinant of protein adsorption and cell 
attachment. Surface hydrophilicity of the hydrogels was measured by 
determination of the water contact angle (the Sessile drop method) using a 
goniometer on hydrogel surfaces which have been blotted dry (Figure 3.3). Flat 
hydrogel surfaces were positioned under the syringe tip and the angle 
measurements made automatically after the contact of the drop with the hydrogel 
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surface. Measurements were done for before and after coagulation bath for 1st, 3rd 
and 5th cycle PVA/Chitosan hydrogel samples (n≥4). To better assess the wettability 
of the hydrogels, continuous measurement of contact angle was performed for 20 
secs with PVA/Gelatin hydrogels (20 measurements, n≥ 3).  
 
 
 
 
 
 
 
 
 
 
3.2.1.4 Shrinkage due to the crosslinking 
Cylindrical Hydrogels with a thickness of 1 mm and a diameter of 1.6 cm were 
produced and their dimensions verified by 6 measurements per sample with a 
digital micrometer for 1st cycle cryogels. The changes in hydrogel dimensions 
(diameter and thickness) were measured by a micrometer and recorded as 
percentage change (n≥3) after coagulation bath treatment of the specimens. 
 
 
Figure 3.4 Contact angle measurement. Representative measurement of 
contact angle on the hydrogels. (PVA/Chitosan 5th cycle hydrogel) 
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3.2.1.5 Surface Roughness 
Surface roughness was determined by Mitutoyo SurfTest 402 Profilometer for 1st 
cycle cryogels. The profilometer was first calibrated with a surface with known 
roughness (1 μm), before the flat samples were placed in contact with the tip of the 
profilometer and the measurements were made on random areas on the cryogel 
surface with a precision of 0.1 micrometer over a length of 5 mm (n≥6). 
3.2.1.6 Surface Morphology 
Surface morphology of the hydrogels in both the dry and wet state was assessed by 
microscopy. For the wet state, hydrogels were observed before coagulation bath 
under an inverted phase-contrast microscope to assess the change in surface 
morphology due to freeze thaw cycle number and also the type of additive. For 
higher magnification observation, samples before and after the coagulation bath 
were freeze-dried for at least 6 hours and then sputter coated with gold for 80 
seconds before being observed  using a Scanning Electron Microscope under high 
vacuum conditions. 
Effect of Freeze-Thaw Cycle number and the Additives 
The main areas where the effects of freeze-thaw cycles on PVA/Chitosan cryogels 
were assessed were the mechanical properties, degradation, protein adsorption 
and smooth muscle cell attachment and proliferation as listed through 3.2.1.7-
3.2.1.13. The same experiments with endothelial cells instead of smooth muscle 
cells were carried out in the presence of all three different additives. The physical 
characterisation experiments outlined between 3.2.1.1-3.2.1.7 were utilized 
whenever they were beneficial for explanation of the results.  
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3.2.1.7 In-situ Degradation 
In order to assess the effect of the coagulation bath on hydrogel degradation, pre-
weighed swollen PVA based hydrogels, before and after treatment, were cut to 1x1 
cm squares and transferred to 24 well plates with sterile forceps. The hydrogels 
were sterilized with 70% ethyl alcohol for 2 hours and then alcohol was washed 
with sterile PBS several times before the hydrogels were suspended in 2 ml sterile 
PBS (10 mM, pH 7.4) and incubated under standard tissue culture conditions (37 °C 
and %5 CO2). The degradation medium was changed weekly. After 2 weeks of 
incubation, samples were removed, washed with copious amounts of distilled 
water and subsequently blotted dry before they were weighed (n≥ 3). Degradation 
was reported as % weight loss. The effect of degradation was also observed with 
SEM imaging. 
3.2.1.8 Uniaxial Tensile Strength Test 
To assess the tensile strength and elasticity of the hydrogels, uniaxial tensile 
strength tests were carried out with dog bone samples that were cut from hydrogel 
slabs with a custom made cutter (length x width: 25 mm x 3mm). Tensile strength 
tests were conducted by a Zwick-Roell Z005 Universal Mechanical tester with 
custom made grips for tissue and polymer samples (Zwick-Roell, Germany) at a 
strain rate of 60%/min. Initially, the hydrogels were put through a preconditioning 
cycle (1 cycle) at the same loading rate up to 60% strain (n≥6). All types of hydrogels 
were tested both before and after coagulation bath treatment and after 1st and 3rd 
freeze/thaw cycles. Samples were tested up to failure. 
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3.2.1.9 Protein Adsorption 
Protein adsorption onto the hydrogels was quantified by Bicinchoninic acid assay 
(BCA) (Pierce, USA). Two standard proteins 1 mg/mL bovine serum albumin (BSA), a 
globular protein with an average Molecular weight of 65 kDa and 1 mg/ml rat tail 
Collagen type I, a fibrillar protein with an average MW of 285 kDa were applied 
onto the hydrogels at room temperature. The protein adsorption was allowed to 
proceed overnight. The desorption of the proteins was performed by incubating the 
hydrogels in a 3M Urea/5% sodium dodecyl sulfate (SDS) solution overnight (n≥6). 
The amount of protein inside the desorption solution was determined by incubating 
10 μL of the solution in 200 μL of BCA reagent solution at 37 ºC for 30 minutes and 
measuring the absorbance at 562 nm with a microplate reader (Biotek ELx800). 
Absorbance values were converted to concentration with respect to a standard 
curve of known BSA and collagen concentrations (Appendix B). 
3.2.1.10 Cell Culture conditions 
For determination of surface feasibility for cell attachment; bovine thoracic aortic 
smooth muscle cells (BASMC)  and bovine thoracic arterial endothelial cells (BAEC) 
(Coriell Institute, NJ, USA) from the same animal were cultured under standard 
tissue culture conditions (37 ºC, %5 CO2) in RPMI 1640 medium (Sigma-Aldrich, UK) 
supplemented with %10 Foetal Bovine serum and 1 % Penicillin/Streptomycin. All 
experiments were conducted with cells between passage 10-18 for smooth muscle 
cells and passage 8-12 for endothelial cells. Smooth muscle cells were initially used 
for determination of the effect of freeze-thaw cycle number on cell behaviour on 
PVA/Chitosan cryogels. The initial use of endothelial cells was to determine the 
PVA/biomacromolecule composite cryogel that supported the best cell attachment 
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and proliferation.  Cells were either seeded separately or successively for co-culture 
experiments. 
All hydrogels, except hydrogels used for smooth muscle cell encapsulation, were 
sterilized by immersion into 70% Ethyl alcohol for 2 hours and following washing 
steps with sterile PBS, stored in culture medium in a CO2 incubator overnight to 
promote protein adsorption. Alternatively, sterilized PVA/Chitosan cryogels were 
coated with sterile filtered rat tail Collagen type I, which is a constituent of the 
native ECM environment of SMCs (Sigma-Aldrich, UK) at a concentration of 100 
µg/cm2. The adsorption was achieved by overnight incubation at 37 °C before the 
hydrogels were washed with PBS several times. This was only done for smooth 
muscle cell experiments on PVA/Chitosan cryogels for different freeze thaw cycle 
numbers. 
The standard culture on PVA composite cryogels were carried out after incubation 
of cryogels in serum containing medium overnight following sterilization. The cells 
were trypsinised and the cell number was quantified by trypan blue before they 
were seeded onto the hydrogels, at a concentration 5x104 cells/cm2 in 20 μL of 
medium. After an initial attachment period (15-30 min), the medium was 
completed to 500 μL. 
3.2.1.11 Fluorescence Microscopy 
To assess cell attachment, proliferation and morphology, hydrogel samples were 
stained with DAPI (a DNA binding dye that stains cell nuclei) and FITC-labelled 
Phalloidin (a fungal toxin with specific affinity to f-actin fibrils; that visualizes the 
cell cytoskeleton). Hydrogel samples were fixed with 3.7% formaldehyde for 5 min 
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and then rinsed with PBS. Afterwards cells were permeabilised by treatment with 
0.1% Triton X solution. After removal of Triton-X, samples were incubated in 1% 
PBS-BSA solution at 37 °C for 30 minutes to decrease non-specific absorption of the 
dyes. 1:1000 dilution of DAPI and 1:200 dilution of FITC-Phalloidin were applied to 
the samples before the samples were incubated in the dark for 15 minutes. After 
washing with PBS several times, the samples were observed under an 
epifluourescence microscope under single or multiple fluorescence modes 
(Olympus, Japan). 
3.2.1.12 Alamar Blue Cell proliferation assay 
Cell attachment and proliferation was quantified by Alamar Blue Cell proliferation 
assay (AbBiotech, USA) at 24 h and 7 d post seeding for BASMC and day 2, 5, 10, 
and 15 for BAEC. Alamar Blue solution (10% in serum free RPMI 1640 medium) was 
applied onto the hydrogels and absorbance of the dye at 562 and 595 nm for initial 
BASMC tests and 570 nm and 600 nm for the rest of the tests, was determined after 
one hour of incubation in culture. Absorbance readings were converted to dye 
reduction % as per instructions of the manufacturer (Appendix C). Calibration 
curves for cell numbers determined by trypan blue assay was drawn for both cell 
types. Dye reduction (%) is indicative of cellular metabolic activity, i.e. higher 
reduction signifies higher cell number for a given cell type, as the metabolic activity 
differs between cell types. 
Summary of the Structure of First Experimental Part 
The determination of cryogel properties was initiated with the determination of the 
physical effects of secondary crosslinking step (coagulation bath), followed by the 
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determination of effects of different freeze-thaw cycle numbers and additives in a 
staggered series of experiments to obtain the data on the possible effects of 
physical characteristics on cell behaviour outcomes 
3.2.2 Endothelial Cell behaviour on PVA based hydrogels 
After determination of the best candidate for the additive to PVA; a more elaborate 
examination of the endothelial cell adhesion and proliferation was carried out on 
the selected additive (PVA/Gelatin).  To this end, endothelial cell proliferation and 
apoptosis were determined via FACS analysis and expression of several cell-cell 
contact molecules was determined with Quantitative Real-time RT-PCR tests. As a 
marker of endothelial functionality, the expression and activity of eNOS synthesis of 
Nitric Oxide (NO) was determined. All these tests were also conducted under shear 
stress conditions produced by direct or ramped turbulent flow produced by an 
orbital shaker. 
3.2.2.1 CFDA Cell Proliferation Assay 
CFDA is a non-toxic dye which can penetrate the cells and change in its distribution 
over time within a cell population can be used as direct evidence of mitosis. For 
labelling with CFDA, cells were seeded onto the hydrogels and allowed to recover 
overnight. Assay solution was prepared by adding 90 l DMSO to the CFDA SE 
solution and mixing well by pipetting gently (stock solution of 10mM). A 1:2000 
dilution of the stock CFDA SE was prepared in sterile PBS, resulting in a working 
concentration of 5 M for the dye. The samples were removed from the incubator 
and washed with PBS. After removal of PBS, PBS-CFDA SE solution was added to 
each sample and the samples were placed into the incubator for further 30 min. 
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PBS-CFDA SE was removed and replaced with complete media and the samples 
were incubated in a CO2 incubator. At days 2, 5, 10 and 20, the cells were harvested 
by trypsinisation (2x) and placed in 1.5 ml eppendorf tubes on ice. The tubes were 
centrifuged at 1000-1500 rpm for 5 mins @ 4oC. The supernatant was removed 
without disturbing the cell pellet and 500µl of 1 X PBS containing 0.1% BSA was 
added into each eppendorf tube and the centrifugation was repeated. After 
removal of PBS-BSA the pellets were gently resuspended in 200µl of 1x PBS-0.1% 
BSA and placed into FACS tubes for analysis. Analysis of Fluorescence of CFDA per 
cell was done for at least a cell population of 10000 for each sample (n≥3) with the 
FACScalibur flow cytometer system (BD Sciences, USA). Decrease of CFDA 
fluorescence intensity per cell is an indicator of active cell division (Figure 3.5). For 
comparison purposes the average fluorescence intensity (FI) was determined and 
1/FI was used for quantification of proliferative activity. 
3.2.2.2Vybrant Apoptosis Assay 
To determine the health of the cells on the hydrogel surface and the strength of the 
initial attachment, the level of apoptosis and necrosis were determined with 
Vybrant Apoptosis assay. This assay is based on labelling of Annexin V, which is a 
marker of apoptosis that binds to phophatidylserine (PS) which is normally located 
in the cytoplasmic side of the membrane and which translocates to the outer layer 
in apoptotic cells, and Propidium Iodide (PI) which is impermeant to viable and 
apoptotic cells and can penetrate only damaged or necrotic cells. Unlike TUNEL or 
caspase based assays  single cell apoptotic condition can be determined, thus this 
assay is more precise for determination of the percentage apoptotic cells. Cells 
were seeded onto the hydrogels at the density required and allowed to recover 
overnight. The next day, cells were removed from the incubator and washed once 
with 0.2% BSA media (1ml per well) to remove the serum. The BSA wash was rinsed 
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and replaced with 0.2% BSA the media for each well before the cells were allowed 
to quiesce overnight. At day 2, 5 and 10 and 20, cells were washed with 1ml of PBS 
and then the cells were trypsinised with 2x Trypsin-EDTA solution for 5 min. After 
trypsinisation, the cells were placed in 1.5 ml eppendorf tubes and placed on ice. 
Cells were kept on ice up until addition of the reagents. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Higher proliferative Capacity 
Figure 3.5 Representative CFDA read-outs from FACS analysis a) A generic 
evolution of the fluorescence readings over culture interval; from 0 to 5 
the decrease in fluorescence intensity denotes cellular division(adapted 
from Vybrant CFDA proliferation assay manual) Inset) Number of cells vs. 
FSC (cell size), which can be used to differentiate between different cell 
types or to validate the uniformity of the cell shape after different 
treatments b) CFDA Fluorescence reading after day 15 of culture 4 read-
outs from PVA/Gelatin hydrogel samples vs. one TCPS control (Red line). 
The proximity of the readings to y axis is an indication of proliferation. 
 
A 
B 
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The Apoptosis assay solutions were prepared as follows: 
An appropriate volume of 5 X ABB is diluted in PBS-0.1% BSA (to 1 X) to allow 
addition of 200 µl to each sample. A 100µg/ml working solution of Propidium Iodide 
(PI) was prepared by diluting 5µl of the 1mg/ml stock in 45µl of 1 X Annexin Binding 
Buffer (ABB). Meanwhile, the eppendorf tubes containing the cells were placed into 
the centrifuge and the cells were pelleted by centrifugation at 1000-1500 rpm for 5 
mins @ 4oC. Cells were placed on ice and the media was removed from each tube 
without disturbing the cell pellet. A 500µl solution of 1 X PBS containing 0.1% BSA 
was added into each eppendorf tube and the centrifugation was repeated. PBS-BSA 
solution was removed without disturbing the pellet and the cells were gently 
resuspended in 100µl of 1 X ABB. Then, 1µl of Annexin V and 0.4µl of PI was added 
to each 100µl volume of cell suspension and the preparation was incubated at 
room temperature for 15 mins. Following the incubation, a further 100µl of 1 X ABB 
was added to the cells, the cell suspensions were placed into FACS tubes, and 
return the samples to ice. Annexin V and Propidium Iodide fluorescence was 
analysed for at least a cell population of 10000 for each sample (n≥3) with the 
FACScalibur flow cytometer system (BD Sciences, USA). Annexin V is an apoptosis 
marker and PI is a nuclei stain; the ratio of their fluorescence intensity is an 
indicator of the cell condition; viable, necrotic, early apoptotic or late apoptotic. 
Cells that shows low level of PI and Annexin V fluorescence are viable cells where as 
cells which only show high fluorescence in Annexin V are early apoptotic cells, high 
fluorescence in both channels denotes late apoptotic cells, whereas only high 
fluorescence in PI filter marks necrotic cells (Figure 3.6). 
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Figure 3.6 Determination of the apoptotic cells by FACs using Vybrant Apoptosis assay. 
Regions are divided   as: R2) viable cells R3) Early apoptotic cells R4) Late apoptotic cells 
R5) Necrotic cells. 
 
3.2.2.3 RNA Isolation and Quantification of gene expression (Real 
time-RT PCR): 
Cell-cell contact is one important part of inflammatory response and also impacts 
on the formation of an endothelial barrier. To this end, three cell-cell contact 
adhesion molecules were selected for quantitative analysis of their expression by 
RT-PCR. Endothelial cells (BAEC) were seeded on both PVA-Gelatin hydrogels and 
TCPS (Tissue Culture Polystyrene) at a density of 5 x 104 cells/cm2, and the total RNA 
was isolated by RNeasy RNA isolation kit (Qiagen, USA) after day 2, 5 and 10. The 
cells were trypsinised using 0.25% Trypsin-EDTA solution for 5 minutes and were 
then collected into RNase-free centrifuge tubes and centrifuged for 5 mins at 300g. 
R2 R3
R4R5
         Viable       E. Apototic 
ApoApop 
      L. Apototic 
ApoApop 
         Necrotic 
ApoApop 
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Afterwards, removal of supernatant cells was disrupted by RLT (Lysing buffer) 
buffer and the lysate was homogenized using a 20 gauge sterile needle (BD 
Sciences) by aspirating cells at least 5 times. An equal volume of 70% Ethanol 
(prepared with RNase free water (GIBCO, USA)) was added and the sample was 
transferred to Rneasy spin column and centrifuged at 8000g for 15 s. Flow through 
was discarded and the same volume of RW1 buffer was added and the column was 
centrifuged again at the same speed. The column was washed by RPE buffer two 
times by the centrifugation at the same speed for 15s and 2 minutes, respectively. 
The spin column was placed inside a collection tube and 40 µl of RNase free water 
was added and the column was centrifuged again for a minute. Isolated RNA was 
quantified by diluting the RNA sample 50 times in Tris-HCL (pH 7.0) buffer and 
measuring the absorbance at 260 nm; theoretically an absorbance of 1 corresponds 
to 44 µg/ml of RNA. Ratio of absorbance at 260/280 was used for the purity 
measurement. Measurements were initially done standard UV-Vis spectrometer 
with a quartz cuvette and later verified with Nanodrop spectrophotometer for RNA 
samples. 
cDNA synthesis was performed by using iScript cDNA synthesis kit.  The volume 
corresponding to 1 µg of RNA for each sample was added to 4 µl of 5x iScript 
reaction mix, 1 µl of Reverse Transcriptase and the necessary amount of water to 
complete the reaction mix to 20 µl. The reaction was carried out at the following 
conditions; 5 minutes at 25 °C, 30 minutes at 42 °C and 5 minutes at 85 °C. The 
amount of cDNA and its purity is again quantified by Nanodrop spectrophotometer (Figure 
3.7).  
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Finally cDNA was analysed by using SYBR Green Jumpstart Taq ReadyMix for 3 
endothelial phenotype markers (ICAM, Selectin P, and PECAM) and one house 
keeping gene (GADPH). Primers for these genes were designed by using Primer 3 
Software by using mRNA sequences obtained from Entrez Nucleotide Database 
(Appendix D). Reaction was carried out by using 25 µl of SYBR Green with 0.2 µM of 
forward and reverse primers 10 ng of cDNA and the necessary amount of water to 
complete reaction mix to 50 µl. Then the PCR reaction was carried out for 40 cycles 
with the following cycling conditions: Initial denaturation (94 °C): 2 min, then 40 
cycles of denaturation (94 °C, 15 s), annealing (60 °C, 1 min), extension (72 °C, 
1min). The efficiency of the primers were checked with calibration curves obtained 
with serial dilutions of target cDNA and then the results were normalized against 
housekeeping gene and negative controls (Figure 3.8). The primer sequences and 
details can be found in Appendix D. Final results are reported by 2-ΔΔCt  method. 
Figure 3.7 Representative mRNA and cDNA amount measurements 
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Figure 3.8 Representative readings for Real-time RT-PCR amplification curve. Dark 
Blue Line (GADPH, Housekeeping gene), Light blue (PECAM), Black (Selectin-P) and 
horizontal lines are negative control. Threshold values (Ct) were determined by an 
algorithm available within the analysis program R 2.2 Inset) Melting curves, to 
assess the specificity of the reaction 
3.2.2.4 Nitric Oxide Synthesis 
Nitric Oxide (NO) synthesis, which is an important indicator of endothelial cell 
function, was determined by the Griess method. Levels of NO secreted by 
endothelial cells were evaluated by measuring nitrate, nitrite metabolite levels by 
mixing 500 µl of culture medium obtained from the samples with the equal amount 
of Griess reagent and measuring the absorption of the final solution after 15 
minutes of incubation at 540 nm with a microplate reader. The absorbance values 
were converted to micromolar through a calibration curve made from known 
concentrations of Sodium Nitrite (NaNO2
- ). 
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3.2.2.5 Effect of shear stress 
To determine the effect of shear stress on endothelial cell behaviour was applied to 
the hydrogels fixed under a nylon O-ring by mounting and securing the culture 
plates on an orbital shaker unit. The shaker unit is placed inside a water-jacketed 
CO2 incubator. The shear stress produced as a result of the orbital motion (Stuart 
Scientific Mini orbital shaker) can be determined by the following formula, which is 
a validated empirical fit (Ley et al. 1989): 
τ =  
where: 
α is the radius of rotation = 0.02 m, ρ is the density of full culture medium (with 
serum and antibiotic addition, measured in house as 987.1 kg/m3), n is the viscosity 
of the full culture medium (measured in-house by a cone and plate viscometer with 
the cone angle of 2 degrees as 9.1 x 10-4 Pa.s), f is the number of rotations per 
second (rps). So from the equation the necessary revolutions per minute were 
calculated for each of the following shear values: 2.5 dyn/cm2, 5 dyn/cm2, 10 
dyn/cm2. Shear stress was applied either by direct application of physiological stress 
levels (10 dyn/cm2) or ramping of the shear rate slowly (referred to as ramping) in 3 
steps from 0 dyn/cm2 to 10 dyn/cm2 (6 hours at 2.5 dyn/cm2, 6 hours at 5 dyn/cm2 
and 12 hours at 10 dyn/cm2) (Figure 3.9). Ramping effect was selected with respect 
to the previous work in our lab that showed that endothelial cells could withstand 
immediate application of shear under these conditions up to 4 dyn/cm2 , so for 
acclimatisation the first step was kept below this limit, upper limit was decided on 
the literature values (Inoguchi et al. 2007, Dangaria, Butler 2007). 
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Figure 3.9 Orbital shaker setup. a) Tissue well plates are secured to the holder area of the 
orbital shaker. b-c) Effect of the orbital movement, b) before start of the motion c) During 
100 rpm rotation. d) Movement of the culture medium within the tissue culture wells. 
 
Cell proliferation and apoptosis were determined by Alamar Blue, CFDA and 
Vybrant Apoptosis assays as described above. Cell morphology was observed with 
DAPI/Phalloidin staining. Gene expression both under direct and ramping shear was 
also determined by Real Time RT-PCR as described above. The Griess method was 
used for determination of the NO synthesis levels. Additionally, endothelium 
formation was observed with SEM, and cell removal due to direct application of 10 
dyn/cm2 shear stress and its effect on surface roughness was characterized by 
obtaining 3D SEM images and subsequent roughness measurements using Alicona 
Max 3D Image production software. Briefly, 3 images of the same surface were 
taken by three tilting positions (0, 10°, 20°) and then these images were matched in 
A 
C 
D 
B 
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the program and 3D constructs were produced. Surface roughness was estimated 
by line and area measurements (n≥ 3). 
3.2.3 Smooth Muscle Encapsulation and Storage via Cryogelation 
The third part of the study was to develop an encapsulation system via cryogelation 
to produce a cell-laden scaffold and a method to cryopreserve the product. For this 
purpose, statistical experimental design methodologies were utilized to assess the 
interaction and effect of several parameters on gelation and cell viability in order to 
reach an optimum design. The design of experiments is an efficient way to 
determine the effect of several parameters on a systems behavior while reducing 
the number of experiments necessary. 2n factorial designs are also beneficial for 
determination of interaction between several parameters changed between two 
levels. Box-Behnken design is good for observation and derivation of higher level 
models around a centralised experimental design. 
3.2.3.1 Determination of Pre-encapsulation parameters: 
pH of the solution mixtures before and after buffering and in the presence and 
absence of the several additives was determined to evaluate its effect on the 
outcome. The viscosity of the different PVA solutions and composite solutions were 
quantified by cone and plate type viscometer analysis (n≥3). 
3.2.3.2 Smooth Muscle Cell encapsulation in Hydrogel structures 
For encapsulation of the smooth muscle cells in a 500 µm thickness hydrogel, 
several factorial experimental design schemes were developed using DesignExpert 
8.0 software (StatEase, USA) to determine the optimum encapsulation conditions 
concerning multiple variables. Variables dealt with were: 
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1) Solution viscosity 
2) Presence of cryoprotectants and their type (DMSO, Optifreeze 
cryopreservant media), 
3) Concentration of the nutrients within the encapsulation system,  
4) Application of further crosslinking with a coagulation bath. 
 Two levels of each factor was taken (for example, presence of DMSO and Serum, 
10%, absence 0%) for the experiments and all the possible combination for these 
two levels (Hence 24 factorial design) were checked in 3 separate randomized 
blocks of experiment for determination of the most significant factors effecting the 
cell viability and their interactions. Cryoprotectant and coagulation bath sterility 
was ensured by sterilization, sterile filtration. Response curves were drawn in light 
of cell survival following encapsulation procedures. The initial screening was done 
by a general factorial experimental design. After evaluation of the results of these 
tests, further determination of the effect of DMSO and serum concentration was 
performed by a separate Box-Behnken experimental design (with cryoprotectant 
type as the third factor) with three replicate blocks. Box-Behnken designs are 
suitable for deriving quadratic interactions between the factors observed, by doing 
3 level combinations of the factors around a central design point. Repetition of the 
central design point solidifies the reliability of the trends (Goodness of fit) set by 
the experiments. 
After initial viability results, with the optimal cryogel formulation, cell proliferation 
was assessed by Alamar Blue assay up to 14 days. Cell distribution was assessed by 
DAPI staining and phase contrast microscopy. Hydrogel formation was observed 
and the stability test was carried out in sterile PBS for 72 hour periods. 
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3.2.3.3 Histology 
To observe the distribution of the cells within the hydrogels, the hydrogel samples 
were fixed with 3.7% Formalin overnight on days 1 and 7 of the culture period. The 
samples were washed and dehydrated via a series of ethanol treatments (%70 up to 
pure ethanol) and finally after treatment with pure xylene before the samples were 
embedded into paraffin wax and cut with a microtome to obtain 4 µm sections. 
Sections were fixed onto frosted glass slides and stained with standard 
Haemotxylin& Eosin stain. Sections were observed with a standard light microscope 
and the images taken by a digital camera fitted to the eyepiece. 
3.2.3.4 Effect of Thawing Rate, Storage Time and Cell Type 
Since one of the aims of the system is to store viable cells and the thawing rate is an 
important determinant of the final gel mechanical properties, the storage and 
thawing rate effects were examined for the encapsulation. Storage was done for 
the periods of 1, 2 and 4 weeks under -70 °C. Immediately after thawing, cell 
viability was checked with Alamar Blue assay and after 3 days of culture cell 
presence and viability was tested by Live/Dead Cell viability assay (described in 
3.2.3.5). The thawing rate was in between 0-30 minutes prior to addition of pre-
heated culture medium. To show that the encapsulation procedure can be applied 
for different cell types, rat arterial smooth muscle cells and bovine thoracic 
endothelial cells were also encapsulated. To prove the protective properties of the 
hydrogel encapsulation, confluent monolayers of bovine smooth muscle cells were 
frozen and thawed with conventional slow-cooling cell storage method and 
observed 2 h after thawing to assess the level of viability. Hydrogel structure and 
the cell distribution were further evaluated by SEM. 
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3.2.3.5 Long Term Cell Viability (Live/Dead Viability assay) 
In order to prove that the cells are sustained throughout the hydrogel and they 
were viable, live and dead viability assays were conducted on samples which were 
freshly removed from culture. The working principle of the kit is that the 
fluorescence of Calcein, which is initially present in the kit solution as Calcein-AM, is 
cell permeant but non-fluorescent. The conversion of Calcein-AM to calcein is only 
possible via intracellular esterase activity and as a result viable cells which catalyze 
this reaction would fluoresce green. The second component, Ethidium homodimer 
(EtHD1) is non-cell membrane permeant and it has ability to bind DNA or RNA; thus 
its fluorescence is limited to damaged cells. After 1, 3, 5 and 7 days of culture, 
hydrogels were removed aseptically washed with PBS and then Ethidium 
Homodimer (4 µM) and Calcein AM (2 µM) mixture in sterile PBS was applied and 
the samples were incubated for 30 minutes at 37 °C. After incubation the gels were 
washed with PBS several times to remove the excess dyes and observed under an 
epifluorescent microscope with two different emission filters. Images are collated 
using the Cell-F imaging program (Olympus, Japan). The green areas denote viable 
cell cytoplasm whereas red areas denoted damaged cells with exposed DNA; which 
is bound by Ethidium Homodimer. As negative control, empty hydrogels were 
stained to; to show the specificity of the staining. 
3.2.3.6 Uniaxial Tensile Strength of Cell Encapsulated Cryogels 
Further mechanical tests were carried out to assess the effect of different gelation 
procedure via encapsulation on cryogel mechanical properties. For this end, the 
optimized gel mixture was poured into Flexercell plates and gel formation was 
achieved by the gelation mixture in the presence or in the absence of the cells. 
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After gelation, empty gels were also exposed to cyclic biaxial strain using a 
FlexercellTM Strain unit system, to assess the effect of fatigue or strain hardening of 
the gel mixture at a strain of 10% at 1 Hz frequency after 24 h. Dog bone shape 
cutter with a different dimension (length x width: 15 mm x 3 mm) was used, due to 
the size limitation of the Flexercell plates. Samples were cut for uniaxial tensile 
strength tests as described in section 3.2.1.10 (n≥6).  
3.2.4 Application of Cyclic Strain to Encapsulated cells 
FlexercellTM Strain unit is capable of applying physiological level of cyclic stresses 
and strains by application of controlled vacuum beneath sterile tissue culture plates 
specifically designed to fit the moulds where the vacuum is applied (Figure 3.10). To 
apply cyclic strain to the encapsulated cells within PVA/Gelatin hydrogels; gels were 
formed within pronectin coated Flexercell culture plates and after thawing and 
addition of culture medium; plates were mounted onto the Flexercell system and 
sealed. A thin layer of initial PVA/Gelatin solution secured the attachment of the 
cryogels ontot he elastomer surface. Then, cyclic strain at the level of 10% was 
applied via the FX4000 controller system for a period of 24 hours which 
corresponds to 86400 cycles.  Afterwards, cell number was determined by Alamar 
blue assay and cell distribution was assessed with Live-Dead cell viability assay and 
morphology of the cells was assessed with SEM. 
92 
 
 
3.2.5. Endothelial/Smooth Muscle cell co-culture experiments 
Since the final aim is to produce a hydrogel structure where SMCs are encapsulated 
within and the endothelial cells cover the lumen surface, cell-laden hydrogels were 
seeded with endothelial cells to show that they support attachment and 
functionality of endothelial cells (Figure 3.11). To this end, by using the optimized 
smooth muscle cell encapsulation protocol, a co-culture system was developed. For 
full gel formation, at least endothelial cell seeding was done on to the cryogel 
surfaces after removal of medium and endothelial cells were allowed to attach to 
the surface. After the initial attachment period, the co-culture system was cultured 
under standard culture conditions. Since serum supplemented RPMI-1640 media 
was feasible for both cell types, medium composition did not need to be changed.  
After initial feasibility experiments, an experimental design was carried out to see 
the effect of three parameters. 
Figure 3.10  Flexercell system a) Mold base for the fitting of Flexercell culture plates.  
Application of controlled vacuum causes deformation of the elastomeric plate, 
deformation of the cryogels was achieved by the vacuum-driven platen movement 
beneath the plate b) Overview of the system which is composed of a vacuum pump, a 
controller system, computer interface and a CO2 incubator. 
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3.2.5.1 Experimental Design for Co-culturing and NO synthesis 
To  determine the best conditions for commencement of endothelialisation, a 
general factorial design (two 3 level and one 2 level factor based, factorial design) 
was employed, for the parameters of (i) storage time (1 day,4 days, 1 week),(ii) SMC 
culture period (1day, 5 days, 10 days) and (iii) shear stress application( 0 and 10 
dyn/cm2) (Table 3.1). The response selected was the NO synthesis level following 
two days of culture. All experiments were conducted in three blocks, in which there 
are at least 3 replicates (54 runs). Also levels of NO were checked after 5 days.  
 
                                               
 
 
 
 
 
 
 
Figure 3.11 Schematic representation of co-culture experiments a) The optimum gelation 
solution is prepared with respect to the results obtained from encapsulation experiments 
b) Smooth muscle Cells are added to the mixture and gels were obtained after a Freeze-
thaw cycle c) After gel formation, endothelial cells were added on to the top of the 
hydrogels for endothelialisation. 
A 
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Table 3.1 List of the experimental combinations for co-culture experiments. The 
experiments conducted for determination of effect of cryogel storage time, SMC culture 
period and shear stress application on NO synthesis by BAEC in co-culture system. 
      Standard 
   Run Number 
Randomized 
Run Number 
         Storage 
           Time 
Culture 
Time 
Shear 
44 1 7 days 5 days 10 
47 2 1 day 10 days 10 
29 3 1 day 1 day 10 
26 4 7 days 10 days 0 
2 5 1 day 1 day 0 
1 6 1 day 1 day 0 
24 7 3 days 10 days 0 
54 8 7 days 10 days 10 
28 9 1 day 1 day 10 
18 10 7 days 5 days 0 
25 11 7 days 10 days 0 
53 12 7 days 10 days 10 
19 13 1 day 10 days 0 
30 14 1 day 1 day 10 
46 15 1 day 10 days 10 
52 16 7 days 10 days 10 
20 17 1 day 10 days 0 
31 18 3 days 1 day 10 
17 19 7 days 5 days 0 
11 20 1 day 5 days 0 
51 21 3 days 10 days 10 
37 22 1 day 5 days 10 
33 23 3 days 1 day 10 
5 24 3 days 1 day 0 
13 25 3 days 5 days 0 
42 26 3 days 5 days 10 
43 27 7 days 5 days 10 
35 28 7 days 1 day 10 
40 29 3 days 5 days 10 
48 30 1 day 10 days 10 
12 31 1 day 5 days 0 
7 32 7 days 1 day 0 
34 33 7 days 1 day 10 
50 34 3 days 10 days 10 
15 35 3 days 5 days 0 
32 36 3 days 1 day 10 
9 37 7 days 1 day 0 
14 38 3 days 5 days 0 
38 39 1 day 5 days 10 
10 40 1 day 5 days 0 
49 41 3 days 10 days 10 
21 42 1 day 10 days 0 
4 43 3 days 1 day 0 
8 44 7 days 1 day 0 
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3 45 1 day 1 day 0 
16 46 7 days 5 days 0 
27 47 7 days 10 days 0 
36 48 7 days 1 day 10 
22 49 3 days 10 days 0 
41 50 3 days 5 days 10 
23 51 3 days 10 days 0 
6 52 3 days 1 day 0 
39 53 1 day 5 days 10 
45 54 7 days 5 days 10 
 
 
3.2.5.2 Indirect Immunofluorescence 
In order to differentiate between endothelial cells and smooth muscle cells, indirect 
immunofluorescence was employed by using two distinct markers of endothelial 
and smooth muscle cells. eNOS (endothelial Nitric Oxide Synthase) is a protein 
responsible for synthesis of NO and it is an endothelial specific variant of NOS 
family. Smooth Muscle α- actin on the other hand is a smooth muscle actin specific 
member of actin cytoskeletal protein family, which is more prominently expressed 
in smooth muscle cell in contractile phenotype. As a negative control, a secondary 
dye was applied in the absence of the anti- α-Smooth Muscle actin antibody. 
3.2.5.3 α-Smooth Muscle actin Staining 
After two days of co-culture hydrogel samples were fixed with 3.7% formaldehyde 
for 30 minutes and then rinsed with PBS. The hydrogels were overturned and cells 
were permeabilised by treatment with 0.1% Triton X solution for 5 minutes. 
Following removal of Triton-X; samples were incubated in 1% PBS-BSA solution at 
37 °C for 1 hour. Afterwards 1:300 dilution anti α-smooth muscle actin antibody 
produced in mice was applied to the samples and antibody was allowed to bind 
overnight. The next day, the cells were washed with PBS, the secondary antibody, 
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1:200 dilution of AlexiFluor 546 Anti-mouse IgG antibody was applied and the 
samples were stored in dark for 2 hours. After two hours, 1:1000 dilution of DAPI 
was added as counter nuclei stain and following an additional 15 minute incubation 
in the dark. Samples were observed under an epifluourescence microscope under 
single or multiple fluorescence modes (Olympus, Japan). As a negative control, a 
secondary die was applied in the absence of the anti- α-Smooth Muscle actin 
antibody. 
3.2.5.4 eNOS staining 
After two days of co-culture hydrogel samples were fixed with 3.7% formaldehyde 
for 30 minutes and then rinsed with PBS. Then the hydrogels are overturned and 
cells were permeabilised by treatment with 0.1% Triton X solution for 5 minutes. 
Following removal of Triton-X; samples were incubated in 1% PBS-BSA solution at 
37 °C for 1 hour. Afterwards 1:300 dilution of anti eNOS type III antibody produced 
in mice was applied to the samples and antibody was allowed to bind overnight. 
The next day, after washing with copious amount of PBS, the secondary antibody, 
1:200 dilution of AlexiFluor 546 Anti-mouse IgG antibody was applied and the 
samples were stored in dark for 2 hours. After two hours, 1:1000 dilution of DAPI 
was added as counter nuclei stain and following an additional 15 minute incubation 
in dark; samples were observed under an epifluourescence microscope under single 
or multiple fluorescence modes (Olympus, Japan). As a negative control, a 
secondary die was applied in the absence of the anti-eNOS antibody. 
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3.2.6 Statistical Analysis 
Statistical analysis of experimental designs (ANOVA, model fitting, lack of fit 
analysis, Box-Cox plot and Normal Plot of Residuals) was done and analyzed in Stat-
Ease Design Expert 8.0 software. For a two way comparison, the Student’s t-test 
with significance level of p≤ 0.05 was used and, for multiple sample sets, one-way, 
two-way or three-way ANOVA analysis was carried out with Tukey’s test or Holm-
Sidak method to determine the variance between samples. Again, the level of 
significance was set as p≤0.05. These tests were done in Statistics package 
extension provided in MS Excel 2007. 
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CHAPTER 4 
4 Results 
The results chapter is divided into 3 sections. Prior to cell culture experiments, 
physical characterisation was done to elucidate the mechanism and the effects of 
the 2-step cryogelation protocol on the final cryogel structure. Thus, section 4.1.1-
4.1.3 presents results related to the physical characteristics of the cryogels and how 
these characteristics are affected by freeze-thaw cycle number, coagulation bath 
treatment and changing the additive used to obtain the composite structure, 
together with their influence on cell culture studies. The second section, deals with 
the evaluation of endothelial cell behaviour and it is further divided to sections 
4.2.1 and 4.2.2 which are related to characterization of endothelialisation on the 
hydrogels under static and shear stress conditions, respectively. The third section is 
about the development of the novel encapsulation technique via cryogelation and 
subsequent co-culture experiments. Sections 4.3.1 and 4.3.2 deals with the 
development and optimization of the encapsulation technique and the application 
of cyclic loading and finally, section 4.3.3 describes the results of the co-culture 
experiments. 
4.1 Physical characterisation of cryogelation 
Due to the fact that, the presence of additives interferes with the cryogelation 
process, coagulation bath treatment was used as a method to ensure the retaining 
of the additives and also as a reinforcement system. Because of the availability of 
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previous body of work on PVA/Chitosan cryogels produced with this method, initial 
programme of experiments used this cryogel formulation, to investigate some 
effects of coagulation bath treatment and freeze/thaw cycles which have not been 
determined before. In the next set of experiments involving cryogels with other 
additives some of the experiments were repeated, to understand any changes due 
to the presence of different additives. Statistical significance is stated for discussion 
purposes and for the cases where it was not stated the detailed analysis is given in 
Appendix F. 
4.1.1 Effect of Coagulation bath treatment (PVA/Chitosan hydrogels) 
As a physical crosslinking method, freeze-thawing results in stronger gels when 
applied in multiple cycles. When PVA solutions are exposed to several cycles, it 
tends to form more crystals which define the properties of the hydrogel. The 
presence of additives might change this process. Also the additives are not as liable 
to crosslink under freezing and thawing as PVA and thus an additional crosslinking 
step is needed. In this study coagulation of the polymers in a supersaturated 
solution was used as a secondary physical crosslinking procedure. During the 
experiments it was noticed that the physical changes due to the coagulation bath 
were drastic and since there was no available data in the literature to assess these 
changes, the characterisation of cryogels before and after coagulation bath was 
carried out with PVA/Chitosan cryogels initially. The first aim was to improve the 
cryogels mechanical properties and also their degradation resistance while trying to 
keep other desirable properties within the acceptable limits. One such property is 
the water content of the hydrogels, which should be above 80% for better imitation 
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of the mechanical properties of the vessels. Initially, several coagulation bath 
solutions were tried, but due to the excessive decrease in water content in high 
coagulation bath concentrations (down to 56.16 ± 4.01), a 1M KOH and 1M Na2SO4 
bath composition was used (concentrations between 0.5 and 2 M were tried). The 
most persistent change induced by coagulation bath treatment was the decrease of 
water content of the hydrogels (p=0.0001), which was observed for all cycle 
numbers and also for different additives and PVA concentrations (Figure 4.1a). The 
6/0.9 ratio was the previous ratio utilized in literature and the water content for it 
was measured to determine the effect of lower PVA and chitosan concentrations. 
The most dramatic change was observed on 3rd cycle PVA/Chitosan hydrogels (from 
86.34± 1.00 % to 68.04± 1.36%). Lower concentration PVA/Chitosan gels (6/0.9 w: 
w ratio, as used previously) had higher water contents (90.72 ± 1.06% and 85.38 ± 
3.41%), before and after coagulation bath respectively, p≤0.001); However they 
were considerably harder to handle. For this reason, they were not assessed any 
further.  
The coagulation bath had a distinct effect on the rehydration capacity of the 
hydrogels as measured by the change in weight upon rehydration. Rehydration and 
reswelling which decreased for 1st cycle PVA/Chitosan gels from 2.16± 0.17 to 1.37± 
0.20 times. Rehydration is a property related to the robustness of the gel structure 
and even though there was a considerable decrease. Two-step crosslinked 
hydrogels were still able to rebound up to their original volume. It also affected the 
morphology of the hydrogels both microscopically and macroscopically. The initial 
hydrogels were hard to handle, fragile and transparent; whereas upon application 
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of the coagulation bath, highly resilient and opaque gels were obtained fulfilling the 
set aims (Figure 4.2).   
 
 
 
 
Figure 4.1 Water content and reswelling behaviour of PVA/Chitosan hydrogels  
a) effect of coagulation bath on the water content after different freeze-thaw 
cycles and a different composition (6/0.9 ratio instead of 9/1, after 1st cycle), in 
all cases there was a significant decrease after coagulation bath treatment 
(p≤0.001), whereas the difference between the samples were not significant 
before coagulation bath treatment b) Rehydration behaviour of PVA /Chitosan 
first cycle hydrogels before and after coagulation bath (n=6); before coagulation 
bath hydrogels have nearly 2 fold more swelling capacity (p≤0.001). 
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Initially, long fibres of meshed together polymer chains were visible under SEM 
observation, but upon coagulation bath treatment the surface porosity of the gels 
decreases and surface became more uniform (Figure 4.2 b) Surface changes 
inflicted by the coagulation bath treatment also affected the surface hydrophilicity 
of the hydrogels, where the surface was considerably more hydrophilic following 
application of coagulation bath.   
 
Surface hydrophilicity of the hydrogels was dependent on the number of freeze-
thaw cycles and also the type of the additive used. However, after application of 
the coagulation bath, the contact angle measurements converged which might 
indicate formation of a thin PVA enriched layer on the surface since PVA is the more 
hydrophilic component (Figure 4.3, 4.4). This was the main disadvantage of the 
Figure 4.2 Surface morphology of the cryogels a) Before b) After coagulation bath 
treatment. There is a distinct decrease in surface porosity and the fibre orientation was 
lost.  Insets) Macroscopic views of the hydrogel surfaces; coagulation bath converts 
transparent weak hydrogels to compacted, opaque structures. Representative of 3 
independent observations. 
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secondary crosslinking, since it is known that highly hydrophilic surfaces are 
unfavourable for cell attachment. 
 
The change in the crystalline structure of the gels after successive freeze-thawing 
cycles, via the presence of more crystallites is reported in the literature several 
times, and  would also determine the way they respond to coagulation bath 
treatment. This also had an effect on their degradation. The application of the 
coagulation bath effectively decreased the weight loss, probably due to dissolution 
and removal of the sol (solution) part of the hydrogels. To see whether these 
effects are general, in the next step different freeze-thaw cycle numbers were used 
to determine changes in physical properties. 
 Figure 4.3 Change in water contact angle of PVA/Chitosan hydrogels (n=6)  For 
different concentrations of coagulation bath (0.5 M, 1 M, 2 M) after 1 freeze-thaw 
cycle, the difference between the different coagulation bath concentrations was 
not significant (p= 0.23). 
15.46
12.23
18.44
-3.00
2.00
7.00
12.00
17.00
22.00
C
o
n
ta
ct
 A
n
gl
e
 (
⁰)
Sodium Sulfate Concentration (M)
Effect of Coagulation Bath Concentration
0.5 M
1 M
2 M
104 
 
 
 
 
 
 
4.1.2 Effect of Freeze-Thaw Cycles (PVA/Chitosan) 
 One important advantage of cryogelation technique is its versatility in producing 
scaffolds with different physical properties with small modifications, such as 
increasing freeze-thaw cycle number. As the cycle number increases, cryogels 
become stiffer and since it is shown that stiffer matrices are better for cell 
attachment, in this part of the study the physical changes induced by freeze-thaw 
cycles and the subsequent effect on cell attachment was evaluated. 
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Figure 4.4 Wettability of PVA/Gelatin hydrogels a) Before b) After Coagulation bath 
treatment The average contact angle for PVA/Gelatin hydrogels were 12.57± 1.09 
before coagulation bath and 5.44 ± 1.05 after coagulation bath (n=3) 
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The decrease in surface hydrophilicity after coagulation bath treatment was 
persistent for all cryogels produced via different number of freeze-thaw cycles 
(Figure 4.5). As it is desirable to have more cell attachment, promoting protein 
adsorption from serum is important. Increasing the number of freeze thaw cycles 
had a positive effect on the protein adsorption capabilities of the gels for 3rd vs. 1st 
cycle hydrogels, It also caused increased stiffness and strength and was also 
significantly effective in increasing cell attachment and proliferation, albeit not 
excessively. After 1 freeze thaw cycle, aligned fibres of PVA clumps in the surface 
morphology were observed. This is lost after the 3rd cycle. Instead huge blobs of 
polymer patches were visible. The decrease in surface porosity was more visible for 
1st cycle hydrogels and in cross-sections the inner porosity of the hydrogels was 
similar (Figure 4.6).  
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Figure 4.5. Change in hydrophilicity with respect to Freeze-thaw cycle and 
coagulation bath treatment for PVA/Chitosan cryogels (n=6). The water 
contact angle was significantly lower upon coagulation bath treatment 
(p≤0.001). 
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Figure 4.6 Effect of Freeze-thaw cycle number and coagulation bath on surface 
morphology of the PVA/Chitosan hydrogels a) 1st cycle BCB, orientation of the PVA 
filaments are apparent b) 3rd cycle BCB, filament orientation as lost and islands of polymer 
meshes has formed c, d) 1st and 3rd cycle ACB respectively, a significant loss of PVA 
alignment occurred, surface undulations have appeared due to the shrinkage effect of the 
coagulation bath; the surfaces were noticeably rougher. e, f) Cross-sectional views after 
coagulation bath for 1st and 3rd cycle respectively, the appearance was similar to the 
surface, only more porous. Representative of 2 independent observations. 
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The 3rd cycle hydrogels were more susceptible to degradation (weight loss) both 
before and after coagulation bath treatment for a 3 week period, where 
coagulation bath treatment caused a significant decrease in the degradation for 
each time point (Figure 4.7a).  
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Figure 4.7 a) Degradation profile of 1st and 3rd cycle PVA/Chitosan hydrogels before 
and after coagulation bath (n=6). The lowest degradation rate was achieved by 1st 
cycle ACB (13.92±5.79 %) whereas the highest rate was with 3rd cycle BCB samples 
(26.77± 0.46 %) b) Adsorption of Bovine Serum Albumin (BSA) onto the PVA/Chitosan 
hydrogels after different numbers of freeze-thaw cycles, the adsorption level on 3rd 
cycle hydrogels was significantly higher (p= 0.006). 
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The 3rd cycle hydrogels had a lower level of degradation compared to the first cycle 
before and after coagulation bath, believed to be mainly due to decreased sol 
composition. Degradation was both freeze-thaw cycle number and additive 
dependent. Together with resistance to degradation the most important aspect of 
coagulation treatment was the significantly improved mechanical properties.  As for 
protein adsorption, quantified by using Bovine Serum Albumin for each cycle 
number, the highest adsorption was observed on 3rd cycle hydrogels where 1st and 
5th cycles had similar adsorption values (Figure 4.7 b). 
The 3rd cycle hydrogels were also effective in promoting cell attachment and 
improving proliferation both for arterial smooth muscle cells and endothelial cells 
(Figure 4.8). Coating of the surface of the hydrogels with Collagen type I caused a 
slight increase in attachment and proliferation. To see whether immobilization of 
proteins covalently would be more effective than adsorption a crosslinker 
(glutaraldehyde) was used for collagen coating. However, the improvement in 
attachment and proliferation was slighter compared to the Collagen type I 
adsorped samples. Endothelial cell attachment was much more pronounced in all 
cases compared to that of smooth muscle cells, which will be discussed in more 
detail in the next section. Due to this low level of attachment, lag of proliferation 
with respect to tissue culture polystyrene (TCPS) was more significant in the case of 
smooth muscle cells (Figure 4.8), where the Alamar Blue reduction on TCPS on day 
7 was 41.37 ± 5.45 % compared to 3rd cycle collagen coated hydrogels’ 23.71± 0.10 
%; which had the highest cell number between the samples.  
* 
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The improvement of cell attachment and proliferation was also observed by 
fluorescent microscopy that demonstrated the endothelial attachment was much 
more effective than smooth muscle cell attachment. Endothelial cells grew and 
reached near confluence by 10 days. 3rd cycle hydrogels attained higher cell 
numbers, validated by cell number counts with CellF program (Olympus, Germany) 
(Figure 4.9). Endothelial cells spread and covered most of the surface on 
PVA/Chitosan hydrogels without any need for surface coating. Thus, PVA composite 
surfaces can be used for endothelialisation experiments with different kinds of 
additives to further improve physical properties that might facilitate cell 
attachment and proliferation.  
 
 
 
 
 
 
 
Figure 4.8 Proliferation of Arterial Smooth Muscle cells on PVA/Chitosan cryogels, 
depending on surface coating (chemical, physical or absent) and freeze-thaw cycle 
number. The highest cell number was attained on 3rd cycle hydrogels with collagen 
coating. Inset) The whole range of measurements for 1 week period; it can be seen 
that smooth muscle cell growth was slower compared to TCPS (n=3), see Appendix F. 
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Figure 4.9 Growth of Endothelial cells on 1st and 3rd cycle PVA/Chitosan hydrogels 
(n=6) a, b) 1st cycle hydrogels after 5 and 10 days of culture respectively 
(Magnification 10x). c, d) 3rd cycle hydrogels. Cell numbers were significantly higher 
in 3rd cycle hydrogels compared to 1st cycle samples, validated by cell counts in 10x 
and 20x magnification images. Cell counts were done with at least 6 micrographs per 
treatment at 20x magnification. e-f)Cells were spread on the hydrogel surfaces on 
day 5 as observed by Phalloidin staining (10x and 20x magnification). 
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Even though, successive freeze-thaw cycles are beneficial, the extent of benefits did 
not compensate for the prolonged cryogel production time (72 hours vs. 24 hours). 
However, this system can be utilized to observe stiffness effects on cell behavior in 
the future. In other words, even though increasing freeze-thaw cycles did not have 
practical value for the current application in terms of cell response; it is a valuable 
tool to clarify the effects of stiffness change on cell behavior without the need of 
changing the concentration of the starting solution, as done in most of the current 
literature. 
4.1.3 Additive Effect (Chitosan, Gelatin, Starch) 
To determine whether the process is reproducible for other additives and to see 
whether a better option can be developed, composite cryogels with 3 different 
additives were prepared. Experiments showed that, the additives had a profound 
effect on the gelation process. Each additive caused a different level of water 
content. The change in terms of mechanical properties to the coagulation bath was 
also different for each composite hydrogel type. For this reason, coagulation bath 
effect experiments were repeated for each cryogel type.  The highest water content 
was attained by PVA/Starch hydrogels (93.05±0.24 %) and the greatest decrease in 
water content following coagulation was observed with PVA/Starch hydrogels (to 
80.95 ± 3.59 %) (Figure 4.10).  Surface morphology was extremely different in the 
presence of the different additives. For PVA/Starch composite surface was covered 
with clumps rich with starch, which were also observed macroscopically while 
PVA/Chitosan retained the aligned fibrillar appearance of the pure PVA cryogels 
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only with thicker chains. PVA/Gelatin hydrogels had a layer of fibres on their 
surface with more apparent porosity (Figure 4.11).  
 
Figure 4.10 Change in water content with respect to additive type and application of 
coagulation bath (n=6). Even though PVA/Starch hydrogels had significantly higher water 
content before coagulation bath treatment (p=0.004), after coagulation bath treatment, 
water content values for all three composites were similar (p=0.69). 
The coagulation bath treatment caused changes in dimensions and shrinkage of all 
hydrogel types. This effect was most visible for PVA/chitosan and PVA/Starch 
cryogels; whereas shrinkage was significantly less in PVA/Gelatin cryogels (Table 
4.1). Differences in surface morphology (Figure 4.11) together with the intrinsic 
differences between the additives ability to absorb proteins led to a significant 
difference between the protein adsorption capacities of the hydrogels. To test 
whether the differences are protein-type dependent, two types of proteins were 
utilized, collagen type I and bovine serum albumin.  Although the amount of protein 
adsorbed depended on the protein type; the trend was the same between cryogels; 
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the highest adsorption was observed with PVA/Gelatin cryogels (Table 4.1). Since 
protein adsorption is the first step in the attachment of the cells to a synthetic 
surface, a composites ability to absorb protein is beneficial. Compared to the pure 
PVA cryogels, which were only able to absorb 31.82±24.17 µg of collagen out of 1 
mg, on PVA/Gelatin cryogels could absorb 338.52± 55.21 µg. 
Table 4.1 Dimension Change and Protein adsorption on PVA based cryogels after 
coagulation bath treatment, * denotes p≤0.05 (n=6) 
 PVA/Gelatin PVA/Chitosan PVA/Starch 
Dimension Change 
(Diameter) (%) 
7.65±0.82* 16.28±0.28 16.49±0.41 
Dimension Change 
(Height) (%) 
10.30±0.11* 25.10±0.90 35.32±0.42 
Adsorbed BSA 
(µg) 
558.59±108.60 487.50±36.74 490.62±85.25 
Adsorbed Collagen 
type I(µg) 
338.52±55.21* 190.97±10.63 188.65±17.54 
 
Figure 4.11 Surface morphology of PVA based composites observed with a Phase 
Contrast microscope (Magnification 100x). a) PVA/Chitosan, b) PVA/Starch c) 
PVA/Gelatin. PVA/Chitosan hydrogels had the conventional aligned layers, whereas 
PVA/Starch hydrogels had areas of starch accumulation and PVA/Gelatin surface was 
filled with fibrous gelatin (n=6).  
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The degradation rate was also strongly affected by the type of additive, especially 
without the application of the coagulation bath treatment. The treatment was 
again effective for all additives over 2 weeks and measurements after 1 month 
period still showed a lower degree of degradation for all types of hydrogels. After 
application of the coagulation bath treatment, the differences between the 
degradation rates of different composites were statistically insignificant (p= 0.59) 
(Figure 4.12). The highest degradation rate without coagulation bath treatment was 
observed with PVA/Starch hydrogels (40.13±3.03 %). 
 
 
 
 
 
 
 
 
 
 
The most apparent effect of both freeze-thaw cycle number and coagulation bath 
was a distinct increase in ultimate tensile strength and an increase in extensibility 
Figure 4.12 Degradation profiles of PVA composites before and after 
coagulation bath treatment up to 1 month. Coagulation bath effectively 
decreased degradation for all three types of composites and also slowed 
down level of degradation over a month compared to the  samples before 
coagulation bath treatment ( p≤0.001) (n=3). 
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(p≤0.001). This effect was observed in all three composites, but to different degrees 
(Table 4.2). The contribution of the coagulation bath treatment to the increase in 
tensile strength was significantly more than that of increasing the freeze-thaw cycle 
number. Also, the number of freeze-thaw cycles had a negative effect on 
extensibility except in the case of pure PVA cryogels. The highest tensile strength 
was attained by 3rd cycle for pure PVA cryogels after coagulation bath treatment, 
but PVA/Starch and PVA/Gelatin cryogels both had similar strengths.  
Table 4.2 Ultimate tensile strength and Elongation at break values for pure PVA and 
composite hydrogels (n=6) 
Cryogel Type UTS(MPa) Lmax(%) 
PVA 1st BCB 0.05±0.03 111.59±34.80 
PVA 3rd BCB 0.48±0.17 124.49±28.88 
PVA 1st ACB 0.48±0.23 147.21±57.72 
PVA 3rd ACB 0.96±0.25 140.13±25.17 
PVA/Chi  1st BCB 0.05±0.01         129.09±33.43 
PVA/Chi  3rd BCB 0.30±0.08 92.84±8.24 
PVA/Chi  1st ACB 0.44±0.12         137.44±58.58 
PVA/Chi  3rd ACB 0.44±0.08 111.97±26.25 
PVA/Sta 1st BCB 0.20±0.06         178.58±27.48 
PVA/Sta 3rd BCB 0.51±0.10 158.94±22.65 
PVA/Sta 1st ACB 0.70±0.10       205.79±18.56 
PVA/Sta 3rd ACB 0.93±0.23 166.66±28.72 
PVA/Gel 1st BCB 0.07±0.02        171.63±22.39 
PVA/Gel 3rd BCB 0.84±0.30 135.15±28.32 
PVA/Gel 1st ACB 0.60±0.14 200.35±30.41 
PVA/Gel 3rd ACB 0.92±0.18 149.62±17.79 
 
The most important aspect of the composites is their capability to promote cell 
attachment and proliferation. All three composite were suitable for cell 
attachment, but PVA/Gelatin hydrogels had significantly higher cell numbers after 
the initial attachment period (Figure 4.13). Cell attachment was concentrated on 
certain areas of the gel, which were probably rich in the additive. On pure PVA gels, 
there was nearly no cell attachment such that after 10 days no proliferation was 
observed. The proliferation rate for the composite hydrogels exhibited a similar 
trend with protein adsorption studies; i.e. PVA/Gelatin hydrogels had the highest 
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rate of proliferation and had significantly higher cell number by day 10 (Figure 
4.14). The cells reached confluency on PVA/Gelatin by day 15 with an initial seeding 
concentration of 1x 105 cells/cm2. PVA/Chitosan hydrogels also supported the 
growth of the cells with near confluence was apparently reached at a slower rate; 
whereas PVA/Starch hydrogels lagged behind significantly. 
 
Figure 4.13 Initial attachment of Bovine endothelial cells to a) PVA/Starch b) PVA/Chitosan 
c) PVA/Gelatin hydrogels, 1st cycle after coagulation bath (Magnification 4x), the highest 
cell number was observed on PVA/Gelatin hydrogels d) Only few cells are observed on pure 
PVA gels, with most of the gel surface empty e) PVA gels after 5 days of culture, cell growth 
was retarded and cell presence was sparse f) PVA/Chitosan hydrogels after 5 days of 
culture, cell number has substantially increased (Magnification 20x). 
Finally, to evaluate their feasibility as encapsulating materials, all three composites 
were used for preliminary encapsulation tests with arterial smooth muscle cells. 
Again, PVA/Gelatin was the most suitable candidate because of its ability to form 
much more stable cryogels under drastically different gelation conditions of 
encapsulation and also the improved cell distribution and numbers achieved. 
PVA/Starch cryogels did not encapsulate many cells, whereas with PVA/Chitosan 
A B 
E D F 
C 
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hydrogels, there were large smears of DNA which indicated cellular damage (Figure 
4.14). 
  
To summarise, water content of all composite cryogels were similar, the highest 
protein adsorption for both BSA and Collagen was on PVA/Gelatin cryogels, the 
difference between the degradation rates of all the composite cryogels were 
statistically insignificant, the strongest cryogels were PVA/Starch cryogels but 
PVA/Gelatin cryogels had comparable strength, whereas PVA/Gelatin outperformed 
the other two composites both in endothelial proliferation and also smooth muscle 
cell encapsulation. All these results suggest that the PVA/Gelatin hydrogels are the 
most suitable option to pursue more elaborate characterization of endothelial cell 
Figure 4.14 Endothelial cell proliferation on 1st cycle PVA based composites and TCPS. 
Confluency was reached on TCPS between days 5-10, whereas for hydrogels it was after 10 
days. PVA/Chitosan and PVA/Gelatin presented more suitable surfaces for endothelial cell 
attachment and proliferation (n=6). PVA/Gelatin had significantly higher number of cells 
compared to other composites by day 15,see Appendix F for Statistical analysis. 
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behavior and the development of a cell encapsulation system. They adsorbed the 
highest amount of protein, showed the least shrinkage and had the highest 
proliferation rate. Their water content, degradation profile and mechanical 
properties were superior or comparable with the other composites. Thus the 
PVA/Gelatin combination was selected for detailed investigation in this study at this 
point. Due to this decision, detailed endothelial cell behavior studies were 
performed with 1st cycle PVA/Gelatin cryogels after coagulation bath treatment, 
which has improved the mechanical properties and degradation resistance as 
expected. The higher freeze-thaw cycle numbers were not pursued, because in the 
encapsulation experiments conducted simultaneously, increasing freeze-thaw cycle 
number was detrimental to the cell viability within the cryogels. Protocols were 
adjusted accordingly for the increased surface hydrophilicity due to the coagulation 
bath treatment(longer incubation at 37 °C to improve protein adsorption). 
 
Figure 4.15 Preliminary Encapsulation tests with the composite cryogels a) PVA/Starch 
b)PVA/Chitosan c) PVA/Gelatin. PVA/Gelatin supported the most cells with  minimum 
apparent damage and also resulted in a much more stable gel. The cell presence on 
PVA/Starch cryogels was minimal; whereas big smears were observed in PVA/Chitosan 
cryogels which indicated extensive cell damage (n=3). 
A C B 
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4.2 Endothelial cell characterization on PVA/Gelatin hydrogels 
4.2.1 Under Static Conditions 
After selection of PVA/Gelatin as the most promising composite, the scaffolds were 
first tested to evaluate their suitability as a basement for endothelial cells. To assess 
endothelialisation of the scaffold surface, four main characteristics of endothelial 
cells were investigated: 
1) Whether there is a significant difference between proliferation of 
endothelial cells on tissue culture polystyrene and the PVA/Gelatin 
surface (FACS, CFDA cell proliferation assay) 
2) Whether presence of the hydrogel surface or mode of attachment to the 
hydrogel surface induces short term or long term apoptosis (FACS, 
Vybrant Apoptosis assay) 
3) To assess the cell-cell contact molecules related to inflammatory 
response(ICAM and Selectin P) and also endothelial barrier formation 
(PECAM) to determine the effect of attachment to hydrogel surface with 
respect to control, tissue culture polystyrene (Real time RT-PCR) 
4) Determination of NO (an endothelial cell health marker) synthesis and 
release and the difference in its level between the hydrogel surface and 
TCPS. 
Endothelial cells grew at a steady pace on PVA/Gelatin hydrogels and started to 
establish cell-cell contacts. By day 10, the surface was nearly fully covered by 
endothelial cells (Figure 4.16). These results were consistent with previous Alamar 
B C 
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Blue assays (Figure 4.14). Low seeding density was selected to ensure that the 
growth of the cells could be monitored. 
 
 
 
 
 
 
 
 
 
 
 
 
CFDA is a non-toxic dye which penetrates into the cells. The decrease in its 
fluorescence intensity is indirect evidence of the division of cells. Since it does not 
rely on any metabolic activity, cell type to cell type differences and differences due 
to cell attachment on to different surfaces (such as TCPS and the hydrogel in this 
Figure 4.16 Endothelial cell proliferation and spreading on PVA/Gelatin cryogels 
observed by DAPI/FITC-Phalloidin staining (n=3) a) Day 2, b) Day 5 c) Day 10 
(Magnification 10x). There was a steady growth. d) Near confluence of endothelial cells 
on PVA/Gelatin cryogels after 10 days of culture (Magnification 4x). 
A B 
C D 
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case) is minimal. CFDA results showed that aside from the initial attachment period, 
the proliferation rate between PVA/Gelatin cryogels and the TCPS was not 
statistically significant by day 10 (Figure 4.17a).  
Both conditions exhibited an exponential growth that peaked by day 15. The 
distribution of the cells was also observed to determine whether there are sub-
populations of cells that grew at a faster pace (Figure 4.17b).  
Figure 4.17 a) Proliferative capacity of endothelial cells on PVA/Gelatin hydrogels vs. TCPS. 
Starting points for the graphs are 0.00048 and 0.00051, respectively corresponding to 
readings taken just after introduction of CFDA. Inset Bar graphical representation, on day 5 
TCPS had significantly higher proliferation b1) Representative reading for day 10; pink line 
(TCPS), Black and Green (PVA/Gelatin) Inset) Forward Scatter counts to prove that the 
average cell size was the same; all curves coincided b2) Representative FACS read-outs on 
day 5, green line (TCPS) black line(PVA/Gelatin). PVA/Gelatin curve skewed around 101 
fluorescence range, implying a faster proliferating sub-population (n=3). 
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On day 5, on PVA/Gelatin hydrogels, a small bump can be seen on the distribution 
which indicated a group of cells with higher proliferative capacity. These cells were 
located on gelatin rich areas of the surface that would give them an advantage in 
spreading and subsequent proliferation, whereas the cells on TCPS showed a wider 
distribution.   
Attachment to a surface does not guarantee long term survival for cells, since lack 
of necessary signals may induce apoptosis. Long-term and short-term apoptosis was 
examined using FACS analysis. Apoptosis results shed light to the initial high 
number of cells observed on TCPS, because there was a significantly higher number 
of necrotic cells observed on the PVA/Gelatin cryogels after day 2 (Table 4.3). 
However, this number decreased significantly by day 5 and only a small group of 
early and late apoptotic cells was present for both PVA/Gelatin cryogels and TCPS 
surface. This trend continued up until day 20 of culture where in both cases the 
number of apoptotic cells was minimal (Figure 4.18).  
Table 4.3 Viable, Necrotic and Apoptotic Cell counts for PVA/Gelatin cryogels and TCPS 
over 20 days, * denotes p≤0.005 (n=9) 
 Viable (%) Necrotic (%) 
Early Apoptotic 
(%) 
Late Apoptotic 
(%) 
Day 2 PVA/Gel 84.70±1.88 14.65±1.35* 0.15±0.07 0.48±0.26 
Day 2 TCPS 96.66±1.26 3.31±1.25* 0.01±0 0.02±0 
Day5 PVA/Gel 97.22±0.16 2.28±0.64 0.25±0.26 0.24±0.20 
Day 5 TCPS 95.89±0.23 3.90±0.14 0.11±0.04 0.10±0.04 
Day 10 
PVA/Gel 
99.67±0.20 0 0.33±0.19* 0 
Day 10 TCPS 99.95±0.03 0 0.05±0.03* 0 
Day 20 
PVA/Gel 
98.63±0.09 1.33±0.10 0.03±0.01 0.01±0.02 
Day 20 TCPS 99.79±0.24 0.20±0.25 0.01±0 0±0 
Attachment of the cells to the compliant PVA/Gelatin cryogel surface did not induce 
any significant apoptotic response. Rather, the only effect was a decreased 
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effectiveness of cell attachment when compared to the TCPS surface. During the 
initial culture period, necrosis of the unattached or loosely attached cells was 
observed more on PVA/Gelatin cryogels. After that, TCPS and cryogel surfaces 
behaved in a similar way, suggesting that PVA/Gelatin cryogels can sustain long-
term culture of endothelial cells, which is crucial for long term bioreactor tests to 
develop long-term compliance. The results of apoptosis assays corroborate well 
with proliferation assays and it appears that the initial necrotic cell count must be 
responsible for the lag observed in proliferation on PVA/Gelatin cryogels. 
Figure 4.18 Propidium Iodide vs. AlexiFluor conjugated AlexiFluor FACS readings (n=3) for a) 
PVA/Gelatin cryogels day 2 b) TCPS Day 2 c) PVA/Gelatin Day 5 d) PVA/Gelatin Day 20. 
Decrease in the counts in regions 3, 4 and 5 showed a decrease in apoptotic and necrotic 
cells. The necrotic and apoptotic counts were higher in the beginning of the culture and 
subsided later. 
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The main function of the endothelium is to act as a selective barrier and the first 
line of response in the case of injury or infection.  Endothelial cells achieve this 
function through cell-cell contact molecules which either hold the integrity of the 
endothelial barrier (such as PECAM I, an endothelial cell specific cell-cell contact 
molecule) or recruiting white blood cells or platelets for commencement of 
coagulation or inflammation (such as ICAM and Selectin P). These 3 proteins were 
selected to evaluate how attachment to hydrogel surfaces would affect endothelial 
response with respect to the standard tissue culture conditions. GADPH was used 
as an endogenous housekeeping gene. Over a 10 day period, expression of PECAM 
mRNA steadily increased which indicated more cell-cell contacts (Figure 4.19). ICAM 
is a constitutively expressed protein whose expression levels increase during 
inflammation. The ICAM levels were steady for the first 5 days and after that there 
was only a slight increase in its expression. At the beginning of the culture Selectin-
P expression on hydrogels was significantly higher than that on TCPS, but the 
expression came to the similar levels by day 10.  
The average Ct values for PECAM on PVA/Gelatin hydrogels decreased (which 
indicates a higher level of expression) from 22 to 16.8 over 10 days whereas the 
expression on TCPS in the same period was steady.  For ICAM the decrease was 
smaller (from 26.9 to 24.1).  
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Figure 4.19 Fold change in expression of ICAM, Selectin-P and PECAM    
respectively on PVA/Gelatin cryogels vs. TCPS for a 10 day period. Fold 
change was calculated by 2 -ΔΔCt method, Fold change with respect to time 
was significant for ICAM for all time points, whereas change in PECAM and 
Selectin P was significant for day 10  (n=3). 
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Lastly, the level of NO (Nitric Oxide) synthesis on PVA/Gelatin cryogels was 
measured by the Griess method. The concentration of NO for the cell seeded on 
TCPS was 0.70±0.02 µM in the beginning of the culture and it was raised to 10.20± 
1.39 µM by day 5. During the same time interval, NO production on the 
PVA/Gelatin cryogels was 0.28±0.05 µM and 5.26± 0.83 µM, respectively. These 
results represent concentration within the medium, thus the cell number difference 
had an effect on the NO levels. However secretion of NO was detectable for both 
cases. NO secretion levels are highly affected by the presence of shear stress and 
this will be discussed in the next section. 
 The results presented suggest that a healthy endothelial lining with NO synthesis, 
cell-cell contacts and full confluency with low levels of apoptosis can be achieved 
on PVA/Gelatin cryogels. The mode of attachment on PVA/Gelatin cryogel surface 
was slower due to the surface properties, which led to initial high levels of necrotic 
cells. But, eventually cells were able cover the cryogel surface and the high level of 
expression of ICAM and PECAM and depressed expression of Selectin-P were good 
indicators of the ability of PVA/Gelatin cryogels to sustain the endothelialisation. 
The next question was, whether this layer would be strong enough to withstand 
physiological shear stress conditions. Thus, the next section deals with how shear 
stress can be used to improve the endothelialisation. 
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4.2.2 Effect of Shear Stress 
Endothelial cells are under constant shear stress due to the blood flow under in-
vivo conditions and the shear stress conditions have a significant effect on their 
behaviour. This can be exploited under in-vitro conditions to facilitate the 
endothelialisation of scaffolds. Also, even though blood flow is generally laminar, 
under certain circumstances such as plaque formation or surgical intervention, it 
can become turbulent and the varying shear stresses generated by turbulent flow 
have markedly different effects on endothelial cells (Chien 2008a). With this in 
mind, endothelialisation on 1st cycle PVA/Gelatin cryogels after coagulation bath 
treatment was evaluated under shear stress conditions induced by an orbital shaker 
motion which creates a turbulent flow. The underlying hypothesis was that, since 
this kind of flow is known to induce proliferation, the endothelialisation period can 
be shortened even for small initial seeding numbers. 
The shear stress level was selected as 10 dyn/cm2 and this was applied either 
directly or via ramping in 3 steps. Direct application of shear caused widespread 
detachment of the cells from PVA/Gelatin surfaces, while cells stayed on the 
surface of TCPS under these conditions, confirmed by microscopical observations. 
This underlines the initially weaker attachment of endothelial cells to PVA/Gelatin 
cryogels (Figure 4.18). However, when the shear stress is applied by ramping, cell 
detachment was prevented and considerably higher number of cells were observed 
even on day 2 (Figure 4.20). 
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The increase in cell number and proliferation was quantified by both CFDA assay 
and Alamar Blue assay and in both cases there was a significant increase in the cell 
number compared to the static culture conditions (Figure 4.22). The coagulation 
bath treatment of the PVA/Gelatin cryogels caused an increase in surface 
roughness of the cryogel surfaces from 5.30± 0.96 µm to 10.93±1.21 µm. After 
application of shear stress the surface roughness decreased down to 2.11± 0.56 µm 
(n=6).  
 
 
Figure 4.20 3D reconstruction of endothelial cell seeded PVA/Gelatin cryogel surfaces after 
24 hours of direct application of shear stress. Detachment of the cells and empty areas was 
the result of direct shear stress application. Shear stress caused a decrease in surface 
roughness. Under these conditions the surface roughness was calculated from  the images 
in random areas of 4x4 µm2 areas and 10 µm length lines by Alicona Max Image analysis 
program as 1.63 ±0.11 µm with the highest peak observed being 8.17 µm. In comparison, 
surface roughness of unseeded empty cryogels which were exposed to shear stress was 
2.11± 0.56 µm. Inset) Representative distribution of surface roughness values. 
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Figure 4.21 Proliferation of endothelial cells under ramped shear stress conditions (n=3) 
(DAPI/FITC Phalloidin staining a) Static culture 2 days b) Ramped shear stress 2 days 
(Magnification 10x, Inset Magnification 20x) , cell number and cell spreading was 
dinstinctly higher c) Lining formation on ramped shear stress samples after day 5; most 
of the surface was covered by a layer of endithelial cells  (Magnification 10x) d) Lining 
formation, endothelial cells were connected within the lining (Magnification 60x) 
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After application of ramped shear, there were no necrotic cells observed by 
apoptosis assay 99.33± 0.05 % of the cells were viable whereas there was a 
population of 0.67± 0.05 % early apoptotic cells. Application of shear stress not only 
increased the proliferation but also decreased the level of necrosis due to lack of 
attachment during the initial period of culture observed earlier. Gene expression 
levels under shear stress conditions demonstrated that the differences between 
PVA/Gelatin surface and TCPS was reduced as shear became the dominant factor. 
Under ramped shear stress, the only significant increase was in ICAM expression 
(Figure 4.23 a), but when compared to the expression levels at static culture 
conditions, all genes were upregulated, most notably Selectin-P and ICAM (Figure 
4.23 b). The level of PECAM expression has also increased indicating improved cell 
Figure 4.22 CFDA results for endothelial cells under ramped shear vs. static 
conditions. There was a significant increase in proliferation (p= 0.0006) and the 
increase in proliferative capacity was nearly 10 fold. 
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to cell contacts even from the onset. The lining formation was also observed by 
SEM, and showed cellular coverage of most of the cryogel surface. The alignment of 
cells was not widespread but visible; the decrease in the roughness of the surface 
was also observed in non-cell seeded cryogels (Figure 4.24). 
Application of shear stress also had a marked effect on NO secretion. Initially, NO 
levels of cells under shear stress were higher for both TCPS and PVA/Gelatin 
cryogels, however after day 5 the direct shear samples exhibited lower levels of NO 
compared to static and ramped shear samples (Figure 4.25). At this point ramped 
shear stress samples still had slightly higher NO secretion.  It is known that 
application of shear stress has the ability to increase NO levels, so the depression 
after 5 days under directly applied stress was due to the diminished number of cells 
due to detachment under simultaneous high levels of shear stress, as observed by 
the SEM too. Both SEM images and fluorescent microscope images demonstrated a 
slight directionality for the cells but the circular nature of the flow prevented a 
higher degree of orientation.  
Laminar physiological shear stress is important for keeping the homeostasis of 
endothelial cells and involves low level of proliferation and secretion of NO. 
However, in tissue engineering a high rate of proliferation is important during the 
commencement of product manufacture and sub- or supra-physiological shear 
stresses can be used to induce these high initial rates of growth. Ability to utilize 
non-physiological conditions can be an important tool in tissue engineering, since 
such conditions can be created in-vitro. 
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Figure 4.23 Real time RT-PCR results for endothelial cells on PVA/Gelatin exposed 
to ramped shear stress at 24 h (n=3) a) Fold change with respect to Static 
PVA/Gelatin Control.  b) Fold change with respect to TCPS control under shear 
Under shear stress, the difference between TCPS and PVA/Gelatin disappeared and 
the shear became the dominant factor; only in ICAM there was a statistically 
significant increase in expression on cryogels compared to TCPS (p<0.001). When 
compared to the static conditions, both ramped and direct shear application caused 
substantial increase in all three genes’ expression. 
 
* * 
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Figure 4.24 SEM images of endothelial cell seeded cryogels a) Unseeded PVA/Gelatin cryogel 
after application of shear, resulted in a smoother surface for the hydrogel b) SEM images of 
endothelial cells on PVA/Gelatin cryogel under static conditions, day 5 c) Endothelial cells on 
PVA/Gelatin cryogels under shear after 2 days; cells showed some orientation d) Endothelial 
cell coverage of the cryogel surface under shear after 5 days, shows a group of cells in contact 
that has covered most of the surface of the gels. 
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4.3 Encapsulation of Smooth Muscle Cells via Cryogelation 
Since arterial smooth muscle cells are embedded in a thick extracellular matrix 
under in-vivo conditions, smooth muscle cells should be cultured in 3D 
environment. Since the effective pore size of the hydrogels are generally smaller 
than cell size, for hydrogel systems it is preferable to encapsulate cells in-situ during 
the formation of the scaffold. The freeze-thawing procedure presents a unique 
opportunity in this sense, since the gelation starts at sub-zero temperatures. The 
gel formation step can be also used as a storage media. However, conditions must 
Figure 4.25 NO synthesis by endothelial cells on TCPS and PVA/Gelatin cryogels 
under static or shear stress conditions. NO synthesis has increased over time for 
both static and shear stress conditions. NO synthesis on PVA/Gelatin cryogels 
was comparable to TCPS on static and   ramped shear conditions on day 2; 
whereas on day 5 static conditions and direct application of shear caused a 
decrease in NO synthesis compared to TCPS (p≤0.001), where as the difference 
between cryogels and TCPS was not significant under ramped shear conditions. 
     * 
    * 
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be such as to ensure cell viability and functionality and this part of the study is 
focused on development of such a protocol for cell encapsulation and storage via 
cryogelation.  
Pure PVA solution in distilled water has a slightly acidic nature, and the addition of 
all three additives caused a further drop in pH of these solutions (Table 4.4) 
Moreover, since thick specimens are targeted, utilization of these solutions in 
distilled water was detrimental for initial nutrient transfer, which resulted in lower 
cell viability in experiments. To stabilize the pH at physiological levels and also to 
provide cells with nutrients during the initial phase of encapsulation PVA- additive 
solutions were dissolved in HEPES buffered RPMI-1640 cell culture medium and pH 
stability was attained (pH 7.22± 0.10). 
Table 4.4 ph and viscosity values of pure PVA and PVA/Additive solutions (n=6) 
 PVA PVA/Gelatin PVA/Starch PVA/Chitosan 
pH            6.22     5.84     5.93    5.24 
Viscosity(mPa.s) 2175.1±9.0 2054.9±9.0 1376.4±13.1 2141.7±32.5 
 
Four parameters were selected to investigate their effect on cell viability after 
encapsulation, (i) PVA viscosity (300.9± 5.8 and 2175.1±9.0 mPa.s, respectively), (ii) 
Coagulation bath treatment after addition of cells, and addition of (iii) DMSO and 
(iv) Serum into the encapsulation media. The results were evaluated by Design 
Expert 7.0 after 3 blocks of experiments of all possible combinations were done in 
triplicates (288 runs) in random order. From the results, it was possible to derive a 
model for encapsulation (p≤0.0001).  The viability results showed that there was a 
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strong dependence on all factors with several interactions between the factors 
having a significant effect on final cell viability (Equation 4.1). 
 
                                                                                   (Equation 4.1) 
Where c is cell viability, x is DMSO concentration, y is serum concentration, z is 
coagulation bath treatment and w is PVA viscosity (For Full ANOVA table see 
Appendix D). By themselves and with two factor interactions, all parameters had a 
positive effect on cell viability. However, including all process variables caused a 
significant lack of fit. By only including the biggest impact factors, the coagulation 
bath treatment and PVA viscosity, and with a square root transformation, the 
equation turns to Equation 4.2: 
                 (Equation 4.2) 
This significant effect of coagulation bath treatment and PVA viscosity was mainly 
due to the difficulty of obtaining cryogels with the low viscosity PVA without 
coagulation bath treatment (cell viability was undetectable with low viscosity PVA 
cryogels without coagulation bath). From Equation 4.1, it can be seen that the 
correlation between high level of coagulation bath and high level of viscosity by 
itself is negative which indicates that it is not necessary to use the coagulation bath 
for high viscosity PVA samples (Figure 4.26). For cell-free cryogels, with both 
viscosities, coagulation bath treatment was necessary to obtain robust samples for 
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1st cycle cryogels, whereas with this mixture strong gels were obtained even after 
one cycle. This huge effect of coagulation bath and PVA viscosity on cryogel stability 
has aliased the effects of DMSO and Serum addition, even though these factors are 
positive contributors to the cell viability. Moreover, the coagulation bath caused 
clumping of the cells on the outer layers of the gel, so an additional model was 
created to see how Serum and DMSO concentration affected the cell viability in the 
absence of the coagulation bath treatment with the high viscosity cryogels. Since 
DMSO is also a solvent of PVA it was important to know the structural effect versus 
the cell viability properties in the presence of increasing DMSO concentrations. 
Both DMSO and Serum significantly increased the viability of the samples; and the 
interaction parameter was also effective (Equation 4.3). Increasing the 
concentration of the serum and DMSO simultaneously resulted in higher viability 
(p≤0.0318). The model input was the result of 39 centred experimental runs, so it 
was possible to derive quadratic relations between serum and DMSO versus cell 
viability. However, ANOVA tests demonstrated a linear relationship instead of a 
quadratic one. The increase in cell viability as the concentration increased was 
rather steep and it can be said that this increasing trend would continue with higher 
concentration of Serum. However increasing their concentration would decrease 
the overall PVA content which would inhibit the gelation process; thus higher 
concentrations of DMSO and Serum was not further examined (Figure 4.27).  
                                                 (Equation 4.3) 
Where x is DMSO concentration and y is Serum concentration and c is cell viability. 
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Figure 4.26 Analysis of Design of Experiment results a) Response Surface for Cell viability 
within PVA/Gelatin cryogels with respect to PVA viscosity and coagulation bath treatment 
at constant values for Serum and DMSO. In the absence of DMSO, viability dipped to 0 for 
low viscosity, no coagulation bath conditions. B) Contour graph of relationship between 
PVA viscosity and Serum concentration, increasing serum concentration in the presence of 
DMSO and Coagulation bath had little effect, since the behaviour was dominated by 
viscosity. 
These results, together with the previous results suggest that the sole addition of 
either DMSO or Serum would not be sufficient for cryoprotection in a gel mixture 
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system and both are necessary to obtain improved viability. When present together 
they caused a synergistic effect, for no coagulation bath and high viscosity 
conditions. Since all the constituents added to gelation mixture would cause 
freezing point depression, the bulk of the gelation would happen during the 
thawing stage. This was the reason for the dry incubation of the gels at 37 °C prior 
to the addition of pre-warmed culture media. This interval is important for the 
development of the mechanical properties of the gels, so the feasible time interval 
for this waiting period was checked within a 30 minute interval of thawing before 
the addition of the culture media. Direct addition of the media impeded the gel 
formation and, in turn, viability; whereas a 10-15 minute thawing period had 
increased cell viability. However further incubation caused a slight decrease; 
suggesting that cells are prone to osmotic shock if the swelling of the cryogel was 
not facilitated (Figure 4.28). 
Another aspect of the method requiring consideration was whether it was safe to 
store cells within the encapsulation mixture under frozen conditions and whether 
this would affect their viability. Cells were stored at -70°C for up to one month and 
upon thawing, no significant difference in cell viability was observed between 
different storage periods (Figure 4.28 inset). The recovery rate has improved up to 
80%. Also no significant differences in gelation were observed for these different 
storage time points, which indicated that the system can be used for storage 
purposes. 
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Figure 4.27 Analysis of Box-Behnken viability design a) Response surface 
for the effect of DMSO and Serum concentration on viability of 
encapsulated cells. Interaction of Serum and DMSO caused an increase in 
cell viability b) Interaction curves between DMSO and Serum; in the 
absence of serum increasing the DMSO concentration caused a slight 
decrease in viability whereas if DMSO concentration was increased in the 
presence of 10% serum, there was a significant increase in cell viability. 
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The presence of the cells, medium and other additives on the gelation mixture 
cause dramatic morphological changes in the final cryogel structures. These have 
been observed by optical microscopy and SEM. After initial exchange of medium to 
ensure the removal of excess DMSO the gels were fragile. However, after 2nd or 3rd 
change of the medium the same day, the cryogels were much stronger indicating 
that gelation continued to proceed during culture time, since the time interval was 
too short for any kind of cell induced change. The final gels were much more 
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Figure 4.28 Effect of thawing rate on cell viability in encapsulated state. 
Direct addition of medium disrupted gel formation at time point 0 min, the 
peak of cell viability for thawing rate was around 10 minutes, the thawing 
without addition of medium was essential, but after a period of time it 
induced further cell death .Inset) Effect of storage period in frozen state on 
cell viability, no significant differences was observed for up to 1 month 
period (p=0.27). 
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transparent and porous compared to conventional PVA/Gelatin cryogels (Figure 
4.29). Cells generally resided in these pore areas, sometimes in clumps.  
 
 
Cryogels with encapsulated cells were distinctly more porous, in that PVA oriented 
in a spider web-like structure of thick strands with a quite uniform distribution of 
circular pores (Figure 4.30). Pores are up to 100 µm in diameter, and their size 
narrowed down at the interior parts of the hydrogels. In SEM observations, the 
Figure 4.29 a) Surface morphology of cell encapsulated PVA/Gelatin cryogels; 
the surface was much more porous compared to the empty cryogel's structure 
in which cells can be observed as spherical bodies initially, Inset) there were 
even bigger pores in which cells could be observed. b) The criss-cross aligned 
fibrous orientation of PVA filaments was observed under these conditions too. 
However, the orientation had many more different directions, Inset) DAPI 
staining of the encapsulated cells; cells could be observed throughout the depth 
of the cryogels, either individually or as groups of cells, entrapped within the 
pore structures as observed in phase-contrast microscopy. 
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spread cells or groups of cells were observed within and around these pores and 
migration of cells into or out of the inner parts of the hydrogel was observed. The 
spread cells suggested that the encapsulation did not restrict the movement of the 
cells and encapsulation environment was porous enough to allow nutrient and 
oxygen transport (Figure 4.31). 
 
 
 
 
Figure 4.30 The microscopic structure of cell encapsulated PVA/Gelatin cryogels. a) Top b) 
Bottom side of the same batch of cryogels fixed after 1 day of culture under standard tissue 
culture conditions. Cryogels were more porous than the conventional cryogels and exhibit 
interconnected porosity throughout the structure. Pore sizes ranged from 10 to 100µm and 
pores were circumvented with thick layers of polymer strands 
144 
 
 
 
 
 
In order to have a better idea of cellular distribution and morphology, 
haemotoxylin-eosin staining was carried out with 4 µm thick sections of hydrogels. 
As seen in the SEM micrographs, cells generally resided within the bigger pores as 
interconnected clumps, due to the segregation effect of the polymer chain 
movement during freezing. Histology results also showed the inferiority of the gels 
Figure 4.31 Distribution of encapsulated cells within the cryogel structure. a) Spread cells 
could be seen within the pore structures mostly in groups of 5-10 cells b) The connectivity 
and the size of the pores enable cell movement in and out of the cryogel structure, with 
pores going deep into the hydrogel core. Inset) Surface pores were closed up over time (in a 
week) of culture by cellular activity 
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produced in the absence of DMSO and Serum, in which the cell number was 
distinctly less, and further validated the previous cell counting results (Figure 4.32). 
It was possible to locate cells throughout the depth of the cryogels, so stratification 
of the system had not occurred and the cells were evenly distributed within the 
scaffolds. To ensure that the cells observed were indeed viable, Live/Dead Cell 
viability assay tests were performed on unfixed samples immediately after 
removing them from culture conditions. The Live/Dead assay indicated that most of 
the cells were viable and metabolically active, as evidenced by their ability to 
metabolize Calcein-AM to Calcein (Figure 4.33). Only, in some areas Ethidium 
Homodimer permeable cells were also observed, but the cells were predominantly 
viable, showing that there was little damage to the cells under the processing 
conditions. 
Figure 4.32 Haemotoxylin-Eosin Staining of PVA/Gelatin cryogel cross-sections a) In the 
absence of DMSO and Serum b) 10% DMSO and 10% Serum.  DMSO and Serum 
presence resulted in higher cell yield. Cells were mainly observed in big pores 
produced during the freezing and thawing process 
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In order to see the protective effect of the encapsulation process, confluent 
monolayers of smooth muscle cells were frozen in a DMSO and Serum 
supplemented medium. Under these conditions there was a huge cell loss on 
monolayer culture conditions (Figure 4.34a), indicating that the cryodamage 
protection resulting from the gel formation. In order to see whether this method 
can be used with other cell types, three more different cell types were 
encapsulated using freeze-thawing; namely rat arterial smooth muscle cells, bovine 
arterial endothelial cells and MC3T3 mouse osteoblast-like cells. Rat SMCs was used 
to see whether the system could be translated to other species and MC3T3 and 
endothelial cell experiments were done to show the viability of the process for cells 
of different size and morphology. All these cells were successfully encapsulated 
within the cryogel structures with similar macroscopic cryogel appearance (Figure 
4.34b-d). 
Figure 4.33 Live/Dead Staining of Smooth Muscle cells in PVA/Gelatin cryogels; a)Day 3 b) 
Day 7. Green dots denote live cells, while areas of red denote necrotic cells. Yellow areas 
were seen when there are dead cells within the cell clumps. Inset) Negative control staining 
of empty cryogel; no unspecific staining or cleavage of the Calcein-AM without cell activity 
was observed. 
A B 
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Steady cell growth was attained with encapsulated cells over a period of two 
weeks. The cell number nearly tripled in this period, which showed that 
encapsulation did not hinder cell proliferation. Over the culture period, cryogels 
became translucent and stiffer, due to both cell activity and ongoing crystallite 
formation, which ensured the stability of the cryogels.  Hydrogels also had a slightly 
reddish colour at the beginning due to the presence of phenol red in the culture 
medium. Also after a 3 day culture period, contraction of the cryogels was generally 
observed which further indicated the activity of smooth muscle cells as they 
migrate and interact with the cryogel the stress applied by their actions caused gel 
contraction.  Encapsulation of the smooth muscle cells following this encapsulation 
procedure resulted in distinctly different cryogel morphology. The results presented 
in this section proved that with necessary modifications, cryogelation can be used 
for cell encapsulation and storage and the system can be modified for different cell 
type. The next step was to quantify the change in mechanical properties caused by 
the new cryogel morphology in the presence and the absence of the cells, and also 
under cyclic strain and how this would affect cell proliferation and orientation, and 
potentially the overall cryogel structure. These results will be presented in the next 
section. 
 
 
148 
 
 
 
 
 
 
 
 
 
 
Figure 4.34 Live/dead staining with other cell types a) Remaining cells after a 
monolayer of smooth muscle cells were exposed to freeze-thawing cycles in 
the absence of the PVA/Gelatin cryogel; most of the layer has been removed 
during the process. b-d) Live/Dead viability assay staining of cell 
encapsulated in PVA/Gelatin cryogels b) Endothelial cells c) Rat Smooth 
muscle cells d) Mouse MC3T3 osteoblast like cells 
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4.3.1 Effect of Cyclic Strain on Encapsulated Smooth Muscle Cells 
The mechanical properties of the cryogels produced by the encapsulation 
methodology (10% Serum, 10% DMSO with high viscosity PVA) were evaluated with 
uniaxial tensile strength test for both cell laden and cell-free conditions. In order to 
observe the effect of cyclic biaxial strain on the cryogel structure, both cell-laden 
and empty cryogels were tested after application of 10% cyclic loading for 24 h. 
Cryogels produced from the cell encapsulation mixture both in the presence and 
absence of the cells had similar mechanical properties with the conventional 
PVA/Gelatin cryogels (Table 4.5).  
Table 4.5 Ultimate Tensile Strength and Elongation at break values for cryogels with or 
without cells produced with encapsulation mixture, * denotes p≤0.05 (n=6). 
Cryogel Type UTS(MPa) Lmax(%) 
Conventional PVA/Gelatin 
 
0.07±0.02 171.63±22.39 
Encapsulation mixture with 
Cells 
 
0.10±0.04 110.46±22.56 
Encapsulation Mixture  
without Cells 
 
0.08±0.02 190.99±17.60 
Encapsulation mixture  with 
Cells after cyclic strain 
 
 0.03±0.01* 314.94±66.74 
Encapsulation Mixture  
without Cells after cyclic 
strain 
0.12± 0.07 189.12±33.85 
 
The change induced by the gelation mixture with and without cells demonstrated 
that, both the additive (proteins in the serum, the osmolarity of the media and 
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DMSO) and cell presence had effects on the cryogel physical properties. Application 
of the cyclic strain did not cause any damage to the cryogels; on the contrary it 
caused a slight increase in mechanical properties for the cryogels without cells. On 
the other hand, the ultimate tensile strength of the cryogels with cells decreased 
after application of the cyclic strain and the cryogels became extremely extensible. 
It should be noted that these cryogels did not go through an acclimatization period 
for the cells, thus the decrease observed could be related to this fact. Application of 
cyclic strain caused a slight increase in cell proliferation compared to the static 
counterparts, however by day 7 this effect levelled off and the cell numbers was 
closer although the difference was still significant (Figure 4.35). 
The application of cyclic strain did not affect the viability of the smooth muscle 
cells, which was observed with Live/Dead viability assay. There was no distinct 
difference between static versus cyclic strain samples in this regard. Cyclic strain 
treatment caused orientation of the cells in primary strain directions (Figure 4.36). 
Groups of cells were observed aligned along the horizontal and vertical axes with a 
slight distortion of the shape of the pores of the cryogel structure. The cryogel’s 
ability to withstand cyclic strain is a good indicator of their feasibility to be used 
under pulsatile flow conditions. 
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Figure 4.35 Smooth muscle cell proliferation within PVA/Gelatin cryogels 
measure by Alamar Blue proliferation assay; cells showed steady growth 
under static conditions (p≤0.001) and application of cyclic strained caused a 
slight increase (p=0.004); which levelled off by day 7 (34.05± 0.06 % Alamar 
Blue reduction versus 35.76± 0.02 %.) (n=6). 
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Figure 4.36 Effect of cyclic strain on PVA/Gelatin cryogel morphology and 
Smooth muscle cells. a) Cyclic strain converted most of the spherical pores into 
ellipsoidal shape b) Live/Dead viability assay results were quite close to that of 
static conditions. Orientation of the Smooth muscle cells c) in horizontal d) in 
vertical direction 
A B 
C D 
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4.3.2 EC/SMC Co-Culture Experiments 
After establishing the encapsulation procedure and characterization of the 
endothelial cell response on the cryogels, the next step was to characterize the 
conditions for the co-culture of endothelial and encapsulated smooth muscle cells. 
For this end, an experimental design based on 3 factors was conducted and the 
Nitric Oxide (NO) synthesis level was selected as the response, as it is a good 
indicator of endothelial health and is an endothelial specific signal which cannot be 
interfered by the smooth muscle cells, unlike in the case of most of the previous 
methods used. The factors were the storage time (1-7 days) for smooth muscle cells 
before seeding endothelial cells, culture time (1-10 days) and application of ramped 
shear stress (0-10 dyn/cm2) which corresponded to 54 runs. The level of NO was 
quantified by Griess Reagent. A statistically significant model for NO synthesis and 
dependence on these 3 factors at the level of 3 factor interaction was obtained 
(p≤0.0001) and the model suggests that both culture time and the application of 
shear stress had a strong positive effect on NO synthesis and their interaction 
confounded this effect. The storage time had a slight negative effect on NO 
synthesis (Figure 4.37). The increase in NO synthesis was steep after 1 day storage, 
whereas the slope of the line for the 7th day storage was smaller.  However, NO 
synthesis increased steadily, and for shear samples it reached similar or higher 
levels than that achieved with the empty cryogels (12.56±0.29 µM for 1 day storage 
and 10 day culture of Smooth muscle cell samples versus the 13.79 ±0.20 µM on 
empty cryogels, n=6). To ensure the compartmentalization of the endothelial and 
smooth muscle cells, both cell types were stained with markers; namely endothelial 
Nitric oxide Synthase (eNOS) for endothelial cells and Smooth muscle α-actin for 
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Smooth muscle cells. e-NOS staining was restricted to the top surface of the 
cryogels where endothelial cells were forming small islands, possibly due to the 
presence of big pores, which were also observed via SEM (Figure 4.38). However 
expression of the eNOS indicated that they were functional.  
It was observed that not all of the Smooth muscle cells within the cryogels were 
expressing Smooth muscle α-actin, which should be expected due to their 
proliferative phenotype, evidenced by cell proliferation. However, there were cells 
within the pore structures that were positive for α-Smooth muscle actin which 
showed that conversion to contractile phenotype from synthetic phenotype was 
indeed possible within the cryogel structure (Figure 4.39). 
 
 
155 
 
 
Figure 4.37 Effect of SMC culture time and cryostorage time on NO synthesis by 
endothelial cells under co-culture conditions. Increasing SMC culture period has a 
positive effect; while storage time had a negative effect b)Interaction between 
shear stress application and SMC culture time; longer the culture time higher the 
effect of shear stress.  
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Figure 4.38 eNOS immunostaining of Endothelial cells seeded on to the cryogels 
after 7 days culture of encapsulated smooth muscle cells, cells were positive for 
eNOS expression (Magnification 60x) and they were mostly restricted to the surface 
of the cryogel (b Magnification 20x); similar patterns were also observed with 
SEM(Inset). 
Figure 4.39 Alpha-Smooth Muscle actin expression by encapsulated Smooth 
Muscle cells under co-culture conditions a) 10x b) 20x magnification; not all of the 
SMCs were expressing smooth muscle actin and cells were confined within the 
pores. 
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4.4 Summary of Results 
Briefly, it was possible to develop cryogels with distinctly different physical 
properties by using three different biomacromolecules as additives and coagulation 
treatment as a secondary physical crosslinking method, which provided additional 
strength and resistance to degradation. Amongst the additive used, PVA/Gelatin 
cryogels were optimal with respect to endothelial cell response and physical 
properties. It was possible to obtain a healthy endothelial lining with strong cell-cell 
contact protein expression and diminishing inflammatory response related gene 
expression. Utilization of a turbulent flow for inducing shear stress was able to 
greatly facilitate endothelium formation, which indicate that sub- or supra- 
physiological stress/strain conditions can be used for the benefit of scaffold 
maturation. Cryogelation can be used as a novel encapsulation and storage medium 
for different cell types, and the system can be made more cell-friendly by stepwise 
addition of DMSO and Serum. Newly formed cryogels had similar mechanical 
properties compared to conventional cryogels and they were able to resist cyclic 
strain. Finally, it was possible to obtain a co-culture of endothelial cells and smooth 
muscle cells by using cell encapsulated cryogels; endothelial cell response was 
dependent again on shear stress but also on the culture time interval for smooth 
muscle cells and also the storage time in frozen conditions for the cryogels. 
Interpretation of these results and their possible applications while be discussed in 
the next chapter.  
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CHAPTER 5 
5 Discussion 
The results of this study suggested that different additives can change the 
morphology and physical properties of cryogels and that coagulation bath 
treatment caused significant physical effects for all kinds of composites studied. The 
first aim of the study was to assess the feasibility of using different additives to 
support cell attachment on PVA based cryogels and determination of the effect of 
different additives on the physical properties of the cryogels.  In the discussion of 
these results, previous results of composite cryogel formation trials will be 
compared with the results of the current study. The effect of additives on 
cryogelation will be explained and the mode of action of coagulation bath 
treatment and its effects on cryogel properties will be evaluated in light of previous 
modelling and physical characterization work.   
For vascular tissue engineering an endothelial lining of the scaffold surface is 
essential. To facilitate endothelialisation, the proposition of the study was that the 
turbulent flow induced shear stress can be used to improve the rate of 
endothelialisation, which was supported by the results. The probable reasons for 
this observation and supporting in-vitro and in-vivo results are presented. 
Apoptosis, proliferation, cell-cell contact and NO synthesis results on PVA/Gelatin 
cryogels were compared with the results of other scaffold types.  
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Another proposal was that PVA cryogelation can be used for formation of scaffolds 
containing encapsulated cells, such as tunica media substitutes with encapsulated 
vascular smooth muscle cells. The effect of each additive used, the reasoning 
behind this and their overall effect on the gel behaviour is discussed with respect to 
other encapsulation techniques and the properties of cryogels. The results 
presented before were aligned with the discussions as presented below (Figure 
5.1). 
 
Figure 5.1 The corresponding parts between results and discussion chapters 
5.1 Physical Effects of Coagulation Bath 
The coagulation bath treatment was effective in decreasing degradation of the 
cryogels and it also imparted a substantial improvement in mechanical properties. 
By-products of the process were a significant increase in surface hydrophilicity, 
changes in cryogel dimensions and a loss of PVA cryostructuration. Gel formation 
Results section 4.1 
Physical 
Characterisation of 
Cryogelation
Discussion 5.1
Coagulation Bath
Discussion 5.2
Freeze/Thaw Cycles
Discussion 5.3
Effect of Additives
Results Section 4.2
Endothelial Cell 
Characterization on 
PVA/Gelatin Cryogels
Discussion 5.4
Static Conditions
Discussion 5.5
Disturbed Shear 
Conditions
Results Section 4.3
Encapsulation of 
Smooth Muscle Cells 
via Cryogelation
Discussion 5.6
Encapsulation via 
Cryogelation
Discussion 5.7
Cryogel Mechanical 
Properties
Discussion 5.8 
Effect of Cyclic 
Strain
160 
 
via crystallite growth by PVA is a useful property that can be exploited to form 
strong hydrogels. It has been shown that these hydrogels are stronger and more 
elastic than conventional chemically crosslinked hydrogels or irradiation-produced 
hydrogels, mainly due to the presence of the crystallites (Katta et al. 2007, Hassan, 
Peppas 2000a). However, in the cases where composite cryogels are needed, such 
as for cell culture applications, the presence of the additives necessitates a 
secondary crosslinking method (Hennink, van Nostrum 2002). Moreover, use of a 
secondary crosslinking method instead of just increasing the number of freeze-thaw 
cycles would decrease the production time.  Since using chemical crosslinking 
would negate the biocompatibility advantages of the cryogels, coagulation 
treatment was selected as the method of secondary crosslinking in this study. Since 
the non-solvent system used is only an over-saturated basic (measured pH 13.16) 
water soluble salt solution (saturated Sodium sulfate solution in 1M KOH), there 
would be no problem of biocompatibility since these components can be easily 
removed by PBS washes. The reason for using a basic solution was to improve 
coagulation since all components are acidic molecules (mixture pHs in solution 
ranged from 5.24 to 6.22). Their solubility is even lower under basic conditions; thus 
they will be more prone to precipitation.  The process can be defined as phase 
inversion precipitation, which is precipitation of a polymer system by introduction 
of a miscible non-solvent which causes abrupt precipitation of polymer chains due 
to the decrease in their solubility (Termonia 1995). This process is even more 
effective if used on a formed polymer structure such as a hydrogel since 
precipitation would occur within the architecture presented by the original 
hydrogel. 
161 
 
The coagulation process depends on the interaction of the polymer system with the 
non-solvent solution. As a non-solvent solution permeates through the hydrogel it 
causes local precipitates that result in strengthening and increasing the degradation 
resistance of the hydrogels. The form and the rate of local precipitation depend on 
coagulation bath temperature, concentration and rate of stirring. The overall effect 
of coagulation is also time dependent (Zhou, Powell 2006). The mode of action can 
be like extending fingers within the gel system or can form immediate precipitates, 
such as a skin layer, on the surface (Figure 5.2). 
Since the coagulates are clumps of two constituents of the composite, an increase 
in the roughness of the surface after coagulation treatment is a predictable result. 
An increase in surface hydrophilicity can be explained by the increased PVA 
concentration on the surface, since it is the more hydrophilic constituent. The 
coagulation process can happen in two modes, either by delayed demixing or 
instantaneous demixing. Delayed demixing occurs when the solvent/non-solvent 
couple miscibility is low and it causes thick skin layers (Termonia 1995).  
However, in this system the non-solvent is only a saturated aqueous solution, so 
the demixing was instantaneous and the result was a thin skin layer, which was 
observed in SEM images as the less porous surface. However, this did not affect the 
cell behaviour negatively, but prolonged the initial attachment period. Cryogels 
formed by freeze thawing have three separate phases, crystalline polymer rich 
regions, water rich (polymer poor) regions and amorphous polymer rich regions 
(Lozinsky 2002). The coagulation bath treatment increases the polymer ratio, and 
while doing so it decreases the crystallinity of the system while at the same time 
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improving the mechanical properties due to the shrinkage of the system and the 
associated increase in density. All these precipitation processes cause a decrease in 
porosity, as there is a decrease in water content. Crystallite parts of the gel act as 
junction points and are important to the elastic behaviour of the gel as the 
stretched amorphous regions recoil with respect to the network backbone provided 
by these crystallites (Mangiapia et al. 2007). In this regard, cryogels are shape 
memory systems that improve their usefulness under cyclic loading conditions, such 
as in the case of arterial pulsatile flow, since they are highly elastic. 
 
 
Figure 5.2 Effect of coagulation bath on a hydrogel system; the nonsolvent 
coagulation solution either produces long columns or finger like extensions 
during its penetration inside the hydrogel; this results in precipitation and 
strengthening of the hydrogel structure (Zhou 2006) 
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Degradation of hydrogels is the result of three different forces acting, depending on 
the constituents; (i) dissolution, (ii) hydrolysis of polymer chains and/or (iii) 
enzymatic cleavage (Brandl, Sommer & Goepferich 2007). Obviously, there are no 
enzymes that can cleave some synthetic polymers and for some polymers, 
hydrolysis is very limited or not at all possible. Even though there are microbial 
enzymes that can fully degrade PVA (Solaro, Corti & Chiellini 2000), PVA is not 
biodegradable in the human body in the sense that it is not hydrolytically cleaved 
and there are no active enzymes present that can degrade it (Wang 2007). Thus any 
degradation is entirely due to physical erosion of the cryogel structure and 
dissolution. Crystallization during the freeze-thawing process is very much 
dependent on the processing conditions such as freezing rate, thawing rate, final 
freezing and thawing temperatures, and duration of freezing and thawing 
(especially thawing for PVA cryogelation), and the properties of the initial PVA 
solution such as PVA concentration, PVA tacticity, presence of additives etc . 
(Willcox et al. 1999).  It is plausible that just one freeze-thaw cycle might not be 
enough for full gelation of the structure. In fact, even after several freeze-thaw 
cycles the system may still be in a sol-gel state. In this sense, another degradation 
process is the removal or leaching out of the solution of part of the final sol-gel 
system after a freeze-thawing cycle, instead of dissolution of already formed gel 
parts. It has been also reported (Nugent et al. 2005a) that in the long term, 
crystallite dissolution can also be observed. However this was generally 
compensated by secondary crystallite formation in the swollen hydrogels so its 
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effect should be a long-term one. This sol-gel ratio should decrease with successive 
freeze-thaw cycles due to higher crystallization degree. There is an upper limit to 
the degree of crystallization that can be achieved with a given concentration of PVA 
which also defines degradation behaviour. Application of the coagulation bath is 
effective in that it protects crystallite regions by precipitating the sol part of the 
structure around it. Even though it disrupts crystallites and subsequently increases 
the amorphous regions, it causes a distinct increase in mechanical properties. A 
solubility based degradation is beneficial in that there are no by-products of 
degradation, which are known to have adverse effects in some cases, basically 
through triggering chronic inflammation (Williams, 2009). 
Other important parameters that affect the degradation of the hydrogels are 
the degree of crosslinking and the water content of the hydrogel. A decrease in 
water content can cause an increase in the resistance of hydrogels to degradation, 
which was the case for the hydrogels in this study after application of the 
coagulation bath treatment. This is especially important for physically crosslinked 
hydrogels which are more prone to dissolution based degradation due to the 
temporary nature of the crosslinks that hold the structure together (Van Tomme et 
al. 2006). The degradation observed in the present study was mainly due to erosion 
and also the sol-gel separation within the hydrogel. The presence of the additives 
affected the gelation process and caused different degradation profiles. 
Degradation occurred through water uptake and subsequent dissolution of the 
polymeric components. Similar dissolution results obtained in this study were also 
obtained with pure PVA cryogels (Hassan, Peppas 2000a). In a sense, coagulation 
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stabilizes the PVA chains that haven’t contributed to crystallite formation and 
would possibly have been dissolved in the absence of coagulation. Increased 
numbers of freeze-thaw cycles for pure PVA cryogels lead to an increased number 
of crystallites and less sol part for dissolution. However, the presence of the 
additives caused a phase separation that led to an additive-rich region that was 
more prone to degradation. This might explain the higher degradation results for 
3rd cycle cryogels obtained in this study. The mere presence of the additives had a 
significant effect on the degradation profiles of the PVA cryogels. The highest 
degradation rate observed was for PVA/Starch cryogels, which was mainly due to 
the higher solubility of starch in aqueous solutions. However, after coagulation bath 
treatment there was no significant difference in degradation profiles of the three 
composites, which suggests that the coagulation bath treatment successfully 
precipitated biomacromolecules within the system. The results with pure PVA 
cryogels also showed that the coagulation bath treatment was even more effective 
on PVA compared to the composite formulations (3.59±0.99 % weight loss for pure 
PVA after 2 weeks compared to 9.20±0.48 % for PVA/Gelatin). Overall, stable 
cryogels which resist degradation for long-times were obtained by the two step 
crosslinking system used in the study. 
5.2 Effect ofNumber of Freeze-Thaw cycles (PVA/Chitosan) 
The effect of thermal cycles was most prominently visible in the mechanical 
properties of cryogels where crystal formation is thought to be the main trigger.  
The gels become stiffer and stiffer as the number of freeze-thaw cycles increases. 
The main determinant is the prolonged thawing duration, as all the previous 
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experiments showed that it promotes more crystallite formation. The freezing 
duration is less effective in conferring stiffness, compared to the effect of thawing 
rate (Wan et al. 2002). The mechanical change with respect to the increasing 
freeze-thaw cycle number is a versatile way to fit the properties of the cryogel with 
the target tissue (Figure 5.3). Mechanical property related changes also affected the 
cellular activity properties. Smooth muscle cell attachment and proliferation was 
slightly higher on 3rd cycle hydrogels and surface coating with collagen type I also 
caused an improvement. This improvement can be related to two effects observed 
in 3rd cycle cryogels. The first is the improved protein adsorption compared to first 
cycle cryogels; most probably due to increased surface roughness, which would 
affect the adsorption of both serum proteins and also collagen. The second effect is 
the increased substrate stiffness. A positive effect of increased substrate stiffness 
has been reported for other polymeric systems too (Tan, Teoh 2007, Balgude et al. 
2001) and it has been proposed that a stiffer substrate promotes better cell 
adhesion and subsequently spreading (Engler et al. 2004). The stiffening effect of 
freeze-thaw cycles could contribute in the same way to provide cells with a stiffer 
substrate. This effect was observed both for endothelial and smooth muscle cells 
and indicated an underlying physical difference related change. In order to 
permanently fix the collagen onto the PVA based composite surface glutaraldehyde 
was used as a crosslinker, as it can interact with both PVA and Chitosan. However 
this treatment did not cause a significant improvement and because of a general 
concern about toxicity it was abandoned. In a high water content hydrogel system 
glutaraldehyde would be hard to remove completely. The poorer attachment by 
smooth muscle cells was overcome by adsorption of fibronectin to the surface as 
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initial trials suggested. However since fibronectin is not a part of the basement 
membrane ECM (Dejana, Corada & Lampugnani 1995), this was not used for 
endothelial cells (Figure 5.4). 
 
 
 
5.3 Effect of Additives on Cryogelation and Cell Behaviour 
Physical hydrogel formation is a process where non-covalent bonds are prevalent, 
such as the hydrogen bonds that are formed between the pendant groups of PVA. 
All the additives used in this study also have the ability to form hydrogen bonds, 
albeit without the same propensity for crystallisation. Moreover, the efficacy of 
blending with the PVA chains determines the rate of interference with 
crystallization and freezing point depression by these biomacromolecules. In the 
Figure 5.3 Stress/strain curve of 15% PVA cryogels after 1-6 freeze-thaw 
cycles and its comparison with the behaviour of porcine aortic root. After 
4 cycle cryogel behaviour was nearly identical to that of aortic root, 
especially within the physiological strain of 0.2-0.5(Wan 2002) 
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freezing process hydrogen bonds may also form between PVA and the additives and 
can provide an additional strength to the final cryogel structure to a certain degree. 
Such a relationship was previously observed with cryogels produced from PVA and 
Egg Albumin (Bajpai, Saini 2006) In the same study BSA adsorption for 2:1 w: w ratio 
hydrogels was reported as 57.8% which was comparable to the results obtained 
inthe current study.  
 
 
Collagen type I is a  protein which is the main constituent of connective tissue, 
whereas bovine albumin is a serum protein responsible for transport of lipid 
molecules in blood (Allen 2006); physical differences between the protein 
molecules together with their different affinity to the surface and different packing 
led to the difference in adsorption amount. Bovine Serum albumin is a globular 
protein whereas collagen type I is a fibrous protein. Thus on a surface, due to the 
restrictions imposed by their shape, packing of bovine serum albumin is much 
easier compared to the collagen and it would decrease the competition for the 
Figure 5.4 Improvement of Smooth Muscle Cell attachment to PVA/Chitosan 
cryogels after adsorption of fibronectin a)before b) after. 
A B 
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available surface thus increase protein adsorption. The difference in their size 
would also have an effect. The inability of PVA to effectively absorb proteins was 
previously demonstrated (Nuttelman et al. 2001), so the ability of the composites 
to absorb proteins can be attributed to the additive presence.  
The presence of the additives also changes the freezing behaviour of the solution 
and thus would indirectly affect the crystallization of PVA. This might be responsible 
for the clustering effect observed with the composite hydrogels, especially with 
PVA/Starch hydrogels, probably due to the highly branched nature of starch as a 
macromolecule. Several different additives have been studied for their effect on 
gelation properties and also on the coagulation bath process. For example, 
PVA/Chitosan blends result in significantly more porous membranes after going 
through the same coagulation procedure (Chuang et al. 1999). In the same study, 
from DSC (Differential Scanning Calorimetry) results it was noted that blending 
caused a decrease in PVA crystallinity too and that there was a phase separation 
between the components. The phase separation between the composite 
components necessitated the use of coagulation bath treatment, since the 
interaction between the components was loose and the additives could easily leach 
out. Also, ESCA (Electron Spectroscopy for Chemical Analysis) studies in Chuang’s 
study found Nitrogen enrichment of the surface, which showed that the 
coagulation did not result in total domination of the surface layer with PVA. In 
another study, two different additives (chitosan and dextran) were compared with 
respect to their effect on cryogel crystallization, morphology and mechanical 
properties and it was shown that dextran was better in promoting PVA 
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crystallization (Cascone et al. 1999). Also different additives cause different 
degradation rates, similar to the results presented in this study. 
 The differences in degradation rates before and after coagulation bath treatment 
can be attributed to the differences of response of each additive to thermal cycles 
and coagulation. The most responsive biomacromolecule amongst the ones utilized 
in thermocycling was gelatin (Hellio, Djabourov 2006). As a denatured form of the 
triple helix structure of collagen, gelatin has the ability to form a assembly of coils 
below its melting temperature, and, particularly, it forms high water content gels at 
30-35 °C (Guo et al. 2003). Since the freezing part of the freeze-thawing cycle is well 
below the melting temperature, the gelatin part can form a gel on the template of 
PVA cryostructures which might be partially responsible for it higher strength. 
PVA/Gelatin cryogels had higher cell proliferation rates, better protein adsorption 
capacity, a similar degradation rate with the other composites and very good 
mechanical properties, which justified their selection for further endothelialisation 
and cell encapsulation studies. However, both chitosan and starch based 
composites were also able to maintain cell proliferation and can also be used for 
other target tissues. For example, it has been observed that PVA/Chitosan cryogels 
were less prone to contamination due to the antimicrobial properties of chitosan 
(Shi et al. 2006) and the PVA/Starch cryogels formed after one freeze-thaw cycle 
were significantly stronger than the others. 
5.4 Endothelial Cell characteristics on PVA/Gelatin Cryogels 
An important aspect of vascular tissue engineering is the investigation of the 
properties of the endothelial lining. Since the endothelium is not only a structural 
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part of the vasculature but also has an active role in thrombus formation, 
inflammation and regulation of smooth muscle cell behaviour, changes in 
endothelial cells in the presence of biomaterials should be monitored. Endothelial 
cells, like smooth muscle cells, exist in two extremes of phenotype, quiescent and 
activated. In quiescent phenotype endothelial cells mainly maintain the tone of the 
vessel wall, quiescence of smooth muscle cells and steady flow of the blood (Boura 
et al. 2005). One of the main agents in these functions is NO secretion, which is 
important for vascular tone and also prevention of platelet adhesion and 
aggregation. Aside from several secreted factors such as prostocyclin, von 
Willebrand factor and factor H, several membrane-bound proteins like 
thrombomodulin, thromboplastin and CD46, cell-cell contact molecules are also 
tightly regulated in the response of endothelial cells (McGuigan, Sefton 2007). In 
the present study, the reason for selection of NO and 3 cell-cell contact molecules 
was the dual nature of their expression and secretion. Their levels are also strongly 
correlated with the activated or quiescent endothelial phenotype. The level of 
confluence is effective in determination of thrombogenicity and non-
thrombogenicity of the endothelium, where a confluent layer is less thrombogenic. 
Thus it is worthwhile to monitor whether there is a decrease in pro-thrombogenic 
factors as the lining formation happens or not.  The reason for starting with lower 
cell densities was that observation of the endothelium formation can be performed 
for a longer period. The main difference between in-vivo conditions and a 
biomaterial surface is the composition of the underlying substrate which is the 
basement membrane in arteries, whereas it is a randomly adsorbed layer of serum 
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proteins on a biomaterial surface, which does not contain any component of the 
basement membrane. 
The first aim was to quantify the proliferation rate on the PVA/Gelatin cryogels 
compared to TCPS. Tissue culture polystyrene is a stiffer surface with surface 
plasma treatment that ensures protein adsorption. However, mechanically it is 
quite different from the natural basement membrane of endothelial cells. The 
compliant nature of the cryogels is much closer to that of the arteries, but their 
compliance and relative hydrophilicity caused a decrease in the initial attachment 
compared to the TCPS. For day 5, the proliferation rates were closer to each other 
and by day 10 there was no significant difference. Similar lagging of growth rates 
with respect to TCPS was also observed with other biomaterials (He et al. 2005). 
Moreover, the specific interaction between cells and the biomaterial base and its 
effect on cell behaviour is also an important factor for the final outcome (Coyle et 
al. 2007). This juncture is critical for PVA based cryogels due to the inherent 
problem with cell adherence to PVA because of its hydrophilicity. As a composite, 
PVA/Gelatin contains gelatin on the surface that acts as the first layer of protein 
adsorption and protein adsorbed from serum will determine the strength of 
endothelial cell attachment. PVA/Gelatin hydrogels exhibited a good capacity to 
absorb serum proteins. Previously, high levels of apoptotic cells have been reported 
for pure gelatine coatings of polystyrene surfaces (Prasad Chennazhy, Krishnan 
2005). This might be purely due to the poor strength of coating which can lead to 
removal during culture which, in turn, would trigger an apoptotic response due to 
the changes in cell attachment mode. 
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In a hydrogel surface, gelatin is embedded within the hydrogel architecture and 
shows low removal rates following coagulation bath immersion. This could explain 
why a similar dramatic increase in apoptosis was not observed in this study. The 
problem with the PVA/Gelatin cryogels was that the initial attachment was less 
effective compared to TCPS surface, since a higher level of necrotic and apoptotic 
cells in the initial period of culture was observed. This was another reason for the 
lag in the proliferation rate.  
Apoptosis of endothelial cells is a prominent outcome of vascular pathology and 
apoptotic cells are procoagulant signals as anti-coagulant surface markers are lost 
systematically during the apoptotic pathway (Irani 2000). Nearly all cardiovascular 
diseases are accompanied by widespread endothelial apoptosis (Stefanec 2000). 
This can be triggered by ROS (reactive oxygen species, biochemical signals such as 
Tumor necrosis factor (TNF), elevated low-density lipoprotein (LDL) concentration, 
changes in physical environment (hypothermia, hypoxia) and disturbances in blood 
flow (Stefanec 2000). On the other hand under normal resting conditions in-vivo 
only 0.1% of endothelial cells show apoptotic pro-properties (Davies 2009), where 
some of the prominent anti-apoptotic factors are NO presence, shear stress and 
VEGF. So, determination of whether a biomaterial surface can sustain endothelium 
without triggering apoptosis is important.  
Necrosis and apoptosis are two distinctly different modes of cell death. Necrosis is 
generally induced by toxic or traumatic events, which leads to organelle damage, 
uncontrolled swelling and rupture of the cells, whereas apoptosis is much more 
controlled; which minimizes the release of cellular contents and can be 
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characterized by cell  shrinkage, chromosome condensation and fragmentation 
(Bonfoco et al. 1995). In the current study, there was a significant group of necrotic 
cells 2 days after seeding onto the PVA/Gelatin cryogels, with a smaller population 
of apoptotic cells present. A similar trend was observed on TCPS too, although to a 
lesser extent. This initial necrotic population can be traced to the cells which were 
unable to attach or have attached only loosely to the surface initially, which can 
trigger both apoptotic and necrotic pathways. Loose attachment and subsequent 
spherical shape was shown to induce apoptotic response in endothelial cells 
previously (Chen et al. 1997). However, in the present study after 5 days and 
removal of unattached cells, the remaining cells were healthy and the percentage 
of both apoptotic and necrotic cells diminished as the endothelium was formed. 
Even up to 20 days, the lining was intact. Thus it can be said that PVA/Gelatin 
cryogel surface was able to sustain long-term endothelial lining without inducing 
cellular death, unlike the tendency observed in some other biomaterials (Coyle et 
al. 2007, Serrano et al. 2006) 
When subconfluent, endothelial cells act in a similar way as fibroblasts and migrate 
and proliferate aggressively (Kudo 2005). However, as confluency is reached, due to 
contact inhibition and organization of cell-cell contacts, a single well-organized 
lining is formed. Thus, for endothelial cells homotypic and heterotypic cell contacts 
and extremely organized cell junctions are crucial for their proper functioning 
(Figure 5.5). PECAM is a good indicator of endothelial cell junction presence or 
formation and it is an integral part of the endothelial diffusion barrier function, 
since it is a cell type specific homophilic adhesion protein (Dejana, Corada & 
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Lampugnani 1995). It is also implicated as taking a part in control of proliferation 
and apoptosis, by inhibiting cell division as a part of contact inhibition and 
suppressing apoptotic pathways, and also having a potential role in 
mechanotransduction together with VE-cadherins (Dejana 2004). So under static 
conditions the ideal profile would be a constant increase in PECAM expression over 
the culture period, which was observed by the PVA/Gelatin cryogels over 10 days. 
PECAM expression level was only slightly higher for PVA/Gelatin cryogels for the 
first 5 days, but by day 10 there was an 8 fold increase compared to TCPS, which 
might indicate that due to the differences in the initial attachment to the surfaces, 
there may be a higher tendency for PVA/Gelatin cryogels to form cell to cell 
contacts.  
ICAM is a surface protein mainly related to endothelium-leukocyte interactions and 
during inflammation its expression increases significantly (van der Zjipp 2003). 
However, even quiescent endothelial cells constitutively express it, and thus it is a 
good marker of constitutive expression during endothelium formation. On 
PVA/Gelatin cryogels, the ICAM expression stayed steady and comparable to that of 
TCPS, consistent with the expectations. This meant that, as the cell proliferation 
progressed and more cells came into contact with each other, they tended to form 
cell junctions and a concomitant several fold increase of ICAM expression 
associated with inflammation did not materialise (Remy et al. 1999). Slight 
increases in ICAM expression by human umbilical vein endothelial cells (HUVEC) 
over a 7 day period were previously observed on plasma treated PET and ePTFE, 
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but the methodology used was trypsinization and subsequent FACS analysis; thus it 
might have underestimated the overall expression (Pu et al. 2002).  
 
 
 
 
 
 
 
 
Selectin-P is a member of the Selectin family of adhesion molecules, which also 
contains L and E Selectins. It is a cell adhesion molecule expressed on activated 
endothelial cells and together with Selectin-E modulates platelet, leukocyte and 
endothelial interactions. Thus it is an important factor and an indicator of 
inflammatory response. The expected ideal case would be an elevated expression 
at the onset of the culture and then a decrease in expression as endothelial cells 
reverted back to their quiescent phenotype. The expression pattern of Selectin-P on 
PVA/Gelatin cryogels followed this pattern. In the beginning of the culture, there 
was an upregulation of Selectin-P expression, but, as in the ideal case, expression 
subsided as the culture progressed and it was only 1.41 fold more than TCPS control 
by day 10. Upregulation of Selectin-P on biomaterial surfaces has been reported 
Figure 5.5 Homotypic cell-cell contacts present in 
arterial endothelial cells; PECAM is an important 
constituent and an increase in its expression points to 
an increase in endothelial cell contacts(Dejana  2004) 
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before (Guidollet et al. 1999), as has the upregulation of Selectin-E (Imbert et al. 
2001) but in these studies the experiments were terminated on day 3 at most, so 
the long term data was not available. For longer term cell cultures (up to 10 days), 
similar upregulation of PECAM and downregulation of Selectin-P was also reported 
for porcine endothelial cells on amniotic membrane (Tsai et al. 2007). 
5.5Effect of Disturbed Shear stress on Endothelial Cells 
Perturbations in wall shear stress are one of the main reasons for acceleration of 
atherosclerotic plaque formation and are known to affect the neointimal 
hyperplasia levels in vascular grafts (Liu 1998). In general, the effect of shear stress 
on cells is magnitude dependent and at high shear rates (≥ 1000 s-1) it can cause 
membrane damage, lysis and/or subsequent apoptosis (Zoro et al. 2008). However, 
since endothelial cells are under constant shear stress under in-vivo conditions, 
they are better equipped morphologically and phenotypically to endure shear 
stresses compared with other cell types, except blood cells (White 2007). For them, 
the mode of shear stress is a more important factor.  
Under normal conditions blood flow is predominantly laminar. However, at 
bifurcation points or due to plaque formation, conditions for turbulent blood flow 
can be created (Hahn 2009). There are several distinct responses of endothelial 
cells to turbulent flow compared to laminar flow induced shear stress. Under 
turbulent flow conditions, cell proliferation is higher, alignment is poorer, and there 
is a higher rate of apoptosis and inflammatory gene expression (Figure 5.6). 
Although, shear stress created by orbital shaker systems has been previously 
proposed as a model for atherosclerosis advancement or neointimal hyperplasia 
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(Dardik et al. 2005), exploitation of the turbulent flow for facilitation of 
endothelium formation or strengthening is not available in the literature. It was our 
aim to show that such utilization of the turbulent flow is feasible and quantify its 
effects.  
The growth of cells on PVA/Gelatin and TCPS showed a similar pattern except that  
from apoptosis data, initial attachment was higher on TCPS. With turbulent shear, 
cells assumed a random orientation, and apoptosis and cell proliferation increased. 
In an orbital shaker system with a circular cell culture plate, the shear stresses at 
the centre and at the periphery are not the same, with lower shear stresses 
expected at the centre. The lower shear area generally shows higher proliferation 
and apoptosis rates, which might be an additional benefit of ramping. However, it is 
useful to have the decreased necrosis effect in the beginning of the culture. 
The Reynold’s number for the flow regime was calculated as (Dardik et al. 2005): 
                                                                                                               Equation 5.1                                                                                                                          
Where  is rotational speed (rps), R is radius of rotation of the orbital shaker 
(provided by the manufacturer as 2.5 mm) and  is kinematic viscosity and the 
value of Re was 1512 with a slight underestimation due to the utilization of 
measurements made in room temperature. Although no lower limit for turbulent 
flow has been set in the literature for such a flow system, previously Doppler 
velocimetry measurements of the flow regime was performed to show oscillatory 
and disturbed nature of the shear stress (Dardik et al. 2005), which has  also been 
verified by a computational model ((Berson et al. 2007) and personal 
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communication with Dr. Sharpe) and with the presence of eddy current and high 
rate of dissipation of energy due to turbulent shear was experimentally measured 
even for rotational speeds as low as 50 rpm (compared to the rate used 135 rpm in 
this study)(Kaku et al. 2006). Thus the claim of disturbed shear effect is valid. 
 
Moreover, dispersed cellular presence and the resulting change in surface 
roughness, surface porosity of the base and oscillatory fluid motion would also 
contribute to the changes in the shear regime. 
Figure 5.6 Effects of shear stress mode on endothelial cell functions. Even though, 
disturbed shear conditions triggers inflammatory responses and causes increased 
permeability they can be used for rapid endothelialisation of graft surfaces due to the 
increased cell turnover (Hahn 2009) 
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In the present study, application of a ramped shear stress regime resulted in a 
dramatic increase in cell proliferation, with a smaller increase in apoptosis which 
was satisfactorily compensated by the increase in cell number. The lining was intact 
at physiological level of stress associated with small diameter arteries (Zhang et al. 
2008), with only small patches of cell free areas observed by microscopy after 5 
days. A similar significant increase in proliferation on TCPS with turbulent flow 
versus both static and laminar flow was observed previously (Figure 5.7). Coating of 
grafts with cell adhesive proteins such as fibrin glue has increased the patency rates 
in the past (Deutsch et al. 2008, Kannan et al. 2005), even though there was still 
endothelial cell loss following implantation mainly due to shear stress. It has been 
reported that the attachment of this layer is vulnerable under turbulent shear 
stress, which exists at the points of implantation (Chien 2008). This was consistent 
with our observation that direct application of shear stress, similar to the case 
when the blood flow is re-established in-vivo, caused widespread removal of the 
endothelial cells. Ramping has been used successfully with other grafts (Inoguchi et 
al. 2007) and it was also beneficial in our model.  The increase in the apoptotic cells 
compared to the static cultures was significant, but negligible when compared to 
the overall viable cell numbers. 
Ramped shear stress related increases in apoptosis were overshadowed by the fact 
that it caused a dramatic decrease in necrotic cell count, which might be due to the 
attachment strengthening effect of sub-physiological level of initial shear, which 
was not strong enough to trigger widespread detachment, but perhaps effective 
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enough to alter gene expression patterns to reinforce cell attachment (Chien 
2008b).  
 
 
 
 
 
 
 
 
 
 
 
The appeal of PVA-based cryogels is the potential to produce scaffolds with a wide 
range of mechanical properties similar to soft tissue. However, as demonstrated by 
the previous results, the attachment behaviour is different compared to TCPS. For 
endothelial cells, the decrease in surface porosity upon coagulation bath treatment 
is beneficial in the sense of ensuring that the endothelial cells would stay on the 
surface of the gel, rather than penetrating inside. The initial increase in surface 
Figure 5.7 Effect of turbulent flow on endothelial cell proliferation on TCPS; 
the proliferation rate was significantly higher over a 5 day period; whereas 
laminar flow inhibited cell growth compared to the static controls. (Dardik 
2005) 
 
182 
 
roughness after application of coagulation bath might be deemed detrimental in 
the sense that rougher surfaces trigger more platelet adhesion, if exposed. 
However, since coagulation improved cell attachment and the surface gets even 
smoother with the application of shear, this will decrease the possibility of 
thrombosis in the uncovered areas of the hydrogel even if the endothelial lining is 
removed. The time constraint is an important problem in tissue engineering, where 
the long culture periods decrease the feasibility of engineered tissues; due to the 
related costs and risks such as contamination (Yow et al. 2006). 
For cell-cell contact gene expression, the application of shear stress was highly 
influential, especially when ramping was applied. Endothelial cells responded to 
turbulent flow in a manner that would trigger an inflammatory response under in-
vivo conditions; i.e. with a marked increase in Selectin-P expression. In the present 
study, the presence of shear stress was the dominant factor and it diminished the 
differences between PVA/Gelatin cryogels and TCPS. Only in ICAM expression, 
which can be seen as a part of inflammatory response when there is a several fold 
increase, there was a significant difference (4.59 fold increase). This jump in pro-
inflammatory gene expression could be observed both for laminar and turbulent 
shear conditions (He et al. 2005). The difference between these cases was that if 
the disturbed shear is maintained then expression would continue steadily, while 
there would be a decline under laminar flow (Chien 2008a). When comparison was 
made between static versus shear conditions, there was a significant increase in the 
expression of all genes. In the current study, the increase in both PECAM and ICAM 
expression indicated a higher level of cell-cell contact, which is essential for the 
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barrier function of the endothelium. Similar jumps under disturbed shear were 
previously observed too (Sorescu et al. 2003). As for quenching the inflammatory 
response, it has been shown that even in 24 hour laminar shear application; most of 
the pro-inflammatory and proliferative genes are downregulated (Chen et al. 2001). 
Microarray analysis further showed that the laminar and disturbed flow conditions 
were distinctly different mechanical stimuli with significantly different gene 
expression profiles (cell adhesion molecules, inflammation, proliferation, apoptosis, 
secretion related genes and receptors) (Brooks, Lelkes & Rubanyi 2002). 
Modulation of phenotype must be an important tool in tissue engineering, where 
cells respond to abnormal conditions in a way that would be beneficial for the long 
term goal of scaffold maturation. Shear stress created by the turbulent flow can be 
considered such a condition, where non-physiological effects can be exploited in 
order to facilitate production of a full endothelial lining. The side effect of invoking 
inflammatory response can be quenched by application of laminar or static culture 
conditions following the application of the turbulent flow and acceleration of 
endothelial formation. This way, the necessary in-vitro culturing time can be 
shortened and endothelial cells would be acclimatised to the conditions of 
implantation. 
A steady release of low levels of NO is crucial in-vivo and has been used as a control 
for endothelial functionality frequently both in-vitro and in-vivo (Sessa et al. 1994, 
Oemar et al. 1998). The mean nitric oxide concentration in blood is reported as 19.6 
µM (Fareed et al. 2004) for healthy adults and is known to fluctuate considerably 
for several pathological and inflammatory conditions. The concentration of NO in 
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culture medium was 5.26 µM for PVA/Gelatin hydrogels by day 5 under static 
conditions, where the lining was not complete, which suggests that physiological 
levels of NO can be achieved once a full lining is in place. In general, shear stress 
can increase production of NO and also several other genes (Ballermann et al. 
1998). The overall NO concentration has increased in culture medium after 
application of shear, 13.79 µM, and it was much closer to the physiological values. 
It has been shown that ramping the shear stress has a positive effect on NO 
synthesis (Noris et al. 1995).Thus, this might explain the difference between direct 
and ramped shear NO levels (8.17 vs. 13.79 µM). Thus, flow conditions, achieved 
the expected positive effect on NO synthesis. 
Tissue engineering seeks to produce healthy artificial tissues under in-vitro 
conditions. However, this does not necessarily mean that the cells used for tissue 
maturation need to be exposed to physiological conditions throughout the culture 
period. Applications of pathological conditions for pre-determined periods of time 
might facilitate tissue maturation, since cells are apt to react to such conditions in a 
fast manner (Resnick et al. 2003). The modulation of these conditions might be 
beneficial for short term gains, such as increased proliferation or increased 
secretion of proteins. Results of this study has shown that on PVA/Gelatin hydrogels 
endothelial lining formation can be facilitated and maintained by short term 
application of shear stress under disturbed flow conditions, to accelerate cell 
proliferation and cell-cell contact formation.  
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5.6 Encapsulation via Cryogelation 
When an aqueous polymer solution is frozen, polymer chains are pushed together 
by the growing ice crystals. This packing effect is the main reason behind the 
hydrogel formation upon freeze-thawing of PVA solutions as packing improves the 
probability of hydrogen bond formation between the PVA chains (Kirsebom, 
Mattiasson & Galaev 2009). Cryogelation via freeze-thawing is a process mainly 
governed by the crystal formation rate. This rate is affected by the concentration of 
the polymer, freezing and thawing rate and freezing and thawing temperatures. It is 
known that the main determinant in the PVA gel formation is the thawing rate 
(Millon et al. 2007). Moreover, the presence of additive and also the composition of 
the solvent would affect crystallization and subsequently the final gel structure. In 
this study, a PVA based cryogel was formed in the presence of cells and several 
other additives without compromising the viability of the encapsulated cells. This 
was achieved through application of cryopreservation methodologies for cells in 
conjunction with the cryoprotectant properties of PVA. 
Cryopreservation has been developed and perfected for sperm, embryo and oocyte 
preservation and storage (Chin Heng, Yu & Chye Ng 2004). Even though 
methodologies developed in these areas are transferable to thicker tissues or 
microcapsules and sometimes provide benefit such as reduced immune reaction 
upon implantation (Sotres-Vega et al. 2006), there are additional necessities that 
have to be covered. For cell encapsulation, the main concerns were the stability of 
the pH of the solution, the temperature of the initial gel solution, the need for an 
adhesion promoting component in the gel solution, protection against cryodamage 
(intracellular and extracellular) and presence of proliferation promoting factors 
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upon thawing and if necessary an additional crosslinking method with minimal 
effect on cell viability. 
For PVA composites developed in this study, the adhesion promotion was solved by 
the presence of gelatin, which blends well with PVA and even reinforced the gel 
structure as the results in the previous sections suggested. Gelatin has been used to 
improve the encapsulation efficacy of other gel structures used in vascular tissue 
engineering such as modified dextran that can be photopolymerised (Liu, 2009). 
However, the gelatin stability was less than the current study and by 3 days nearly 
twice the amount of gelatin released from cryogels was released from these 
systems. No such problems occurred with the encapsulation system developed in 
this study. 
To stabilize the pH of the gelation mixture and also to provide necessary nutrients 
to cells upon thawing, as gel presence may prevent the initial diffusion of the 
nutrients, a HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffered 
medium solution(Serum and antibiotic free RPMI 1640 supplemented with HEPES) 
was used and shown to stabilize pH in 7.20-7.40 range. 
Cryodamage can happen either directly (during cooling stage) or indirectly (due to 
long term storage at subzero temperatures). So, in a storage system, protection 
against both these forces is essential. This protection against cryodamage is two-
fold.  The first step is to prevent intracellular ice crystal formation which can be 
achieved by DMSO or glycerol. Both act by replacing the intracellular water; i.e. 
dehydration of cytoplasm (Toner, Kocsis 2002). The next step is the prevention of 
intercellular ice crystal formation which can pierce the cellular membrane and 
187 
 
induce apoptosis or direct necrosis. In particular, replacing the water bound to the 
membrane surface is crucial. Molecules such as albumin or trehalose have been 
shown to be effective in reducing membrane damage. The presence of serum is 
helpful for the prevention of intercellular crystal formation. Also, polymer chains of 
PVA would provide a better protection with their interactions with the membrane, 
as this property was previously observed with the freeze-thawing of mouse 
embryos (Nowshari, Brem 2000). Besides being active in ice crystal formation 
prevention, the serum will also alter gel formation resulting in the presence of big 
particles such as serum albumin in its constitution and also by providing cells with 
necessary growth factors upon thawing and also to a limited extent by providing 
cell adhesion proteins that will adsorb to the inner surface area of the gel. This 
would also provide a change in the freezing regime because of the higher 
osmolarity of the final solution due to presence of serum and media contents, The 
improved osmolarity has been shown to be beneficial for viability of the 
encapsulated cells (Villanueva, Bishop & Bryant 2009).  
DMSO was chosen in this study as the principal cryoprotectant due to two reasons. 
Firstly, there is a body of work that suggested DMSO is a superior cryopotectant in 
complex 3D structures (Pancrazio, Wang & Kelley 2007). Secondly, DMSO has the 
ability to dissolve PVA and by changing the freezing regime, it was hypothesized 
that it would form bigger pores during cryogelation. This hypothesis was supported 
by the results of the current study. Finally, the presence of the cells acted as fillers 
for reinforcement of the system, and thus alleviated the need for longer thawing 
regimes. The presence of 2 million cells, acting as beads with a volume of at least 10 
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µm3, has also changed the phase separation process resulting in a better porosity 
(Nicodemus, Bryant 2008). Histology sections demonstrated that cells are present 
in the big pores in the hydrogel structure. In these pores cells were generally 
arranged in large groups, which showed the relationship between pore formation 
and cell presence. Moreover, due to the improved porosity the final cryogel 
structure was more suitable for migration of the cells, and also for nutrient and 
oxygen transport, and would be feasible for secondary seeding of cells if the cell 
number is lower than expected after thawing. Both the presence of PVA and DMSO 
markedly improved the viability of the encapsulated smooth muscle cells. The 
presence of serum had a positive effect by itself, but when applied together with 
DMSO the increase in viability was even higher. 
To prevent cryodamage cell suspensions were frozen slowly to prevent water 
crystal formation and thawed rapidly in order to prevent recrystallisation, which 
would cause similar damage. Although, the initial step of controlled freezing is 
beneficial for gel formation, rapid thawing is detrimental. When a PVA solution 
dissolved in distilled water is thawed in a rapid fashion (30 min, for example), the 
final product is an extremely weak gel. However, the encapsulation mixture was 
able to form stable gels in much shorter thawing rates (gel formation was achieved 
even with 5 minute thawing procedures, by adding the culture medium slowly in 
minute amounts, which disrupted the cryogel formation less). This response was a 
direct result of the effect of the mixture components on the final gel structure. As 
the suspension freezes, formation of water crystals will result in a phase separation 
between the frozen and non-frozen phases which are affected by the solute 
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concentration. High solute concentration leads to freezing point depression that 
directly affects the rate of water crystal formation. Crystallite formation also 
depends on the ability of the components of the solution to bind water. The 
increase in pore size can be explained by the difference between the packing of 
strands of polymer chain by the pushing out effect of crystallisation compared to 
packing of spherical cells which would lead to less effective packing and result in 
more space. The viscosity effect mainly depends on the characteristics of the PVA 
solution, such as polydispersity ratio, or stereoregularity and degree of hydrolysis. 
The final gel has three distinct parts, as in the conventional cryogel; a solution part, 
an amorphous layer and crystallites that decrease the movement of amorphous 
parts. However, the difference is that the solution part is now a suspension of cell 
rather than a simple aqueous solution, which was the reason behind the dramatic 
changes in the gel structure. In a way, the primary aim of encapsulating and 
preserving viable cells (which was achieved as the cells were viable upon thawing 
and were able to proliferate afterwards) had a positive side-effect of improving the 
cryogel ultimate tensile strength and porosity.  
Current cryopreservation techniques are mainly devised and optimized for cell 
suspensions and their application to adherent monolayers or thick biological 
samples are known to be less effective (Malpique et al. 2009). Even though cells 
remained viable, they tend to go into the apoptosis route and lose the capability to 
proliferate (Heng et al. 2006). Specifically, vascular tissue cryopreservation can 
cause prolonged proliferation lag periods (Lehle et al. 2005). It has been shown that 
the presence of polymers or encapsulation of the cells is beneficial for cell viability 
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after thawing. This has been achieved by microcarrier systems such as PEG, alginate 
or matrigel (Itle, Pishko 2005). However, these are pre-formed systems on which 
freeze-thawing cycle of storage may have some adverse effects; especially on 
mechanical properties. Thus, PVA offers a unique opportunity to combine these 
two beneficiary properties with the ability to form cryogels for development of a 
one-step preservation and scaffold production method. Moreover, such 
encapsulation techniques would also enable incorporation of growth factors or 
angiogenic factors. However, the additive content should be carefully monitored 
since, depending on the solution viscosity of the PVA, below a certain concentration 
PVA cryogels formed are not stable (Figure 5.8). 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 Relationship between cryogel stability freeze-
thaw cycle number and concentration. The stability 
improves with freeze-thaw cycles and with concentration. 
Thus for 1 cycle cryogels, dilution of PVA solution with too 
much additive can cause gel instability. This was the reason 
why higher DMSO and Serum concentrations were not 
used (Szczesna-Antczak 2001) 
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In the current study, cell viability was not affected by 1 month cryostorage at -80 °C 
and most probably longer storage times can be achieved in liquid nitrogen, most 
probably up to a year. Also, the protective capabilities of the cryogel was shown, 
where monolayers of smooth muscle cells cryopreserved resulted in distinctly less 
viable cells. A decrease in viability after the storage time frame within a month was 
observed with cardiomyocytes (Yokomuro et al. 2001) (Figure 5.9). Thus the current 
results of steady viability over a 1 month storage period were encouraging. 
Moreover, the mechanical properties of the final cryogels can be easily improved by 
changing the cell concentration and final thawing rate, resulting in a wide range of 
cryogels with different mechanical properties since the thawing rate is the 
determining step in mechanical property development for cryogels, that can be 
used for different targets in the vascular tree, so the same batch solution might be 
used for different problems. To our best knowledge, such a system developed with 
cryogelation as in the current study does not exist in literature. The only similar 
effort in tissue engineering area was the encapsulation of pancreatic islet cells in 
PVA cryogels while preserving their functionality (Qi et al. 2004). However, in that 
study only cellular functionality was reported. Another body of work was done to 
encapsulate yeast and bacteria cells for chemical engineering application but 
without any modification of cryogelation procedures (Szczesna-Antczak, Galas 
2001). However, these systems have shown similar high porosity and permeability 
and improved mechanical strength and their successful utilization in bioreactor 
systems was a proof-of concept for tissue engineering applications (Plieva et al. 
2008). Since the encapsulation procedure is affected by several parameters as 
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discussed above, to clarify their effects in a systematic way, factorial experimental 
designs were utilized. 
Statistical experimental models, or in a more general and sophisticated manner 
combinatorial methods with high throughput screening are a useful way to deduce 
several factors. Through them, interactions with several parameter in an 
experimental system can be determined, while minimizing the number of 
experiments necessary to reach statistically significant conclusions. Utilization of 
these methodologies is not widespread in the biomaterials field but certainly 
combinatorial approaches are very useful tools for biomaterial research (Brocchini 
2001), especially when the multifactor nature of most of the processes pertaining 
to cell/biomaterial interaction is concerned (Kennedy et al. 2006). There might be 
limiting, inhibiting or compounding effects of several factors which would remain 
unrevealed with one-factor tests. Moreover some factors would only be able to 
work synergistically; such as in the case of DMSO and Serum in this study. 
Optimization of a wide range of parameters on the same experiment settings is 
particularly important in biomaterials, since the behaviour is so dependent on 
properties such as cell passage number, batch and the chemicals used. Also, when 
the necessity of doing long-term experiments in tissue engineering is considered, 
multi-factor experimental designs can become indispensable tools in tissue 
engineering (Villani et al. 2008, Chen et al. 2006). In this study, design of 
experiments methodologies revealed the necessity of using DMSO and Serum 
together for improving the cell viability in the cryogelation system and also the 
relationship between the coagulation bath and PVA viscosity while at the same time  
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providing results about the interactions between PVA viscosity, DMSO and serum.  
 
 
5.7 Cryogel Mechanical Properties and Effects of Encapsulation 
One of the appealing features of using cryogelation aside from non-toxic nature of 
the process is the improved mechanical properties of the final structure due to 
extensive crystallite formation which makes it easier for the structure to carry the 
load applied (Hassan, Peppas 2000b). The unique advantage of PVA cryogels in the 
area of cardiovascular tissue engineering is their close resemblance of the typical 
exponential stress/strain curve of arterial samples. For arterial tissue, this 
behaviour is conventionally explained by the differential behaviour of collagen (high 
stiffness) and elastin (low stiffness) constituents, which are crudely, imitated by the 
amorphous and crystalline regions of the PVA cryogels (Millon, Wan 2006). In a 
way, addition of complex carbohydrates such as chitosan or starch would even 
further mimic the aortic behaviour, by providing the properties of proteoglycans. It 
Figure 5.9 Viability of cardiomyocytes with respect to the cryostorage period. 
Longer storage time caused lower cell viability (Yokomuro 2001) 
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has been reported that increasing the number of freeze-thaw cycles had an effect 
on mechanical properties which levels off after several freeze-thaw cycles (Wan et 
al. 2002). The increase in the cryogel strength upon application of cyclic strain 
during cryogelation can be due to induction of extensive secondary crystallization 
triggered by extensive mobility of the sol portion of the hydrogels due to the strain 
(Millon, Mohammadi & Wan 2006).  
Since freezing is equiaxial in the present study, the properties of PVA composite 
cryogels are isotropic, previously it was shown in our laboratory that the PVA based 
composite cryogels have similar stress/strain curves to those of the porcine aorta 
(Mathews et al. 2008). This similarity has been also noted by other works, and it has 
been suggested that the uniaxial straining of the PVA cryogels during formation can 
lead to anisotropic mechanical properties, even more similar to that of vasculature 
(Millon, Mohammadi & Wan 2006). 
The improvement in mechanical properties in the presence of the additives can 
be explained by their effects on PVA structuration and freezing. The initial effect in 
increase in tensile strength of the system by encapsulation mixture due to the 
presence of additives may be the depression of the freezing temperature of the 
mixture and by preventing freezing promoted more crystal nuclei formation. For 
the cryogel structure, staying in these low temperature conditions for a long time 
without freezing results in a more crystalline structure with coarser crystallites. 
Previously, it has been shown that the presence of both hydrophilic and 
hydrophobic particles in the gelation mixture had a reinforcing effect on the gel 
structure by improving phase separation and packing of the PVA chains (Lozinsky, 
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Savina 2002). Thus the effect was dependent on the surface hydrophilicity of the 
particles, their size and concentration. In this sense, the contributors to the 
improved cryogelation in the encapsulation system were; cells, DMSO and serum 
proteins. The biggest contributor is DMSO, which is known to improve the 
crystallinity and hence the mechanical properties of cryogels (Lozinsky 2002). The 
ionic strength increase due to the presence of complex salts in the culture medium 
might have a dissociative effect on hydrogen bonding and such effects were 
previously reported with simpler salt solutions (such as sodium Chloride)(Nugent et 
al. 2005b) However, nucleation capacity of the proteins in the serum and cells in 
particular can easily overcome this barrier. Together with the effect of the different 
biomacromolecule additives on tensile strength, a wide range of cryogels with 
notably different mechanical properties can be prepared either with or without 
cellular presence within the cryogels. 
5.8 Effect of Cyclic Strain on Smooth Muscle Cells  
The cyclic strain has a regulatory function in-vivo in which it ensures contractile 
phenotype in smooth muscle cells and consequent quiescence (Kurpinski 2006). It is 
also important for alignment of the smooth muscle cells as it provides the 
mechanical cues for such alignment (Standley 2002).  2D in-vitro studies have 
demonstrated that the cyclic strain inhibits smooth muscle cell proliferation 
(Morrow et al. 2008). However, in 3D scaffold conditions an increase in 
proliferation was also observed (Figure 5.10). This is mainly due to the different 
mode of transmission of the strain (strain was transferred from all strands of the 
polymer matrix rather than the substrate adhesion points in the case of 2D 
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stretching) and also the different shape and attachment of the smooth muscle cells, 
which also results in different responses under static conditions (Stegemann, 
Nerem 2003). In the current study, the application of cyclic strain resulted in a slight 
increase in proliferation, extensive alignment by the cells and comparable viability 
with respect to the static culture conditions, similar to previous observations 
(Butcher, Barrett & Nerem 2006). This points to PVA cryogel extensibility being 
favourable for transmission of mechanical stimuli. One experimental problem 
would be the overestimation of the cyclic strain levels, as it was shown that the 
strain function of the Flexercell is not very reliable (Colombo, Cahill & Lally 2008). 
 
  
 
 
 
 
 
 
 
Generally, mechanostimulation together with cell activity leads to gel compaction. 
Even though PVA cryogels weren’t compacted, there was a decrease in their tensile 
Figure 5.10 Effect of cyclic biaxial strain on smooth muscle cell 
orientation and viability. Strain cause higher alignment and 
higher cell numbers (Butcher 2006) 
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strength compared to the static controls. This was mainly due to the cryogels not 
being completely formed, as the observation of the cryogel formation showed that 
gel formation continues during culture. This disruptive effect wasn’t apparent for 
cryogels which went through cyclic strain without cells; since disrupted connections 
can be re-established quickly. However with the cells present and with their 
movement and possible MMP activity, the level of disruption would be more 
severe, resulting in reduced strength. This can be overcome by increasing initial 
static culture period. The experiments were conducted as they were so that the 
tests could be conducted at exactly same time point. It has been shown that the 
long-term application of cyclic strain (up to 20 weeks) would result in an 
improvement in mechanical strength (Kim et al. 1999). Also biochemical stimulation 
with growth factors such as b-FGF or PDGF together with mechanical stimuli could 
result in faster improvement of mechanical properties (Stegemann, Nerem 2003). 
5.9 Endothelial Cell/ Encapsulated SMC Co-culture 
Aside from being responsive to mechanical cues, endothelial cells are in contact 
with the blood cells and also smooth muscle cells via paracrine and endocrine 
pathways. It has been shown in the past that the co-culture of endothelial cells on 
smooth muscle encapsulated scaffolds promoted smooth muscle quiescence and 
prevent hyperplasia depending on the eNOS expression level (Kader et al. 2000). 
The communication between endothelial cells and smooth muscle cells are two way 
and both can induce quiescence or proliferation on each other (Leung, Sefton 
2007). For these reasons, in this study the effects of three factors on endothelial 
functionality (via NO synthesis and eNOS presence) were checked. The culture time 
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indirectly corresponded to the smooth muscle cell number, as our previous results 
showed they proliferated within the hydrogels for the given time period. Storage 
time parameter could affect the cryogel stiffness by the effect of period of freezing, 
while the cell number was shown to be steady in this study. The shear stress has 
been shown to improve NO synthesis and it was used to see whether there would 
be a further improvement as a result of interactions with the other factors. 
This effect of shear stress was augmented when it was applied to the endothelial 
cells seeded to the longest cultured cell encapsulated cryogels. Storage time did not 
have a substantial effect on NO synthesis. The encapsulated smooth muscle cell 
culture experiments showed that the cryogel was remodelled during the culture 
time and with the higher cell number and a stronger hydrogel, higher secretion of 
NO could be triggered. Unresponsiveness to the storage time suggested that the 
cell number was the same and the cryogel structure did not change much due to 
the longer storage. Since the main gelation step is thawing as stated above. 
Previously, it has been shown that seeding of endothelial cells after a period of 
culture onto the encapsulated smooth muscle cells results in a more contractile 
phenotype (Williams, Wick 2005). However in Williams and Wick’s study there was 
migration of endothelial cells into the scaffold too. This problem was prevented by 
addition of a smooth membrane surface for porous collagen scaffolds which was 
also successfully applied in-vivo (Wu et al. 2007). Direct contact of endothelial cells 
with smooth muscle cells are shown to slow down their spreading ability; thus it is 
better avoided (Wallace, Champion & Truskey 2007). In the current study, 
immunofluorescent labelling of eNOS as an endothelial-only marker in co-culture 
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experiments showed that the endothelial cells remained on the outer surface, as 
required. Also under co-culture conditions, some of the smooth muscle cells within 
the porous body of the cryogel were expressing α-smooth muscle actin which 
denoted a conversion to the contractile phenotype following proliferation. 
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CHAPTER 6 
6 Conclusion and Future Work 
The main conclusions of the present study are, presented with reference to the 
objectives set out in section 1.1 of this thesis: 
1. The utilization of a two step physical crosslinking system for production 
of highly elastic, soft tissue-like composite hydrogels was developed. 
Effects of this crosslinking system on the physical properties of cryogels 
in the presence of different additives were elucidated, which 
contributed to the current literature on cryogel production (Liu et al. 
2009). Also there was a gap in the literature as to the effect of 
successive freeze-thaw cycles on cell behaviour on cryogels and 
preliminary findings of this study showed that increasing the number of 
freeze-thaw cycles would be a good route to pursue to improve cell 
behaviour on top of mechanical benefits (Vrana et al. 2008). It has been 
concluded that the two-step crosslinking methodology utilized is a 
versatile method to produce composite cryogels with a wide range of 
additives , which can resist degradation and have good mechanical 
properties.  Of the systems investigated, PVA/Gelatin had the most 
desirable properties for the further investigation towards target 
application, vascular tissue engineering. 
2. In the light of the findings on the effects of disturbed shear stress’ 
positive effect on cell proliferation of endothelial cells, the current study 
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developed a ramp disturbed shearing regime which improved 
endothelialisation of the cryogel surface substantially with a limited 
increase in apoptosis and good NO synthesis levels. The upregulation of 
pro-inflammatory molecules can be dampened by the static culture 
conditions, as was shown in the results section. Also, to our best 
knowledge, a comprehensive characterization of endothelial cell 
behaviour on cryogels was missing in the literature; so the current study 
has also set the groundwork on that front. In general, a PVA-based 
composite cryogel surface can be fully endothelialised with functional 
endothelial cells and this process can be controlled by changing the 
shear stress conditions. Moreover, endothelial cells can withstand 
physiological shear stress levels following attachment to the cryogel 
surface. 
3. Freeze-thawing has a good prospect as a potential encapsulation 
method, with suitable modification of the conventional techniques. In 
the current study, an encapsulation and storage method based on 
freeze-thawing regime and PVA/Gelatin composites was developed and 
implemented for several different cell types. Cryogels were able to 
sustain cellular viability and proliferation and have shown comparable 
mechanical properties to the conventional cryogels. 
4.  The developed cryogel model was also able to sustain a co-culture 
system. As required, segregation of the cells in the co-culture system 
(endothelial cells on the surface, while smooth muscle cells within the 
cryogel structure) was achieved and both cell types were shown to be 
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healthy. The initial goal of developing a system that uses PVA 
cryogelation for both scaffold formation and cell cryostorage was 
achieved. The developed system can be practically used for other soft 
tissue applications and this study has developed a research route for the 
future. 
These promising results suggested that, PVA based cryogels can be further 
investigated for their possible applications in biomaterials and tissue engineering 
fields. Following sections contain planned future work for attaining superior 
outcomes. 
6.1 Future Work 
6.1.1 Cryogel formation and Encapsulation via Cryogelation 
This study demonstrated that cryogelation is a versatile system that can be used to 
produce hydrogels with varying mechanical properties and physical properties. The 
ability of these cryogels to promote cell attachment can be achieved by the 
development of composites with biomacromolecules and the changes induced by 
the presence of these biomacromolecules further widens the scope of cryogels that 
can be produced. These composite cryogels with a wide range of properties can be 
produced by using a two step non-toxic physical crosslinking method, which is cost-
friendly and advantageous over chemical methods in the sense that no remnant 
chemicals would be present in the gel.  
Cryogelation is a physical crosslinking process, which depends on the hydrogen 
bond formation and crystallization capabilities of PVA. However, as shown in the 
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results section, PVA needs additives to become suitable as a scaffolding material. 
Thus, a next step in this field of research would be the design of artificial 
polypeptides that contain amino acid sequences which would allow abundant 
hydrogen bonding and crystallization to allow cryogelation and that at the same 
time that contains sequences for cell and growth factor binding which would result 
in a more robust and cell-friendly storage and encapsulation system. Recently, 
custom-made proteins with engineered functions have been tailored and it has 
been shown that a “from scratch” approach is easier for production of functional 
artificial proteins (Koder et al. 2009). This would allow a wider control over the final 
properties of the hydrogel, such as O2  binding for long term O2  supply or controlled 
release triggered upon cell spreading, with minimal dependence on synthetic 
polymers. In the same manner, tethering of cell-adhesive sequences or introduction 
of these sequences into the PVA chains during synthesis would be another route; 
similar to that achieved for biodegradation of modified PEG systems (Bryant et al. 
2004, Burdick, Anseth 2002). 
Another aspect of cryogelation is using catalysis systems that would work at 
subzero temperatures which would result in even more robust gels, while minimally 
compromising cell viability (Kirsebom, Mattiasson & Galaev 2009). Also instead of 
slowly freezing the system, vitrification (solidification or freezing without any crystal 
formation) can be used to ensure higher cellular viability since the thawing was the 
actual gel formation part. Vitrification is known to improve cellular viability after 
storage and it has also been used for storing tissue engineered scaffolds (Wen et al. 
2009). However, the lack of ice crystal formation and high rate of temperature 
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change in both freezing and thawing in vitrification might also affect crystallite 
formation by PVA too, so this system should be tried to see the benefits with 
respect to cell viability and the degree of gel stability. Another possibility would be 
elimination of DMSO from the mixture with more benign but equally effective 
cryoprotectants such as polyampholytes becoming available (Matsumura, Hyon, 
2009). Finally, a mild chemical coagulation bath was shown to be effective in 
improving the stability of the cryogels with encapsulated cells, although it caused 
some morphological problems (for example, clumping of the cells). A biological 
coagulation bath solution (a saturated carbohydrate, protein, lipid solution; that 
would cause a similar polymer precipitation) can be used instead and it might be 
also act as an additional reservoir for nutrients. 
Another possible route for improving encapsulation efficiency is to add 
recombinant morphogens, which are known to affect smooth muscle cell survival 
and proliferation, such as Sonic Hedgehog (Morrow et al. 2009). Another aspect of 
cryogelation is its possible protective capabilities for mesenchymal or embryonic 
stem cells, which are known to be more susceptible to cryodamage or cryodamage-
induced apoptosis, and pores in the gel can help them maintain their clump-like 
structure. Similarly, addition of growth factors, either to the gelation mixture or via 
micro or nanocapsule formulations to improve their protection, could improve 
cryogel behaviour (Coleman, Case & Guldberg 2007). 
6.1.2 Cryogel Endothelialisation and Shear Stress Conditions 
In this study it has been shown that the endothelialisation of a hydrogel surface can 
be facilitated by application of turbulent flow induced shear, or disturbed shear in 
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general, to utilize the activating effect of it as a signal. This aspect has only been 
investigated for pathological conditions, but similar suggestions for the use of non-
physiological stimuli are present in the literature. As an example, it has been 
suggested that the strain and shear stress values should be matched with those of 
the foetal development, since this phase is known for fast remodelling of 
cardiovascular system with low levels of MMP activity (Stock, Vacanti 2001). At 
strains levels of 5%, with a low oxygen tension and a high heart rate, vessel 
development is optimum (Stock, Vacanti 2001).  Alteration of stress and strain 
conditions to trigger large scale cellular response would be beneficial in this sense. 
One possible route would be the application of turbulent flow in the beginning of 
the culture period to facilitate the endothelialisation, then converting back to a 
laminar flow mode to quench the inflammatory response. Thus, in the end a strong 
endothelium which expresses minimum amount of inflammation related proteins 
can be achieved. This can be further improved by surface coating of the cryogels 
with either single components of basement membrane such as laminin or collagen 
type IV or a concoction of them. The basement membrane composition together 
with the effect of shear stress would have a synergistic effect and also can lead to a 
much stronger endothelium which cannot be removed by the shear conditions in-
vivo. In a similar way, utilization of nanofibrous thin layers, such as those produced 
by electrospinning, might provide a more resilient endothelial lining due to the 
more favourable properties of the surface for cell attachment and focal adhesion 
formation (He et al. 2006). Hybrids of smooth muscle cell encapsulated cryogels 
and electrospun composite fibres would be able to match the mechanical 
properties of cryogels with superior endothelialisation of nanofibres. The effect of 
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fibre properties on endothelial cells has been widely studied (Ma et al. 2005, Santos 
et al. 2008) and this route is being investigated in our laboratories.  
The current study established the properties of the endothelial lining formed on 
PVA/Gelatin cryogels. However, blood compatibility is closely related to the blood 
endothelium interactions; thus a necessary step for determination of the non-
thrombogenicity of the system is utilization of full blood for determination of 
platelet activation and adhesion and also leukocyte endothelium interaction. It has 
been suggested that endothelial cells do not need to be in their natural luminal 
location to function as a regulatory unit and perivascular implantation of 
encapsulated endothelial cells in a 3D collagen matrix can perfectly direct non-
thrombogenicity of implanted products while keeping them quiescent (Methe, 
Edelman 2006/12). Our preliminary results showed that endothelial cell 
encapsulation was indeed possible via the method developed in this study and such 
a system would be beneficial as a generic auxiliary, perivascular scaffold for 
developing non-thrombogenicity for other scaffolds; such as bone tissue 
engineering scaffolds as the highly dense endothelial presence in scaffold proximity 
may result in secretion of anti-thrombotic and anti-inflammatory factors. 
Another uncharted route is the application of shear stress to encapsulated smooth 
muscle cells. It has been shown that denudation of endothelium and the presence 
of turbulence is a strong contributor of neo-intimal hyperplasia formation and this 
fact can be exploited to improve ECM formation and proliferation of smooth muscle 
cells (Opitz et al. 2004) 
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The next step in this research field in our laboratories is the utilization of pulsatile 
flow to determine tubular PVA scaffold maturation under co-culture conditions. For 
this end, a CellMax bioreactor system was modified by another research group for 
utilization of 4mm diameter tubular scaffolds (Figure 6.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Tubular PVA/Gelatin scaffolds for bioreactor experiments a)Tubular 
PVA/Gelatin cryogels before coagulation bath treatment b) after coagulation bath 
treatment and sterilization c) PVA Gelatin cryogel within the bioreactor casing; 
system is connected to CellMAX cartridges which provides the oxygenation of the 
circulating medium and a pump whoich is capable of applying 6 different modes of 
pulsatile flow. 
A 
B 
C 
C 
B 
C 
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Tubular scaffolds from PVA/Gelatin cryogels were manufactured and their diameter 
and thickness were controlled by using the coagulation bath treatment. These 
tubes will be used for co-culture under pulsatile flow applications. The important 
analysis would be characterization of ECM secretion under these conditions, since 
one of the biggest problems of vascular tissue engineering is elastin production in-
vitro (Patel et al. 2006, Heydarkhan-Hagvall et al. 2006).
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Appendix A 
Mold Design for Cryogel Formation 
Figure A1. Mold design used in cryogelation experiments, bottom part. 
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Figure A.2 Mold’stop part. 
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Appendix B 
Calibration curves for protein adsorption and Nitric Oxide 
Synthesis 
 
The following graphs are representatives for calibration curves drawn before any 
set of experiments. For Collagen type I negative control readings were done with 
0.2% Acetic acid solution to see its interference.  For both BSA and collagen type I 
the curve was drawn up to 2 mg/ml concentration in order to ensure the reliability 
at the target range of 1 mg/ml. 
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Appendix C 
Alamar Blue Percentage of Reduction determination 
 
The percentage reduction of Alamar Blue after 1 hour incubation was calculated 
using two different formulas, depending on the wavelengths used for absorbance 
measurements. When 570 nm and 600 nm were used, as recommended by the 
manufacturer, following formula was used:  
                                    Equation C.1 
Where extinction coefficients (Es) are as in the table below: 
Table C.1. Extinction coefficients of Alamar Blue in reduced and Oxidized states 
Wavelength (nm) Reduced (R) Oxidized(O) 
570 155677 80586 
600 14652 117216 
Where A570 and  A600  refers to readings from the treatment samples and AN570 
and AN600 refers to negative controls, Alamar blue solution only incubated in the 
same conditions. 
When due to the technical difficulties other wavelengths needed to be used, 
following formulation was used (for 565 nm (Low wavelength, LW) and 592 nm 
(High wavelength, HW)) 
AOLW= Absorbance of Alamar Blue in media (RPMI 1640) - Absorbance of Media 
only 
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AOHW= Absorbance of Alamar Blue in media (RPMI 1640) - Absorbance of Media 
only 
Correction Factor R0= AOLW/ AOHW 
And Percentage reduction is equal to: 
                                                       Equation C.2 
Where  ALW and AHW are readings from the treatment samples(i.e. cells seeded onto 
the hydrogels) ANLW and ANHW are negative control readings( Alamar Blue solution). 
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Appendix D 
List of primers 
 
Table D.1 List and sequence of primers used in the study 
Target Gene Product size Left Primer Right Primer 
ICAM 162 bp AAGAGTGCCTGGCAAAAAGA GAGGTCAGCGCTAATTCTGG  
PECAM 164 bp CTGGAGTCTTCAGCCACACA TATAACCCGCTGTCCCACTC 
 
Selectin P 234 bp GGGCTATCTCTCAGGGAACC GACATGACTGAGCGACGTGT 
GADPH 176 bp GGGTCATCATCTCTGCACCT GGTCATAAGTCCCTCCACGA 
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Appendix E 
ANOVA table for 24 factorial design 
 
After all experimental runs are completed ANOVa was carried out for the design 
space to determine the contribution of each factor and their interactions; to fit the 
overall response in an equation based on equation E.1: 
 
 
Table E.1. Full ANOVA table for the model developed for cell viability for 24 factorial design. 
* denotes statistical significance( p≤0.05) 
Source Sum of  
Squares 
df Mean 
Square 
F-Value p-Value 
Model 157.37 15 10.49 4905.83 < 0.0001* 
A-DMSO 0.17 1   0.17 80.31 < 0.0001* 
B-Serum 0.17 1   0.17 80.84 < 0.0001* 
C-Co.B. 54.52 1 54.52 25494.49 < 0.0001* 
D-PVA 65.30 1 65.30 30534.30 < 0.0001* 
AB   3.306E-004 1   3.306E-004 0.15    0.6994 
AC 0.051 1   0.051 23.70    0.0002* 
AD 0.046 1   0.046 21.66    0.0003* 
BC 0.010 1   0.010 4.75    0.0447* 
BD 0.13 1   0.13 59.76 < 0.0001* 
CD 36.83 1 36.83 17223.70 < 0.0001* 
ABC 0.045 1   0.045 21.22    0.0003* 
ABD   3.627E-003 1   3.627E-003 1.70    0.2113 
ACD  6.706E-004 1   6.706E-004 0.31    0.5833 
BCD 1.803E-003 1   1.803E-003 0.84    0.3722 
ABCD        0.085 1   0.085 39.72 < 0.0001* 
   Pure Error        0.034 16   2.138E-003   
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       Std. Dev.        0.046 R-Squared 0.9998 
                 Mean  3.81  Adj R-Squared 0.9996 3.81 Adj R-Squared 0.9996 
C.V% 1.21 Pred R-Squared 0.9991 
PRESS 0.14 Adeq Precision       173.966 
 
 
 
The Model F-value of 4905.83 implies the model is significant.  There is only 
a 0.01% chance that a "Model F-Value" this large could occur due to noise. 
 
Values of "Prob > F" less than 0.0500 indicate model terms are significant.   
In this case A, B, C, D, AC, AD, BC, BD, CD, ABC, ABCD are significant model terms.   
Values greater than 0.1000 indicate the model terms are not significant.If there are 
many insignificant model terms (not counting those required to support hierarchy), 
their removal may improve your model. 
 
The "Pred R-Squared" of 0.9991 is in reasonable agreement with the "Adj R-
Squared" of 0.9996. 
 
"Adeq Precision" measures the signal to noise ratio.  A ratio greater than 4 is 
desirable. Ratio of 173.966 indicates an adequate signal.  This model can be used to 
navigate the design space. 
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Appendix F 
Statistical Analysis 
The following examples cover how the statistical analysis were made and elaborate 
some cases where gving the statistical analysis within the main text was not feasible. 
Collagen  adsorption 
The p value obtained (0.004) was low enough to claim that there is a significant 
difference between the test groups; and with Tukey’s pairwise multiple comparison 
method; it can be shown that PVA/Gelatin surface adsorbed significantly higher 
amounts of collagen compared to PVA/Chitosan and PVA/Starch cryogel surfaces. 
Table F.1. Tukey’s test results for Collagen adsorption experimentsq value changes with the 
number of the samples and when it is significant it is denoted with a “Yes” remark. 
Comparison Difference    of 
Ranks 
q value p≤0.05 
Gel vs. Chi 101.000 4.242 Yes 
Gel vs  Sta 94.000       3.948 Yes 
Chi vs Sta 7.000 0.294 No 
 
Smooth Muscle Cell Proliferation with respect to Freeze/Thaw Cycle number and 
Collagen Coating 
The p value obtained (0.005) was low enough to claim that there is a significant 
difference between the test groups; and with Tukey’s pairwise multiple comparison 
method; it can be shown that there was a significant difference between 3rd and 1st  
cycles; both when collagen coating was used (q= 4.51) or not used (q=3.88) 
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Endothelial Cell Proliferation on Cryogels with Different Additives Day 10 and Day 15 
For day 10 the p value was slightly higher than the significance level set for this study 
(p= 0.08 where significance level was set as p≤ 0.05), however by day 15, p=0.011 and 
there is a statistically significant difference between PVA/Gelatin vs. PVA/Chitosan and 
PVA/Starch (q=3.00 and 3.58, respectively) 
When required, 2 or 3 way ANOVA tests were carried out such as in the case of change 
in water content with respect to, additive, coagulation bath treatment and cycle 
number. Afterwards, the pairwise comparison tests were done with Holm-Sidak 
method. 
Table F.2 Three-way ANOVA analysis of water content of cryogels 
Variation Source DF SS MS F p 
Additive 3 1.431 0.477 20.059 <0.001 
CB treatment 1 3.322 3.322 139.730 <0.001 
Cycle 1 2.992 2.992 125.846 <0.001 
Additive x CB 
treatment 
3 0.193 0.0642 2.702 0.051 
Additive x Cycle 3 0.620 0.207 8.690 <0.001 
CB treatment x 
Cycle 
1 0.183 0.183 7.691 0.007 
Additive x CB 
treatment x Cycle 
3 0.214 0.0714 3.002 0.035 
Residual 80 1.902 0.0238   
Total 95 11.057 0.116   
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